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The type I interferon (IFN) system is a potent anti-viral innate immune response. It is
primed by IFN-p and IFN-0C4, which are the immediately expressed IFNs following
detection of virus infection. IFN-P establishes the anti-viral immune response within
the infected cell, augments further IFN production through the induced expression of
IRF-7, a transcription factor for other IFN-as, and promotes the adaptive immune
response. Induction of IFN-P requires the activation of multiple transcription factors,
including NF-kB; some of these are maintained in an inactive state within the
cytoplasm of the resting cell. PKR is an IFN-induced, dsRNA-activated kinase
capable of phosphorylating and activating the IkK, which ultimately releases NF-kB
enabling its nuclear translocation. Within the nucleus NF-kB associates with IRF-3
and AP-1 on the IFN-P promoter to induce IFN-P expression. Delineation of the
pathways that result in IFN-P expression has revealed viral proteins which target
components of these signalling networks. To date no anti-IFN mechanisms have been
observed for Semliki Forest virus (SFV), an alphavirus of the Togaviridae. The SFV
genome is 11 kb in length and encodes two open reading frames; the non-structural
proteins (nsP 1-4), which encode the replicase complex and the structural proteins.
Studies with Sindbis virus, a closely related alphavirus have suggested that nsP2 may
play a role in IFN suppression. Previous studies with SFV nsP2 observed that 50 %
of nsP2 was translocated to the nucleus. When nsP2 nuclear translocation is
prevented, the infection has reduced neuropathology.
This thesis explores the importance of IFN in SFV encephalitis. A quantitative PCR
assay for IFN-P and IFN-a transcripts and a quantitative IFN bioassay were
developed to determine differences in IFN expression under different infection
conditions. Mouse models and primary cell lines were used to establish the
importance of PKR for IFN-P expression during SFV infection and to determine
whether SFV nsP2 has a role in modulating IFN responses. In the absence of PKR, at
early times post-infection, cultured cells reproducibly produced significantly lower
levels of IFN-P transcripts. Reduced levels of functional IFN were also demonstrated
xii
by bioassay. Previous data has shown that PKR is not required for IFN-P induction.
The sensitivity of the qPCR assay has allowed the demonstration that PKR, although
not critical for IFN induction, is involved in IFN-P induction and is particularly
important at early time points post-infection.
SFV-nsP2 has been postulated to be involved in IFN interference. Comparing SFV4
to SFV4-nsP2-RDR (a mutant virus with a single amino acid change within the
nuclear localisation signal of nsP2, which prevents its translocation into the nucleus)
demonstrated that relative to the number of infected cells, the SFV4nsP2-RDR mutant
induced over ten-fold more IFN-P transcripts than the wildtype SFV4 strain; this
upregulation was specific to IFN-p. The IFN bioassay results supported this data;
SFV4-nsP2-RDR induced higher functional IFN levels in comparison to wt SFV4.
Both viruses grew to similar titres and at similar rates. In the mutant and wt
infections both NF-kB and IRF-3 translocated into the nucleus; however, preliminary
EMSA data has suggested that the amount ofNF-kB bound to the IFN-P promoter is
reduced during a wt infection. This suggests a possible mechanism for the differential
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This thesis focuses on the interaction of Semliki Forest virus (SFV) with the
interferon (IFN) response. The aim of this chapter is to review the IFN response and
the plethora of IFN evasion mechanisms currently described for viruses. Further
evidence is provided to support the complexity of pathogen-host interactions by
reviewing another cytokine, tumour necrosis factor (TNF) and several virus TNF
evasion mechanisms. Despite the wealth of information available on virus
interactions with the IFN response, little is known about this with regard to
alphaviruses, which are in many other ways amongst the most studied of viruses. The
second section of this chapter reviews the virulence and pathogenicity of SFV; an
alphavirus used as a model to study virus encephalitis. Determining alphavirus
interactions with the IFN system is important, it adds to knowledge on this important
model system and since many alphaviruses can cause encephalitis, in the absence of
vaccines, IFN has been proposed as a potential therapy.
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Introduction
The anti-viral immune response
Innate Immunity
Immunity is critical for host survival against infection; the vertebrate immune system
has evolved two major systems to combat disease. These are classified as the innate
and adaptive immune responses. The innate immune response is the primary non¬
specific response to an invading pathogen. Host cell receptors encoded within the
germline detect pathogen associated molecular patterns. With respect to RNA virus
infections, a replication intermediate, dsRNA, is detected by several receptors
including Toll like receptor - 3 (TLR-3), retinoic acid inducible gene -I (RIG-I),
melanoma differentiation associated factor 5 (mda-5) and PKR (Matsumoto et ah,
2002; Yoneyama et al., 2004; Andrejeva et ah, 2004; Clemens et ah, 1993). These
induce the IFN response, a component of innate immunity. Other components of
innate immunity are also involved in anti-viral immune responses and include natural
killer (NK) cells, complement, phagocytes, chemokines and various cytokines
including interferon (IFN). NK cells induce death of virally infected cells through
non-specific receptor interactions; for example, poor expression ofMHC I molecules
acts as a positive signal for NK cell induced cell death (this is important as many
viruses downregulate expression ofMHC I molecules to avoid detection by cytotoxic
T cells, Plougastel et ah, 2006). Complement and phagocytes play a role in anti-viral
immunity alongside antibodies and IFNs induce the expression of thousands of genes




In addition to direct anti-pathogen effects the innate immune response induces and
skews the adaptive immune response. Antigen-presenting cells (APCs), dendritic
cells (DCs) and macrophages express pathogen epitopes on major histocompatibility
complex II (MHC II) molecules which are presented to CD4+ T helper cells (Th).
Further stimulation of T cells by APCs is required for complete activation of T cells.
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Co-stimulation can be in the form of additional adhesion molecule interactions and/or
cytokine signalling. Specific cytokine dominance surrounding maturing CD4+ Th
cells can influence the type of Th cell response. Initially activated T cells, To cells,
release interleukin (IL) - 2, IL - 4 and IFN-y. IFN-y inhibits the proliferation of Th 2
cells. Th2 cells favour B cell activation and antibody production. On the other hand
IL - 10, a Th 2 cell cytokine, inhibits IFN-y and IL-2 secretion and so inhibits Th 1
responses. The Thl response promotes CD8+ cytotoxic T cell activation and hence is
a key component in anti-viral immunity. Th 1 cells secrete IFN-y, IL-2 and TNF-P;
these contribute to both macrophage and T cell activation. CD8+ T cells detect
antigen presented on MHC I molecules. MHC I molecules are expressed on the
surface of all nucleated cells with the exception of neurones where expression can be
induced by IFN-y (Rottenberg and Kristensson, 2002). This subclass of T cells
requires a stronger co-stimulation signal than the Th cells. DCs are the only cells
capable of activating CD8+ T cells alone, all other APCs must be associated with a
Th 1 cell so that a secondary signal (IL - 2) can be sent from the Th 1 cell to activate
the CD8+ T cell. The active CD8+ T cell then traverses the body until it comes into
contact with a cell expressing peptide bound MHC I molecules, where the peptide is
specific for the activated T cell, upon which it secretes mediators (perforin and
granzymes) of target cell death.
B cell responses
Antibodies function primarily against extracellular pathogens. Extracellular virions
can be neutralised and opsonised by specific antibodies. In addition, enveloped
viruses express viral antigens on the surface of the plasma membrane of the cells they
infect and these can be targeted by antibodies for complement mediated destruction.
Th 1 cells secrete IL - 3 which induces B cell class switching. B cells primarily
secrete immunoglobulin (Ig) M. Upon IL - 3 exposure the antibody secreted is
changed to IgGi or IgG3. Antibody binds and neutralises the virus by preventing host
cell interactions and hence infection. Ig mediated uptake of virus by phagocytes via
Fc receptor interactions or via complement receptors is referred to as opsonisation.
Antibody activation of complement on the cell surface ultimately results in
perforating the lipid envelope inducing death by osmotic dysregulation.
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The Role of IFNs in Innate Immunity
The anti-viral immune response is initially dominated by IFNs; these are the first
cytokines secreted in response to cellular infection with virus. They act in an
autocrine and paracrine manner by inducing expression of anti-viral proteins within
the infected cell and by inducing an anti-viral state within neighbouring non-infected
cells. Isaacs and Lindenmann (1957) first discovered the anti-viral activity of IFNs,
since then several other roles for IFN have been elucidated, including control of cell
proliferation and modulation of the immune response (Tanaka et ah, 1998; Biron et
al., 1999). IFNs, which are only found in vertebrates (Oritani and Kanakura, 2005),
are sub-divided into type I IFNs, consisting of the IFN-as, IFN-p, IFN-co, -x, -k, -8
and -s; type II IFNs, IFN-y the immune IFN and a novel subgroup of IFNs partially
related to IFN-a, IFN-?i.
Type I IFNs
Type I IFNs all converge upon the IFN-a/p receptor (IFNAR), which is expressed on
the plasma membrane of all cells examined, to induce signalling and gene expression
(Brierley and Fish, 2002). IFN-a is encoded on human chromosome 9; 14 genes
encode the different IFN-a subtypes although only 13 functional proteins are
expressed as ifnal3 encodes the same protein as ifnal (Oritani and Kanakura, 2005;
Bekisz et al., 2004; Foster and Finter, 1998). The mature IFN-a proteins share
between 75 % and 99 % homology (Bekisz et al., 2004). IFN-p and IFN-oo are also
encoded on human chromosome 9, but share less homology with IFN-a, 30 % and 75
%, respectively (Bekisz et al., 2004) and are only encoded by a single gene locus
(Roberts et al., 1998). IFN-a is predominantly associated with leukocytes;
plasmacytoid dendritic cells produce approximately 10 times greater amounts of IFN-
a than other blood cells (Siegal et al., 1999). IFN-P is historically the fibroblast IFN,
but can be produced by most cells. Of the more recently discovered IFNs, IFN-x, -8
and are not expressed in humans. IFN- x is a 172 amino acid polypeptide and is
only expressed by ruminant ungulate species during pregnancy; the trophoblast
secretes IFN- x to facilitate implantation (Martal et al., 1998). Despite its absence in
humans, this IFN still functions on human cells (Martal et al., 1998). IFN-8 is a 149
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amino acid glycopeptide only expressed in porcine trophoblasts. Unlike IFN- x, IFN-
5 is species specific and does not function on human cells (Lefevre et al., 1998).
IFN-£, otherwise known as limitin, has homology to IFN-a, -{3 and -co and is only
expressed in mice. However, in contrast to other IFNs it does not influence
proliferation of myeloid or erythroid progenitors (Kawamoto et al., 2003).
To date two other human type I IFNs have been discovered, IFN-k and IFN-s. IFN-k
is expressed in human keratinocytes (LaFleur et al., 2001) and IFN-s is thought to
have a reproductive function in placental mammals (Bekisz et al., 2004).
Another type of IFN, the IFN-k family, possesses anti-viral activities and shares
homology with IFN-a. However, IFN- k interacts with an alternative receptor, a class
II receptor composed of IFN k receptor 1 and IL - 10 receptor 2 which may define
this as a new class of IFNs. Despite associating with a different cellular receptor,
IFN-k induces the same signalling components (ISGF3) as the IFNAR (Kotenko et
al., 2003). IFN- k (1 - 3) are also termed IL - 28A, IL - 28B and IL - 29 (Bekisz et








Human IFNAR Induction of
antiviral state
IFN-co Human IFNAR Induction of
antiviral state





















IFN-k Keratinocytes Human Unknown
Table 1A: Different subtypes of type I IFN
All of the currently known type I IFN subtypes are listed. The table indicates the cells and




The second class of IFNs, IFN-y is produced by NK cells, CD4 Thl cells and CD8
cytotoxic suppressor cells. It is not induced directly by virus infection, but by
mitogens or antigens presented on MHC class I and II molecules (Samuel, 2001).
IFN- y has only a single gene locus and unlike the type I IFNs, IFN-y mRNA contains
both exons and introns (Rottenberg and Kristensson, 2002). IFN-y, once expressed
associates with the IFN- y receptor (IFNGR). This receptor is composed of two
subunits IFNGR 1 and IFNGR 2, which form a heterotetramer. IFNGR 1 is
ubiquitously expressed, although CNS expression of the IFNGR is restricted to
specific locations within the brain, the olfactory bulb, piriform and entorhinal cortex,
midline thalamus and the medial hypothalamic structures (Rottenberg and
Kristensson, 2002; Robertson et al., 2000). Expression of the IFNGR 2 subunit is
regulated by specific cytokines. Ligand attachment to the IFNGR activates signalling
cascades which induce the expression of a two wave response. Bound IFNGR
activates Jak 1 and Jak 2, receptor associated tyrosine kinases, to phosphorylate signal
transducer and activator of transcription (STAT) -1, resulting in STAT 1 dimerisation
and nuclear translocation. Within the nucleus the STAT 1 homodimer associates with
IFN- y activated sequences (GAS). These sequences are present within the promoters
of specific genes and induce their transcription. Two such genes are the transcription
factors IRF-1 and class II transactivator (CIITA). These mediate the second wave of
signalling and induce the expression ofMHC I and II molecules, upregulate the IP-10
chemokine and activate a plethora of anti-viral mechanisms although with reduced
kinetics in comparison to the type I IFNs (Bach et al., 1997; Farrar and Schreiber,
1993). The pathway described above is the most researched signalling pathway of
the IFNGR; however, other signalling pathways exist, including the mitogen activated
protein kinase pathway (Sakatsume et al., 1998). Many of the components of the
IFN- y induced anti-viral response are also induced by the type I IFNs and are
described further in the following sections; these include Mx A, RNase L, PKR and 2'
- 5' OAS (Arnheiter and Haller, 1983; Castelli et al., 1997; Clemens and Elia, 1997).
In addition to these proteins, IFN- y induces the expression of nitric oxide synthase
(NOS) in macrophages (Marietta, 1993a; 1993b; Chesler and Reiss, 2002). NOS
produces nitric oxide (NO) by converting L-arginine into L-citrulline (Marietta,
1994). NO and its reactive products are effective anti-viral molecules, NO
8
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nitrosylates viral proteins specifically cysteine and tyrosine residues resulting in
structural misfolding of the protein and functional impairment (Colasanti et al., 1999).
The roles of type I IFN
Type I IFN is composed of 12 functional IFN-a proteins, IFN-p and IFN-co all of
which converge onto the same IFNAR. This raises the question as to why there are so
many subtypes. There are several possible explanations:
1) Different subtypes of IFNs induce differential gene expression.
2) Different IFNs are induced by different pathogens.
3) Different IFNs are expressed at different times during an infection.
It is possible that different IFNs induce a different array of gene expression as
differential requirements by type I IFNs for downstream signalling components have
been observed. All type I IFNs require the Janus N-terminal kinase (JNK), Tyk-2, a
component of the Jak/STAT signalling pathway; however, IFN-p can induce
signalling in the absence of Tyk-2 (Pellegrini and Schindler, 1993). In fact, IFN-P
can induce the expression of additional genes not induced by other IFNs, for example
the hypoxia-inducible factor 1 gene (Rani et al., 1996).
Different IFNs are induced by different pathogens. IFN expression is promoted by
transcription factors, IFN regulatory factors (IRFs). Different IRFs induce different
subsets of IFN. The fact that different IFNs are induced by different regulatory
factors suggests that different IRFs may be activated by different pathogens. For
example, IRF-5 stimulates synthesis of a specific set of IFN-as, distinct from those
targeted by IRF-7 and is only activated by certain viruses e.g. Newcastle disease virus
(NDV) (Barnes et al., 2001).
Different IFNs are expressed at different times during an infection. In response to a
viral infection host cells initially produce IFN-P and IFN-a4. These IFNs induce
expression of IRF-7, which induces the expression of other IFN-a genes (Marie et al.,
1998). IRF-7 is only activated if virus is still detected within the cell. This enables
the cell to control the expansion of IFN expression and primes cells adjacent to





A variety of different cellular receptors, including TLRs, PKR, RIG-I and mda-5,
enable the cell to detect virus at multiple stages of infection (Yoneyama et al., 2004;
Clemens et al., 1993; Andrejeva et al., 2004). Pathogen bound receptors activate
signalling cascades, which ultimately activate NF-kB, IRF-3 and AP-1, the
transcription factors required for IFN-P gene expression.
The Toll-like receptors
Toll was first discovered in drosophila in association with embryogenesis (reviewed
in Takeda et al., 2005). However, adult drosophila lacking Toll mutants were
observed to be more susceptible to fungal infections than wild type adults. It was
determined that the cell surface expressed Toll interacted with 'spaetzle' and that this
interaction induced the production of an antifungal protein drosomycin (Brennan and
Anderson, 2004). The sequence homology ofToll with the intracellular component of
the IL-1R led to the discovery of 11 mammalian Toll-like receptors (TLR), each of
which detects particular pathogen associated molecular patterns (PAMPs). For
example, TLR-2 binds bacterial lipopeptides (Hirschfeld et al., 2000); TLR-3 binds
dsRNA (Matsumoto et al., 2002); TLR-4 associates with lipopolysaccharide (LPS)
(Poltorak et al., 1998), TLR-5 interacts with bacterial flagellin (Mizel and Snipes,
2002), TLR-7 detects ssRNA (Heil et al., 2004) and TLR-9 detects unmethylated CpG
motifs expressed on DNA viruses (Lund et ah, 2003). TLR-3, -7 and -9 are localised
to endosomal compartments and are well placed to monitor neighbouring infected or
dead cells (Honda et al., 2005). Other TLRs are cell surface expressed and have
greater association with bacterial, fungal and parasitic infections. In addition to their
role in anti-bacterial immune responses, TLR-2 and TLR-4 can also detect virus. For
example, TLR-2 binds the haemagglutinin protein of measles virus (Bieback et al.,
2002) and TLR-4 binds the fusion protein of respiratory syncitial virus (RSV) (Kurt-
Jones et al., 2000). This suggests that TLRs are less specific than first thought as
multiple pathogens can interact with and activate the same receptor.
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TLR activation of transcription factors required for IFN-p expression
All of the TLRs, with the exception of TLR-3 signal through myeloid differentiation
factor 88 (MyD88) to activate NF-kB (Medzhitov et ah, 1998). TLR-3 associates
with TNFR-associated IFN-P inducing protein (TRIF) to activate NF-kB and IRF-3
(Yamamoto et ah, 2003), see figures 1A and IB .
MyD88 dependent NF-kB activation (Figure 1A)
Ligand bound TLRs recruit MyD88 directly (Medzhitov et ah, 1998) or interact with
MyD88 through MyD88 adaptor-like protein (Mai) e.g. TLR-2 and TLR-4 (Mansell
et ah, 2004; Fitzgerald et ah, 2001). MyD88 associates with IL-1R associated kinase
family members (IRAK) 1 - 4 (Martin and Wesche, 2002); interactions between
IRAK-1 and MyD88 induce hyperphosphorylation of IRAK-1 (Li et ah, 2002). The
hyperphosphorylated form of IRAK-1 is released and associates with a ubiquitin
kinase (Deng et ah, 2000), TNFR associated protein 6 (TRAF6) (Burns et ah, 2000).
TRAF6 activates the transforming growth factor P activating kinase - 1 (TAK-1)
(Ninomija-Tsuji et ah, 1999), which phosphorylates the downstream kinases IKKa
and IKKp (Yi and Krieg, 1998). NF-kB is held within the cytoplasm by the
inhibitory kB complex (IkB). Phosphorylation of the IkBcc subunit targets the
subunit for ubiquitin-dependent, 26 S proteosome-mediated degradation releasing
active NF-kB dimers for nuclear entry (Figure 1A) (Li et ah, 1995; Scherer et ah,
1995).
TRIF dependent NF-kB activation (Figure 1A)
TLR-3 directly associates with and activates TRIF to induce IFN-P gene expression;
TLR-4 can also induce IFN expression, although at a reduced rate (Doyle et ah, 2003)
by indirect activation of TRIF through the TRIF related adaptor molecule (TRAM)
(Oshiumi et ah, 2003). For TLR-3 activation ofNF-kB, a protein complex including
TRAF-6, TBK-1 and a poly-ubiquitinated form of RIP-1 are recruited to TLR-3
(Figure 1 A) (Cusson-Hermance et ah, 2005). The necessity of TRAF6 has been
questioned and could be cell type dependent (Sato et ah, 2003; Gohda et ah, 2004;
Meylan et ah, 2004). This complex ultimately activates IKKa and IKKP, which
phosphorylate IkB to release NF-kB as described before.
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MyD88 dependent IRF activation
Plasmacytoid dendritic cells (pDCs) detect virus through TLR-7 and TLR-9 (Heil et
ah, 2004; Lund et ah, 2003), which signal through MyD88. pDCs are capable of
inducing massive amounts of IFN-a. It is thought that MyD88 interacts with the high
pDC basal levels of IRF-7, IRAK-4 and TRAF-6 (Izaguirre et ah, 2003; Uematsu et
ah, 2005; Honda et ah, 2004). These interactions result in IRF-7 activation through
the ubiquitin ligase activity of TRAF-6 (Honda et ah, 2004) and induce high IFN-a
expression. In addition, IRF-5 was recently associated with TLR-7 induction of IFN
gene expression in pDCs (Schoenemeyer et ah, 2005).
TRIF dependent IRF-3 activation (Figure 1B)
TRIF activates TRAF-family member associated NF-kB activator kinase (TANK) -
binding kinase - 1 (TBK-1) and IKKs, either of which can induce IRF-3
phosphorylation and activation (Fitzgerald et ah, 2003; Sharma et ah, 2003). TRIF
interactions with TBK-1 and IKKs are facilitated by TANK family protein NAK-
associated protein 1 (NAP1) (Figure 1B) (Sasai et ah, 2005). TBK-1 is thought to be
the predominant kinase, as it is constitutively expressed in many cell types whereas
IKKs has a restricted expression (Perry et ah, 2004). Mice or primary cell cultures
lacking TBK-1 are severely impaired in their ability to induce IFN and IFN stimulated
gene expression or activate IRF-3, whereas IKKs"" cell lines express normal IRF-3
activation in response to dsRNA or LPS (McWhirter et ah, 2004; Hemmi et ah, 2004).
Complete IRF-3 activation also requires the phosphatidylinosital 3 - OH kinase
(PI3K). Ligand bound TLR-3 recruits PI3K, which activates the downstream kinase
Akt, which further phosphorylates IRF-3. Akt phosphorylation of IRF-3 promotes c-
AMP response element binding protein (CREB) - binding protein (CBP) co-activator
interactions (Figure IB, Sarkar et ah, 2004).
IRF-3 encodes nuclear import and export signals, which enable it to move freely
between the nucleus and cytoplasm. Phosphorylation of the IRF-3 C-terminus
prevents nuclear export and enables dimerization and activation (Nguyen et ah, 1997;
Taniguchi et ah, 2001). Upon activation IRF-3 recruits p300 and CBP (Suhara et ah,
2002). Both of these possess an intrinsic histone acetyltransferase activity, which
ultimately makes the promoter site more accessible to transcription factors.
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Figure 1A: Induction of NF-kB
Virus infection can be sensed at multiple levels; by both plasma membrane receptors and
intracellular cytoplasmic receptors (red). Receptors are associated with adaptor proteins
(pink), which link the receptors to downstream signalling complexes (orange). Some
receptors require additional proteins (yellow), which enable them to associate with the
adaptor protein. MyD88 signalling requires additional proteins, 1RAK-1 and 1RAK-4
(purple). All of the signalling complexes converge on the inhibitory kappa kinase (IKK,
green); this kinase phosphorylates IkB (grey) targeting it for poly-ubquitination and
proteosome degradation. Free NF-kB (blue) can then enter the nucleus where it associates












Figure 1B: Induction of IRF-3
Virus infection can be sensed at multiple levels by both plasma membrane receptors and
intracellular cytoplasmic receptors (red). Receptors are associated with adaptor proteins
(pink), which link the receptors to downstream signalling complexes (orange). Some
pathways do not show downstream signalling complexes as these have yet to be elucidated.
TLR-4 requires an additional protein (yellow), which enables it to associate with TR1F. In
addition to TRIF induction of IRF-3, TLR-3 recruits PI3K, which activates the downstream
kinase Akt (pale blue). These kinases are required for complete phosphorylation of IRF-3.
All of the signalling pathways converge on TANK-binding kinase 1 (TBK-1) or Inhibitory
kappa kinase e (IKKe) (green); these kinases phosphorylate IRF-3 (blue). Phosphorylation of
IRF-3 results in homodimer formation and activation; active IRF-3 enters the nucleus to
associate with promoters containing specific domains e.g. IFN-P promoter.
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Cytoplasmic-localised receptor activation of transcription factors
required for IFN-P gene expression
PKR, RIG-I and mda-5 proteins are dsRNA receptors localised to the cytoplasm and
are ideally situated to ascertain virus infection within the cell (Clemens et ah, 1993;
Andrejeva et ah, 2004). All three receptors activate NF-kB. RIG-I and mda-5 can
also activate IRF-3. Activation of both NF-kB and IRF-3 is required for IFN-P gene
expression.
PKR is an IFN-induced dsRNA activated serine/threonine kinase (Clemens et ah,
1993). dsRNA associates with the PKR dsRNA binding motifs (dsRBM) located in
the N-terminal region. This association induces a conformational change resulting in
PKR autophosphorylation and activation. Binding to dsRNA also facilitates
homodimer formation. PKR activation ofNF-kB is associated with PKR:IKKp
interactions, through a mechanism independent of PKR kinase activities. There is
much evidence showing the importance of PKR in NF-kB activation; dominant
negative forms ofPKR, 2-aminopurine (a PKR inhibitor) and PKR deletions, all
prevent NF-kB activation following IRF-1, TNF-a, IFN-y and dsRNA treatment
(Kirchhoff et ah, 1999; Cheshire et ah, 1999; Deb et ah, 2001; Kumar et ah, 1997).
RIG-I (retinoic acid inducible gene I) and mda-5 (melanoma differentiation associated
gene 5) are members of the 'helicard' family, which possess an RNA-binding helicase
domain and 2 caspase recruitment domains (CARDs) (Yoneyama et ah, 2004). The
importance ofRIG-I for IFN expression was demonstrated by Kato et ah, (2005);
RIG-I7" cells infected with vesicular stomatitis virus (VSV) have severely impaired
IFN-P responses compared to wt cells. To induce IFN-p gene expression, dsRNA
interacts with the helicase domain causing a signalling cascade to be induced by the
CARD domain. RIG-I recruits IFN-P promoter stimulator protein (IPS) -1 (Kawai et
ah, 2005), which associates with Fas-associated death domain (FADD) and RIP-1
activating IKKa/p and ultimately NF-kB (Figure 1 A) (Kawai et ah, 2005). RIG-I
also activates IRF-3 via TBK-1 or IKKs (Figure IB). IPS-1 is localised to the outer
membrane of the mitochondria (Seth et ah, 2005); the importance of this localisation
is demonstrated by HCV NS3-4a protease, which cleaves IPS-1 disrupting RIG-I
signalling. The position of the NS3-4a cleavage site causes IPS-1 to detach from the
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mitochondrial membrane resulting in its dysfunction (Foy et al., 2005; Meylan et al.,
2005).
Activation of ATF-2/c-Jun
Several other transcription factors are required to complete the IFN-P enhanceosome,
ATF-2 and c-Jun (Thanos and Maniatis, 1995). These transcription factors are also
activated in response to dsRNA; dsRNA induces the stress activated mitogen
activated kinase (MAP) pathway (Servant et al., 2002; Chu et al., 1999; Iordanov et
al., 2000). This consists of p38 MAPKs and c-jun N-terminal kinases (JNK); MEK 3
and 6 are the upstream kinases of p38 MAPKs and MEK 4 and 7 are the upstream
kinases of JNK. P38 MAPK and JNK then phosphorylate and activate latent
cytoplasmic ATF-2 and c-jun respectively. These transcription factors associate to
form the heterodimer AP-1, which translocates into the nucleus and associates with
the IFN-P promoter.
IFN-p Enhanceosome
IFN-P expression requires multiple transcription factors, NF-kB, IRF-3, ATF-2 and c-
Jun, to associate with specific positive regulatory domains (PRD) of the IFN-p
promoter (Figure 1C). The promoter region is located between 105 and 55 bp
upstream of the transcriptional start site. Figure 1C indicates the layout of the PRDs
within the promoter. The NF-kB p50 and p65 heterodimer binds to PRD II; the ATF-2
and c-Jun heterodimer associates with PRD IV, and PRD III and PRD I bind to
interferon regulatory factors (IRF), -3 and -7 (Maniatis et al., 1998; Berkowitz et al.,
2002; Panne et al., 2004). NF-kB transcription factors are part of the Rel family; five
distinct subunits have been isolated from mammals, NF-kB 1 (p50/pl05), NF-kB2
(p52/pl00), p65 (Rel A), Rel B and c-Rel (Chen et al., 1999). A highly conserved
region is found within all of these transcription factors termed the Rel homology
domain (RHD); this has been implicated in DNA binding, subunit dimerization and
interactions with the IkB proteins (Baldwin Jr, 1996). ATF-2 and c-Jun are basic
region leucine zipper proteins (bZIP); which include a DNA binding region and a
dimerization domain (Ellenberger et al., 1992). The IRF family encodes 10
mammalian IRFs (Nguyen et al., 1997; Taniguchi et al., 2001). Each contains a
conserved DNA binding domain within the N-terminus, which recognises the IFN
16
Introduction
stimulated response element (ISRE, 5' - AANNGAAA - 3'). A further two
architectural proteins are required to complete the formation of the enhanceosome to
enable IFN-P expression, the high mobility group I (Y) proteins (HMG I (Y)). These
are situated, one on each ofPRD II and PRD IV in association with NF-kB and ATF-
2/c-Jun respectively (Yie et al., 1999).
Figure 1C: The IFN-p Enhanceosome
(Taken from Falvo et al., 2000)
The NF-kB subunits, p50 and p65, bind to PRDII in association with HMG1(Y) molecules;
the IRFs either IRF-3 or 1RF-7 interact with PRDI1I and PRDI and the components ofAP-l
(c-jun and ATF-2) are located at PRDIV with HMG1(Y) molecules on the IFN-P promoter.
Together these transcription factors represent the IFN-P enhanceosome.
The role of IRFs
IRFs, including IRF-3, IRF-5, IRF-7 and IRF-9, induce IFN and ISGs; they contain a
DNA binding domain at the N-terminus and an IRF-association domain at the C-
terminus to enable dimerisation (Lohoff and Mak, 2005). In addition to IFN-P and
IFN-0C4 expression (Schafer et al., 1998), IRF-3 is implicated in direct activation of
RANTES specifically after paramyxovirus infection (Lin et al., 1999), and induction
of IL-15 and ISG56 (Grandvaux et al., 2002). IRF-7 is induced following IFN-P
expression and augments the IFN-a response (Marie et al., 1998). TLR-3, -4, -5, -7
and -9 can activate IRF-5, which is constitutively expressed in B cells and DCs. It
induces pro-inflammatory genes and several ISGs (Takaoka et al., 2005; reviewed in
Moynagh, 2005). Interestingly, IRF-5 activation is virus specific; NDV, VSV and
HSV-1 infections all activate IRF-5-dependent gene expression whereas Sendai virus
does not (Barnes et al., 2001; 2004). IRF-9 is a component of the IFN stimulated
gene factor 3 (ISGF3), a complex induced following activation of the type IIFNAR,
which promotes the expression of genes containing ISREs within their promoters.
Of the other IRFs, IRF-1 plays a key role in type II IFN induced gene expression.
IRF-1 was the original IRF to be described; it is constitutively expressed at low levels
in most cell types (Lohoff and Mak, 2005). IFN-y expressed by NK cells activates the
IFN- y receptor on APCs and induces IRF-1 in a STAT-1 dependent signalling
I PBW I WOlil-l I W>i 1
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cascade (Elser et al., 2002; Coccia et al., 2000). IRF-1 promotes the expression of IL-
12p35 and IL-12p40 subunits, which induce IFN- y expression and plays a key role in
skewing the T helper cell response to a Thl response (Galon et al., 1999; Elser et al.,
2002; Lohoff et al., 1997). Within T helper cells, IRF-1 associates with three separate
binding sites of the IL-4 promoter to repress its expression; IL-4 is essential for
driving the Th2 response (Elser et al., 2002). IRF-1 also induces iNOS expression,
upregulates the IE-12P2 receptor subunit and induces caspase-1 expression to cleave
preIL-18 into IL-18, another cytokine that stimulates IFN- y production (Kamijo et
al., 1994; Fantuzzi et al., 2001). IRF-4 function appears to antagonise IRF-1 function
and its expression is restricted to lymphocytes and macrophages (Eisbenbeis et al.,
1995). IRF-4 promotes Th 2 cell responses; Irf4_/" T cells are impaired in their ability
to differentiate into Th 2 cells and IRF-4 binds to the IF-4 promoter to induce
transcription (Fohoff et al, 2002; Hu et al., 2002).
IFN signalling
Primary IFN expression, IFN-P and IFN-0C4, signals through the type I IFN receptor,
IFNAR on the infected cell as well as on uninfected cells in the vicinity of the
infected cell, priming their anti-viral state. The importance of the IFNAR is
demonstrated in many mouse experiments; mice encoding IFNAR mutants are more
susceptible to lethal viral infections (Muller et al., 1994; Van den Broek et al., 1995;
Hwang et al., 1995; Garcia-Sastre et al., 1998; Grieder and Vogel, 1999; Knipe et al,
2001). The IFNAR is composed of two subunits IFNAR1 and IFNAR2 (reviewed in
Mogensen et al., 1999). The intracellular components of the subunits are attached to
tyrosine kinases. IFNAR1 is associated with Tyk2 and IFNAR2 is associated with
Jakl (Colamonici et al., 1994; Novick et al., 1994). IFN attachment to the receptor
induces conformational changes resulting in dimerisation of the receptor subunits; this
causes autophosphorylation and activation of the associated tyrosine kinases (Novick
et al., 1994). Tyk2 is responsible for the phosphorylation of the IFNAR subunits,
creating new docking sites for the STATs (reviewed in Goodbourn et al., 2000).
STAT-2 is initially associated with IFNAR2. Following Tyk2 phosphorylation of the
IFNAR, STAT-2 docks with IFNAR1 and recruits STAT-1 (reviewed in Samuel,
2001). STAT-1: STAT-2 heterodimers translocate to the nucleus and associate with
IRF-9 forming the ISGF3 (Veals et al., 1992; Goodbourn et al., 2000). This complex
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interacts with the cis acting IFN stimulated response element (ISRE) contained within
many ISG promoters (Figure ID). Despite the importance of the classical Jak -
STAT pathway, several STATs are activated by type I IFNs, STAT-1, -2, -3, and -5
(Darnell et ah, 1994); STAT-4 and -6 activation by IFN-a is restricted to endothelial
cells and cells of lymphoid origin (Torpey et ah, 2004; Matikainen et ah, 1999). All of
these STAT types can be phosphorylated, resulting in activation and dimerisation;
many of the homo- or heterodimers formed can also activate gene transcription
(Darnell, 1997). The ISGF3 is the only complex known to bind to ISREs and
stimulate transcription; however many ISGs contain other binding sites within their
promoters, IRF binding sites and IFN-y activated sequences (GAS), the later of which
different STAT dimers can bind to and initiate gene transcription (Darnell, 1997).
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Figure 1D: Type I IFN Jak-STAT signalling
IFN binding to the IFNAR causes conformational changes, which result in dimerisation of the
receptor subunits. This induces autophosphorylation and activation of the associated janus
kinases (Tyk2, Jakl). STAT-2 is initially docked with IFNAR2. Following Tyk2
phosphorylation STAT-2 docks with IFNARl. Here it recruits STAT-1, these form a
heterodimer and translocate to the nucleus. Within the nucleus the STAT heterodimer
associates with IRF-9 forming the IFN-stimulated gene factor 3 (ISGF3). ISGF3 associates
with IFN-stimulated response elements (ISREs) found in the promoters of IFN stimulated
genes such as PKR, OAS and Mx A.
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Alternative IFN signalling pathways
Recent advances have been made in discovering alternative signalling pathways
induced by IFNs to activate ISGs; these include CRK proteins, p38 MAPK and PI3K.
The CRK proteins are homologues of the viral CRK, an oncogene encoded by avian
sarcoma virus, which transforms cells and induces tumours in newborn chicks (Mayer
et ah, 1988). CRK proteins interact with tyrosine kinases and guanine nucleotide
exchange factors, e.g C3G (Ahmad et ah, 1997; Feller, 2001). C3G is a guanine
nucleotide exchange factor for RAP1, a GTPase that responds to hormones and
cytokines to induce cell proliferation and differentiation (Bos et ah, 2001). It is
postulated that RAP-1 functions to control growth in an IFN dependent manner, the
effect is determined by stimulant and cell type (Flattori et ah, 2003). Another
observed CRK IFN signalling interaction was the association ofCRKL with STAT-5.
These complexes translocate to the nucleus and bind to GAS elements (Fish et ah,
1999). It is possible that CRKL functions as a nuclear adaptor for STAT-5, as this
complex is essential for GAS promoter induction (Grumbach et ah, 2001).
P38 MAPK signalling is essential for the induction of anti-proliferation effects. It is
important in both ISRE and GAS element dependent gene induction as inhibition of
p38 MAPK blocks IFN-a dependent genes controlled by ISRE elements and p38
MAPK is required for GAS dependent type I IFN gene transcription (Li et ah, 2004;
Uddin et ah, 2000). However, its exact role in gene expression has yet to be
elucidated, as it is not required for STAT phosphorylation or ISGF3 formation (Uddin
et ah, 1999). A specific role for p38 MAPK in anti-viral immunity has been
demonstrated as IFN-a induced anti-viral responses were suppressed following p38
inhibition during VSV and EMCV infections (Mayer et ah, 2001).
PI3K is activated by type I IFNs through the insulin receptor substrate pathway
(Uddin et ah, 1995; 1997). It induces Akt, a kinase linked to promotion of survival or
apoptosis pathways. The pathway that is promoted is dependent upon the cell type
(Vivanco et ah, 2002). PI3K is also involved in the regulation of IFN-P dependent
phosphorylation of the p65 subunit ofNF-kB (Rani et ah, 2002) and regulation of IFN
inducible activation ofmammalian target of rapamycin (MTOR), which induces
initiation ofmRNA translation (Lekmine et ah, 2003).
21
Introduction
Augmentation of IFN signalling
IRF-7 gene expression is induced following IFN-P expression. IRF-7 is a regulatory
factor involved in the positive feedback loop for the induction of further IFN-a
subsets. It is maintained within the cytoplasm and activated by TBK-1 and IKKs, the
same kinases responsible for IRF-3 activation (Fitzgerald et ah, 2003). After
activation, IRF-7 translocates to the nucleus where it interacts with promoters of the
delayed early IFN-a genes, IFN-a2, -5, -6 and .8 inducing their expression. This
produces a concentrated and varied IFN response (Marie et ah, 1998). Differential
IFN induction provides an innate control of the IFN response, preventing exponential
expression of pro-inflammatory and anti-viral genes.
Control of STAT signalling
In addition to the IRF control of IFN expression many other proteins play a role in
suppression of the Jak-STAT signalling pathway e.g. SOCS, PIAS proteins and SHP-
1 proteins. Suppressors of cytokine signalling (SOCS) have 8 members and each
contain a central SH2 domain. SOCS are induced by several cytokines e.g. IFN-y and
function by binding the kinase domain of Jaks suppressing their activation (Yasukawa
et ah, 1999). SHP-1 is a cytoplasmic tyrosine phosphatase; it contains two SH2
domains and directly interacts with Jak kinases catalysing their dephosphorylation
(David et ah, 1995). To enable SHP-1 activation, SHP-1 is recruited to SH2 binding
sites on cytokine receptors where it is phosphorylated by JAKs and activated inducing
its phosphatase function (reviewed in Tonks et al., 2001). PIAS (protein inhibitors of
activated STAT) directly interact with activated STAT proteins in response to IFNs or
IL-6 to prevent DNA binding (Shuai, 1999; Liao et al., 2000). There are five
mammalian members, PIAS-1 - 5; PIAS-1 associates with STAT-1 to inhibit DNA




The IFN response induces the expression of hundreds of genes that contribute to
formation of the anti-viral state, modulation of cell proliferation and induction of the
adaptive immune response.
Formation of the anti-viral state
Protein Kinase R (PKR)
PKR is highly effective against viral replication. It is constitutively expressed in most
cells and maintained in an inactive form in the cytoplasm (Meurs et ah, 1990). Its
expression is enhanced by IFN through the ISRE (Kuhen and Samuel, 1997). dsRNA
binding to PKR enables homodimer formation and PKR activation (Katze et al.,
1991). The length of the dsRNA determines PKR: RNA complex stability; 80 bp is
the optimum (Manche et al., 1992). Large quantities ofRNA suppress the activity of
PKR as saturation of the dsRBMs prevents dimer formation and PKR activation
(reviewed in Samuel, 2001). In addition to dsRNA, PKR activity is controlled by the
PKR activator (PACT), the PKR inhibitor (p58IPK) and heat shock proteins (Hsp),
(Patel et al., 2000; Tang et al., 1999; Melville et al., 1997). For example, Hsp 40
binds to p58IPK, suppressing its inhibitory role and Hsp70 has been shown to possess
both PKR stimulatory and inhibitory activities (Melville et al., 1997; 1999).
Active PKR induces complete host cell protein synthesis shutdown by
phosphorylating the serine 51 residue of the eukaryotic translation initiation factor 2a
(eIF-2a) (Meurs et al., 1992). eIF-2a in association with GTP is required for the
recruitment and attachment ofMet-tRNA to the 40S ribosomal subunit. Further
association of this complex with mRNA and other translation factors results in the
hydrolysis ofGTP to GDP. In order for translation initiation to continue, the eIF-2a
bound GDP must be recycled to GTP through the guanine nucleotide exchange factor
(eIF-2B). However, once phosphorylated eIF-2a binds strongly to eIF-2B preventing
its release and the recycling ofGDP to GTP, ultimately halting translation initiation
and viral replication (Ramaiah et al., 1994; reviewed in Goodbourn et al., 2000).
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Other roles for PKR include cell growth control (Zamanian-Daryoush et al., 1999)
and tumour suppression (Donze et ah, 1995); for example, PKR phosphorylation of
90 kDaNFAT protein and PKR induction of apoptosis. Nuclear factors of activated T
cells (NFAT) proteins are essential for early T cell gene induction e.g. IL-2, which
stimulates T-cell proliferation. NF90 binds dsRNA and is phosphorylated in a
dsRNA dependent manner by PKR; this promotes nuclear translocation and
dimerisation with NF45. In the nucleus this heterodimer associates with the antigen
receptor response element 2 (ARRE2) found with the IL-2 promoter to induce
transcription (Langland et ah, 1999). The involvement ofPKR in the induction of
apoptosis is shown by the over expression ofwild-type PKR, which results in the
induction of apoptosis in the presence of dsRNA (Lee et ah, 1997). PKR has also
been shown to upregulate Fas gene expression, which is directly linked to an
apoptosis inducing pathway via the Fas associated death domain (FADD)
(Balachandran et al., 1998). An important link between cell proliferation and induced
cell death is PKR activation ofNF-kB, which was described previously. Other
transcription factors influenced by PKR, which are pertinent to the IFN response
include STAT-1, IRF-1 and p53 (Williams, 1999).
2'-5'OAS and RNase L
The OAS/RNase-L antiviral response is especially successful in inhibiting replication
of viruses in the Picornaviridae, Poxviridae and Reoviridae families (reviewed in
Samuel, 2001). 2'-5' Oligoadenylate synthase (OAS) polymerises ATP forming
various sizes of 2'-5'oligoadenylates (2'-5'A) (Kerr and Brown, 1978). Three forms
of human OAS have been isolated, OAS1, 2 and 3, however examination of the mouse
genome indicates three individual Oas genes with 8 isoforms of Oas 1 (Mashimo et
al., 2003). The relevance ofmultiple murine isoforms is still not understood. The
Oas lb isoform has been linked to innate resistance to West Nile virus in mice
(Mashimo et al., 2002), suggesting that the different isoforms provide protection
against different types ofRNA viruses. The different forms of OAS (1, 2 and 3) have
been localised to different sub-cellular organelles with different requirements for
RNA concentration and optimal reaction conditions (Rebouillat and Hovanessian,
1999). 2'-5'A, the product ofOAS, binds to the duplicated phosphate binding motif
in the N-terminal domain of the latent endoribonuclease, RNase-L (Hassel et al.,
1993). This enables dimer formation (Dong and Silverman, 1995), which activates
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RNase-L to cleave the 3'side of-UpXp- sequences of both cellular and viral ssRNAs
catalysing their degradation (Floyd-Smith et al., 1981). RNase-L has been shown to
degrade 28S ribosomal RNA and so is another protein leading to translation inhibition
(Iordanov et al., 2000). It is also involved in the induction of apoptosis, as RNase-L"7"
mice show defects in apoptosis following viral infection (Li et al., 2004). Li et al.,
(2004) determined that chemical inactivation of the c-Jun N-terminal kinase (JNK)
prevented apoptosis by 2'-5' A, suggesting that RNase L and JNK function within the
same signalling pathway to promote apoptosis.
ADAR-1
ADAR-1 is an RNA specific adenosine deaminase expressed ubiquitously in the
nuclei of higher eukaryotes (Bass, 2002). It alters adenosine to inosine through
deamination in both viral RNAs and cellular pre-mRNAs (Poison et al., 1991; Bass,
1997). The resulting inosine, which is read by transcription machinery as guanine
(Alberts et al., 1994), causes dsRNA helix instability due to incorrect base pairings.
Two forms of editing can occur, site specific editing and promiscuous editing. Site
specific editing induces mis-sense codons in favourable secondary structures and is
commonly observed in mRNAs important to the nervous system (Kallman et al.,
2003; Wong et al., 2001). Promiscuous editing results in hyper-editing creating an
unstable RNA duplex. Cellular mRNA that is hyper-edited is retained within the
nucleus (Bass and Weintraub, 1988; Kumar and Carmichael, 1997; Zhang and
Carmichael, 2001; Dong et al., 1993; Kameoka et al., 2004). Hyper-edited mRNAs
interact with a protein complex containing vigilin, resulting in the formation of
heterochromatin to cause gene silencing (Wang et al., 2005). The hyper-editing of
viral RNA may enable the host cell to remove the virus dsRNA in conjunction with a
cytoplasmic endonuclease that cleaves specific hyper-edited dsRNA species (Scadden
and Smith, 2001). In addition to decreasing the stability of viral replication
complexes, hyper-editing could induce mutations into the virus genome.
Interestingly, hepatitis delta virus is hyper-edited in vitro and this is required for
virion formation but not replication (Poison et al., 1996; Casey, 2002).
MxA
MxA belongs to a family ofGTPases which are members of the dynamin family
(reviewed in Haller and Kochs, 2002). The IFN-induced MxA protein sequesters
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nucleocapsid structures through its C-terminus. This class of antiviral proteins are
particularly effective against negative sense RNA viruses. During bunyavirus
infection MxA prevents nucleocapsid translocation to the Golgi apparatus, the
intracellular site of viral assembly. MxA also prevents Thogoto virus nucleocapsid
nuclear translocation, the nucleus is the replication site of this orthomyxovirus (Kochs
et al., 2002; Kochs and Haller, 1999).
Other IFN induced genes
PKR, RNase L and MxA are important in the formation of the anti-viral state and yet
mice triply deficient for each of these proteins can still induce an antiviral effect
against EMCV (Zhou et al., 1999). Many other IFN induced antiviral genes have
been elucidated and include:
(i) ISG-20, a 3'-5' exonuclease specific for RNA viruses (Espert et al., 2003);
(ii) ISG-15, a ubiquitin-like protein with antiviral activity against Sindbis
virus. ISG-15 prevented lethal Sindbis virus infection and reduced viral replication
although did not control virus spread (Lenschow et al., 2005).
(iii) Viperin, an IFN-a and -y induced protein with anti-viral activities against
human cytomegalovirus and hepatitis C virus (Chin and Cresswell, 2001; Helbig et
al., 2005).
(iv) promyelocytic leukaemia protein (PML) expression is enhanced by IFN-
a/p (Chelbi-Alix et al., 1998); it accumulates in nuclear bodies and in the
nucleoplasm in association with chromatin. PML deficiency increases the
susceptibility of cells to virus infections and over expression ofPML inhibits
replication ofVSV, LMCV, influenza virus and human foamy virus (Regad and
Chelbi-Alix, 2001). PML is essential for IFN induced apoptosis, it is thought that
nuclear bodies, whose structural integrity is maintained by PML, act as platforms for
p53 regulation (Moller and Schmitz, 2003). The specific mechanism ofPML
antiviral properties is not yet understood, but many viral infections demonstrate
disrupted nuclear bodies and re-localisation ofPML.
Modulation of cell proliferation and immune responses by IFNs
In addition to induction of the anti-viral state, IFNs can suppress cell proliferation and
induce the adaptive immune response. IFN modulation of cell growth ranges from
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apoptosis induction, for example through PKR and RNase L, to induction of G1 arrest
and pauses at other phases of the cell cycle (Roos et ah, 1984). Progression of the cell
cycle is determined by cyclin-dependent activation of cyclin-dependent protein
kinases (CDKs). These phosphorylate multiple proteins including the retinoblastoma
tumour suppressor protein (pRb). Phosphorylation of pRb results in release of E2F
transcription factors which induce expression of genes essential for progression into
the S phase of the cell cycle (Weinberg, 1995; Muller, 1995). All stages of the cell
cycle are potential targets for the IFN response. For example, IFN increases the
expression level of CKI p21, a cyclin-dependent kinase inhibitor, IFN-oc inhibits IL-3
induced cyclin expression and prevents pRb dependent transcription factor activation
by maintaining pRb in a hypophosphorylated state. These effects are accompanied by
high level PKR activation linking translational suppression to cell cycle arrest
(Prietzsch et al., 2002). Signalling pathways also contribute to cell proliferation
inhibition; CRK proteins link the type I IFN receptor to C3G/Rapl growth inhibition
pathway (Ahmad et al., 1997) and Vav contributes to p38 MAPK inhibitory responses
through interactions with Rac for which it functions as a guanine nucleotide exchange
factor (Crespo et al., 1996).
Type I IFNs link the adaptive and innate immune responses. They increase the
efficiency of the transitional phase by augmenting the levels ofMHC class I
molecules and the availability ofMHC I antigens (Boehm et al., 1997; Guidotti and
Chisari, 2001). They regulate the expression of Thl cytokines through IRF-1, e.g. IL-
12, IL-18, IL-15 and IFN-y (Biron, 2001). They increase the expression of
chemokines, RANTES, a T cell chemokine, and MlP-la, the macrophage
inflammatory protein (Cremer et al., 2002; Zang et al., 2001). They can also enhance
NK cell cytotoxicity by increasing perforin expression (Biron et al., 1998) and
influence DC maturation (Luft et al., 1998).
Inverse Interference
Given their potent anti-viral activities viruses from many virus families have evolved
mechanisms to antagonise the IFN response. Viruses have developed proteins and
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nucleic acids to interfere with and disrupt all stages of this response, from the initial
induction of IFN to effector protein expression and activation (reviewed in Garcia-
Sastre, 2002; Samuel, 2001; Goodbourn et al., 2000).
DNA viruses
Herpesviruses
The herpes family induces IFN through a variety of pathways and encodes genes to
control the induced IFN response (reviewed in Mossman and Ashkar, 2005). For
example, Herpes simplex type 1 (HSV-1) induces IFN through TLR-2 and TLR-9.
TLR-2 is activated by viral glycopeptides expressed on the surface of the virion
(Kurt-Jones et al., 2004). TLR-9 is located in the endosome and is activated by
unmethylated CpG motifs in the HSV-1 genome (Krug et al., 2004). The ICP0
protein expressed by HSV-1 inhibits the activation of IRF-3 and IRF-7 by functioning
as an E3 ubiquitin ligase (Boutell et al, 2005; Lin et al., 2004). However, it also
induces the activation ofNF-kB by targeting the IxBa subunit for polyubiquitination
(Diao et al, 2005). Several herpes viruses contain NF-kB binding sites within some of
their gene promoters and require this cellular transcription factor to promote their own
replication. For example, human cytomegalovirus (HCMV) contains 4 NF-kB
binding sites in its major immediate early promoter and so requires NF-kB activation
in the absence of IFN activation (Meier and Pruessner, 2000; Sambucetti et al., 1989).
In addition to ICP0 inhibition of IRFs, the HCMV p65 structural protein affects the
DNA binding capability ofNF-kB, IRF-1 and IRF-3 (Browne and Shenk, 2003;
Abate et al., 2004) and Kaposi's sarcoma herpes virus (KSHV) encodes several viral
homologues of IRFs, which suppress the IFN response through interactions with
cellular IRFs and partners of cellular IRFs (Cunningham et al., 2003). For example,
KSHV vIRF-1 binds to the transcription enhancers p300 and CBP and so prevents
their histone acetylase function suppressing transcription (Burysek et al., 1999; Lin et
al., 2001; Seo et al., 2000) and KSHV vIRF-4 interacts with IRF-7 inhibiting its
phosphorylation and nuclear accumulation (Zhu et al., 2002).
Following IFN expression, viruses of the herpesviridae can also interfere with IFNAR
signalling and expression of ISGs. For example, the HSV-1 expressed VHS protein is
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a viral inducer of host cell translation shut-off. VHS is an endoribonuclease, which
degrades cellular transcripts in fibroblasts (Lin et al., 2004). VHS mediated transcript
degradation would prevent IRF-7 expression and hence the second wave of IFN-a
expression and augmentation of the IFN response (Smiley, 2004). HSV-1 also
prevents the phosphorylation of Jak-1, Tyk-2 and STAT-1 and -2 by increasing the
expression of the suppressor of cytokine signalling (SOCS) - 3 (Yokota et al., 2001;
2004). In addition to HSV-1 interference of IFNAR signalling, HCMV causes the
degradation of JAK-1 and IRF-9, a component of ISGF-3 (Miller et al., 1998; 1999)
and murine CMV (MCMV) pM27 protein binds STAT-2 targeting it for
ubiquitination and proteosome degradation (Zimmermann et al., 2005). Herpes
viruses encode proteins that mop up viral dsRNA and so prevent the activation of
many anti-viral proteins; for example the HCMV genome encodes two ORFs, TRS1
and IRS1, whose proteins bind and sequester dsRNA (Child et al., 2002). PKR is
antagonised by the HSV-1 ICP34.5 protein, which recruits cellular phosphatase 1 and
this complex dephosphorylates eIF-2a thereby counteracting PKR activity (He et al.,
1997). Another HSV-1 protein, Usl 1 directly binds to PKR and prevents
autophosphorylation and activation (Cassady et al., 1998; 2002). KSHV vIRF also
inhibits PKR; vIRF-2 binds PKR and prevents autophosphoryation and vIRF-3
represses activation of caspase 3 and so prevents PKR triggered apoptosis (Burysek
and Pitha, 2001; Esteban et al., 2003).
Poxviruses
Vaccinia virus (VV) targets the IFN response at multiple stages. Firstly, at the initial
TLR signalling cascade, A46R contains a TIR domain and targets MyD88, Mai, TRIF
and TRAM, and A52R associates with IRAK2 and TRAF6 blocking NF-kB
activation by TLR-3 (Stack et al., 2005; Bowie et al., 2000; Harte et al., 2003).
Secondly, at the induction of IFN stimulated genes, B18R encodes a soluble cytokine
receptor for IFN-a/p, which acts as a decoy for these cytokines (Alcami et al., 2000).
This contains 3 Ig domains that bind to type I IFN with high affinity. Thirdly the
virus targets ISGs, E3L protein binds dsRNA to prevent PKR activation and K3L
competitively binds PKR and blocks phosphorylation of eIF-2a (Davis et al., 1993;
Xiang et al, 2002).
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Further virus specific targeting ofPKR by DNA viruses is observed in adenoviruses;
virus associated RNAs (VA RNAs) act as competitive substrates for PKR preventing
PKR activation and dimerisation (Mathews and Shenk, 1991). Epstein Barr virus
encodes RNAs, EBERs, which show homology to VA RNAs and can functionally
substitute for VA RNAs (Elia et ah, 1996).
Double stranded RNA viruses
Reoviruses cause gastroenteritis and myocarditis (reviewed in Clarke et ah, 2005).
The reovirus a3 protein, which forms the outer capsid binds dsRNA in a sequence
independent manner and prevents PKR activation in vitro (Denzler and Jacobs, 1994;
Huismans and Joklik, 1976; Schiff et ah, 1988; Imani and Jacobs, 1988).
Negative stranded RNA viruses
Paramyxoviruses
The paramyxoviruses have non-segmented negative-stranded RNA genomes; they
include the Rubula-, Henipah- and morbilivirus genera. Many paramyxoviruses
including Simian virus 5 (SV5), human parainfluenza virus 2, Sendai virus, mumps
virus and Hendra virus inhibit mda-5, a dsRNA binding protein (Andrejeva et ah,
2004). Insertion of several guanine nucleotides into the phosphoprotein (P) ORF
during transcription results in expression of the alternate V protein (Thomas et ah,
1988). The paramyxovirus V protein is also an inhibitor of IFN responses. V
proteins expressed by the Rubulavirus genus induce poly-ubiquitination of specific
STAT proteins (Parisien et ah, 2001; Ulane et ah, 2002). For example, Simian virus 5
(SV5) targets STAT-1, human parainfluenza virus 2 is specific for STAT-2 and
mumps virus targets both STAT-1 and STAT-3 (Parisien et ah, 2001; Ulane et ah,
2003). During Rubulavirus infection, a specific protein complex is formed consisting
ofV protein, STATs, DDB1 (UV- damaged DNA binding protein) and the Cullin
family of SCF ubiquitin ligases which results in poly-ubiquitination and ultimately
degradation of STAT (Ulane et ah, 2002; 2003). STAT-3 degradation by mumps
virus prevents IL-6 induced signalling and alongside STAT-1 degradation is thought
to enable the virus to control a broader range of cytokine signalling in response to
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viral infection (Ulane et al, 2003; Levy and Lee, 2002). The V proteins of
Henipaviruses suppress STAT activity without inducing protein degradation. They
sequester STAT-1 and STAT-2 in high molecular weight cytoplasmic complexes and
are capable of nuclear shuttling enabling the viruses to relocalise nuclear STAT
proteins to the cytoplasm (Rodriguez et al., 2002; 2003). The V protein of measles
virus shares little (20 %) homology with the previously mentioned V proteins and
blocks IFN signalling by preventing nuclear import of STAT-1 and STAT-2
(Palosaari et al., 2003). Similar to the V proteins expressed by the Henipahviruses,
measles virus also sequesters STAT proteins in cytoplasmic bodies in association with
the measles virus nucleocapsid protein (Palosaari et al., 2003; Bohn et al., 1990).
In addition to blocking/disrupting IFNAR signalling, other paramyxoviruses affect
type I IFN expression. For example, the NS1 and NS2 proteins of respiratory sycytial
virus (RSV) prevent phosphorylation and activation of IRF-3 (Bossert et al., 2003;
Spann et al., 2004). Measles virus and RSV specifically target TLR-dependent IFN-a
production in plasmacytoid dendritic cells (Schlender et al., 2005). The effectiveness
of targeting DCs is demonstrated by the general immunosuppression induced by
measles virus during an in vivo infection (Moss et al., 2004; Schneider-Schaulies et
al., 2003).
Many other negative strand RNA viruses interfere with IFN induction. Rabies virus
phosphoprotein targets TBK-1 phosphorylation of IRF-3 and prevents STAT-1
nuclear accumulation (Brzozka et al., 2005; Vidy et al., 2005); Ebola virus VP35
protein prevents IRF-3 phosphorylation (Basler et al., 2003) and Thogoto virus
(THOV) ML protein interacts with IRF-3 but does not affect its phosphorylation. The
ML protein interferes with IRF-3 dimerisation and CBP recruitment within the
nucleus (Jennings et al., 2005). To prevent ISG expression, VSV and Rift Valley
fever virus encode the M protein and the NSs protein respectively to induce global
cellular transcription inhibition (Ahmed et al., 2003; Le May et al., 2004). VSV M
protein targets the transcription factor IID (TFIID) and reduces the efficiency of
nuclear-cytoplasmic transport ofmRNAs (Yuan et al., 1998; Her et al., 1997). Rift
Valley fever virus NSs protein interacts with components, specifically the p44
subunit, of the transcription factor IIH (Le May et al., 2004) to prevent RNA
polymerase II function thereby inhibiting host mRNA synthesis including IFN
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transcripts. Bunyamwera virus NSs also shows IFN-a/p suppression (Weber et al.,
2002) and interacts with RNA polymerase II (RNAPol II). Disruption ofRNAPol II
phosphorylation patterns inhibits mRNA elongation and 3'-end processing (Thomas
et al., 2004). The NS1 protein of influenza virus has been attributed many roles in
host cell modulation; it was the first IFN antagonist identified. Its capacity to bind
dsRNA prevents cellular detection of viral replication through RIG-I and TLR-3 and
sequestration of dsRNA removes its ability to activate ISGs such as PKR, ADAR and
OAS (Garcia-Sastre et al., 1998; Garcia-Sastre, 2004). Influenza A virus also induces
the expression of a natural cellular inhibitor of PKR, p58IPK (Lee et al., 1990).
Positive stranded RNA viruses
Flaviviruses
Hepatitis C virus (HCV) is a positive-sense, single-stranded RNA virus. HCV
NS3/4A protease interrupts IFN-P induction through cleavage of TRIF, the adaptor
protein for TLR-3 and -4, and IPS-1 the adaptor protein for RIG-I (Foy et al., 2005;
Li et al., 2005; Ferreon et al., 2005). IFNAR signalling is also disrupted by HCV.
HCV replication suppresses STAT-1 activity by increasing the levels of protein
phosphatase 2A and SOCS-3 (Heim et al., 1999; Duong et al., 2004; Bode et al.,
2003). The HCV NS5A protein reduces ISG induction by promoting IL-8 expression,
an IFN antagonist (Khabar et al., 1997; Geiss et al., 2003). In addition, NS5A and
HCV E2 affect PKR activity. NS5A or E2 binding to PKR prevents its catalytic
activity thereby repressing host translation shut-off (Taylor et al., 1999; Noguchi et
al., 2001; Gimenez-Barcons et al., 2005). HCV infection also results in reduced
expression of ISG56 and antagonism of the OAS/RNase L pathway (Sumpter et al.,
2004; Taguchi et al., 2004). Some HCV genomes appear to have evolved to have few
RNase L cleavage sites in their genome (Han et al., 2004).
Bovine viral diarrhoea virus (BVDV) has two pathological types, cytopathic (cp) and
non-cytopathic (ncp) (Hoff and Donis, 1997). Infection of pregnant cows within the
first 120 days of pregnancy with the non-cytopathic strain results in persistently
infected calves (Brownlie et al., 1989). To establish a persistent infection, ncp BVDV
interferes with the immune system and does not induce an IFN response (Adler et al.,
1997; Charleston et al., 2001). During an ncp BVDV infection IRF-3 translocates to
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the nucleus but does not associate with DNA. If co-infected with an IFN inducing
virus, IRF-3 activity can not be rescued, suggesting that ncp BVDV IFN inhibition is
mediated by disrupting the IRF-3 IFN-(3 promoter binding (Baigent et ah, 2002).
Picornaviruses
Picornaviruses are small positive-sense RNA viruses, they include, foot and mouth
disease virus (FMDV), hepatits A virus (HAV) and poliovirus (Ruekert, 1996). The L
proteinase encoded by picornaviruses is responsible for viral polyprotein cleavage,
but has also been implicated in host translation initiation factor eIF-4G cleavage
(Strebel and Beck, 1986; Devaney et ah, 1988; Guarne et al., 1998; Medina et al.,
1993). eIF-4G cleavage prevents cap-dependent mRNA translation, ultimately
inducing host cell shut-off, including shut-off of IFN mRNA (Chinsangaram et al.,
1999; Grubman and Chinsangaram, 2000). HAV inhibits IFN-P expression through
interactions with the IFN-P enhanceosome (Brack et al., 2002). It is believed that this
facilitates HAV persistent infection. More recently, poliovirus has been shown to
cleave the p65-RelA subunit ofNF-kB. Initial infection induces NF-kB and IFN
expression however, at later stages the poliovirus 3C protease cleaves the NF-kB p65
subunit. This effect has also been observed in other picornaviruses including, ECHO-
1 virus and rhinovirus 14 (Neznanov et al., 2005). In addition to affecting IFN
induction, poliovirus initiates the degradation ofPKR (Black et al., 1993).
To date no inverse interference mechanisms have been elucidated for the Togaviridae.
However, recent observations suggest that these viruses do encode mechanisms to
suppress IFN expression. Sindbis virus non-structural protein 2 (nsP2) was mutated at
796
a conserved amino acid, proline , and infections with this mutant virus induced
significantly larger amounts of type I IFN compared to another mutant virus which
replicated at a comparable rate (Frolova et al., 2002). Interestingly, SV is also
innately resistant to PKR induced translational shut off (Ventoso et al., 2006). Ross
River virus (RRV) causes cytokine dysregulation in infected macrophages, including
IFN-p (Way et al., 2002).
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Target Protein Virus Virus Function
Protein
IFN-P Induction IRF-3, IRF-7 ICPO HSV-1 E3 ubquitin ligase
NF-kB, IRF-1, IRF-3 P65 HCMV Affects DNA binding
P300, CBP vIRF-1 KSHV Sequestration
IRF-7 vIRF-4 KSHV Prevents phosphorylation
and nuclear accumulation
MyD88, Mai, TRIF, TRAM A46R vv Binds through TIR
domain
IRAK, TRAF-6 A52R vv Blocks NF-kB activation
RIG-I, TLR-3 NS1 Influ V Binds dsRNA and
prevents activation
mda-5 ? SV5 Inhibits signalling
IRF-3 NS1, NS2 RSV Prevent phosphorylation
and activation
TBK-1 P Rabies Prevents IRF-3
phosphorylation
IRF-3 VP35 Ebola Prevents IRF-3
phosphorylation
IRF-3 ML THOV Prevents dimerisation and
CBP recruitment
TRIF, IPS-1 NS3/4A HCV Cleaves adaptor proteins
IRF-3 ? NcpBVD Prevents IRF-3 DNA
V binding
IFN-(3 enhanceosome 7 HAV Prevents IFN-P
expression
NF-kB (p65) 3C PolioV Cleaves NF-kB
preventing transcription
IFNAR Signalling Jak-1, Tyk-2, STAT-1, STAT-2 VHS, HSV-1 Increases host SOC-3 to
UL13 prevent phosphorylation
Jak-1, IRF-9 HCMV Induces degradation
STAT-2 PM27 MCMV Targets for ubquitination
and degradation
IFNAR B18R VV Soluble IFNAR
STAT-1, IRF-9 E1A ADV Prevents ISGF3 formation
STAT-1 V SV5 Degradation
STAT-2 V HPIV2 Degradation
STAT-1, STAT-3 V Mumps Degradation
STAT-1, STAT-2 V Henipa Cytoplasmic sequestration
STAT-1 ? HCV Induces cellular
phosphatase 2A
STAT-1 Core HCV Induces cellular SOC-3
Anti-Viral PKR, RNase L, ADAR TRS1, HCMV Binds dsRNA and
Proteins IRS1 prevents activation
EIF-2a ICP34.5 HSV-1 Recruits cellular
phosphatase 1 to
dephosphorylate eIF-2a
PKR, RNase L, ADAR Usll HSV-1 Directly binds, preventing
activation
PKR, RNase L, ADAR VIRF-2 KSHV Directly binds, preventing
activation
PKR, RNase L, ADAR E3L VV Binds dsRNA and
prevents activation
PKR K3L vv Prevents eIF-2a
phosphorylation
PKR, RNase L, ADAR VA RNA ADV Binds dsRNA and
prevents activation




PKR, RNase L, ADAR NS1 Influ V Binds dsRNA and
Anti-Viral




PKR P58IPK Influ V Induces cellular PKR
inhibitor
ISGs NS5A HCV Promotes IL-8 expression
PKR NS5A/E2 HCV Binds and prevents
activation
PKR ? Polio V Degradation
RNase L RLI EMCV Induces cellular inhibitor
Global TFIID M VSV Reduces mRNA nuclear-
Transcription cytoplasmic transport
Shut Off
TFIIH (p44 subunit) NSs RVFV Prevents RNAPol II
function
RNAPol II NSs BunV Inhibits mRNA
elongation
Global ISGs VHS HSV-1 Endoribonuclease;
Translation Shut degrades ISG mRNA
Off transcriptsEIF-4G L FMDV Cleavage prevents cap-
dependent translation
Table 1B: Virus inverse interference of the IFN response
Many viruses possess mechanisms to evade the IFN response; in the table are examples of
how viruses evade IFN-P induction, IFNAR signalling and anti-viral proteins and how they
induce host transcription or translation shut off to suppress expression of IFN.
Tumour Necrosis Factor and cell death pathways are other
targets of viral antagonism
IFNs play a critical role in the immune response and hence are heavily targeted by
viruses to suppress their induction and responses. However, they are not the only
cytokine family targeted by viruses. The tumour necrosis factor (TNF) family of
cytokines regulate cell death and survival; they are expressed by immune effector
cells and associate with specific receptors, which are expressed on all cells tested to
date (reviewed in Ware, 2005). Induction of apoptosis or promotion of cell survival is
dependant upon downstream signalling from the receptor. TNF receptors (TNFR)
possessing death domains, recruit adaptor proteins and pro-caspases to form death-
inducing signalling complexes (DISC), which process downstream caspases into their
active form, resulting in genome cleavage and destruction of cellular integrity. This is
known as the extrinsic apoptosis pathway (Hofmann, 1999; Zimmermann et al.,
2001). For example, Fas association with Fas ligand initiates the recruitment of the
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adaptor protein, Fas associated death domain (FADD), which in turn recruits pro-
caspase 8 or 10. Within the resulting DISC these upstream caspases are activated
enabling them to process pro-caspase 3 into its active form. Caspase 3 then cleaves
inhibitors of caspase activated DNase (ICAD), which results in the fragmentation of
cellular DNA (reviewed in Benedict et al., 2002). Diversions from this pathway can
occur; DISC based caspase 8 can also cleave BID into its active form, tBID, which
recruits Bax. Bax oligomerisation and association with Bak in the mitochondrial
membrane induces the release of cytochrome c, which also signals cell death
(reviewed in Benedict et al., 2002). Survival pathways are induced through the
recruitment of TRAF and other kinases, which ultimately activate NF-kB and AP-1,
transcription factors that promote the expression of pro-inflammatory genes.
As in the IFN system, viruses interact at all levels of TNF signalling. Many viruses
express TNF receptor (TNFR) decoys to prevent TNF association with and activation
of cellular receptors. For example, the poxvirus Shope fibroma virus encodes a
TNFR2 orthologue (Smith et al., 1990), another orthologue is found in the smallpox
virus (Reading et al., 2002) and the T2 protein ofmyxoma virus binds TNF (Upton et
al., 1991). Adenovirus E3-10.4K and E3-14.5K proteins downregulate death receptor
expression on infected cells (Shisler et al., 1997). These proteins target death
receptors to endocytic compartments within the cytoplasm (Tollefson et al., 1998).
Reduction in the expression of death receptors protects infected cells from immune
cell induced death through FasL, TNF or TRAIL release (Ashkenazi and Dixit, 1999).
Interference with DISC signalling is a common feature of y-herpesvirus infections.
Equine herpesvirus-2, herpesvirus saimiri, KSHV and bovine herpesvirus-4, all
express homologues of cellular FLICE (caspase 8) inhibitor proteins (FLIPs, Bertin et
al., 1997; Thome and Tschopp, 2001). FLIPs contain death effector domains, which
interact with death inducing adaptor proteins and prevent their activation. Inhibitors
of apoptosis proteins (IAPS) are cellular proteins which control caspase activation
(Deveraux and Reed, 1999); to date eight have been identified (Shi Y, 2002).
Poxviruses encode proteins with similar functions to IAPs. CrmA modifies caspase 8
and inhibits caspase 1 preventing IL-ip processing (Tewari and Dixit, 1995). African
swine fever virus encodes a homologue of IAP, vIAP (Neilan et al., 1993), which
inhibits caspase 3 activation.
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Viruses have also developed orthologues of anti-apoptotic proteins e.g. Bcl-2 and Bcl-
Xl- These proteins prevent the loss of mitochondrial membrane integrity and hence
inhibit the release of cytochrome c. Adenovirus encodes E1B-19K, which interacts
with Bax inhibiting its oligomerisation (Sundararajan and White, 2001). EBV and
KSHV encode BHRF1, BALF1 and KSbcl-2, respectively, which suppress the release
of cytochrome c from the mitochondria (Elenderson et ah, 1993; Marshall et al., 1999;
Sarid et al., 1997). Eluman T cell leukaemia virus type I (HTLV-1) and the HIV Nef
protein interfere with Bcl-2 family member expression. HTLV Tax protein activates
the Bc1-xl promoter and inhibits Bax expression (Tsukahara et al., 1999); Nef induces
the phosphorylation ofpro-BAD suppressing apoptosis in T cells (Wolf et al., 2001).
Semliki Forest virus
Alphavirus Family
Semliki Forest virus (SFV) is an alphavirus of the Togaviridae. It is an enveloped
single-stranded, positive sense RNA virus with a genome of approximately 11 kb in
length. SFV is studied as a model for neurotropic virus infections and as an example
of the alphavirus genus. Alphaviruses are arboviruses transmitted by mosquitoes
(Weaver et al., 2000). Thirty seven alphaviruses are known to cause human disease;
these can be classified into seven antigenically distinct viruses: Eastern equine
encephalitis virus (EEE), Venezuelan equine encephalitis virus (VEE), Sindbis virus
(SV), Semliki Forest virus (SFV), Barmah Forest virus, Middleburg virus and Ndumu
virus. The alphavirus family is endemic across the Americas, Africa and Australia
(reviewed in Tsai et al., 2002).
Alphavirus infections have a wide host range, however, horses are particularly
susceptible to EEE, Western equine encephalitis (WEE), VEE, SF and Middleburg
viruses. The clinical disease and pathology of infection varies for each virus, but
most cause encephalitis and or arthralgia. The severity of infection is determined by
many factors but age is an important one; neonates are much more susceptible to a
morbid infection (reviewed in Fazakerley, 2002). In humans, EEE causes severe
CNS infection often resulting in 70 % fatality in some human epidemics and has
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caused fatal outbreaks amongst commercial fowl (Tsai et al., 2002). VEE can result
in large human and equine epidemics with 100,000's of cases. In addition to
encephalitis, VEE can induce spontaneous abortions with massive cerebral necrosis
and cerebral calcification in the foetuses (Wenger, 1977). Chikungunya virus,
distributed throughout Africa and South East Asia, induces severe symptoms
consisting of chills, incapacitating joint pains, fever and rash (Moore et al., 1969;
Nimmannitya et al., 1969). SFV is 'Category 2' pathogen in the UK and is studied as
a model for alphavirus infection.
SFV is an arbovirus and is transmitted by mosquitoes, primarily Aedes africanus or
Aedes aegypti. SFV is normally found in sub-Saharan Africa. Its natural host species
is unknown but infections have been observed in horses, monkeys and man. The first
strain of SFV termed L10 was isolated in Uganda (Smithburn and Haddow, 1944) and
since then several other strains have been isolated or derived from these primary
isolates including avirulent strains. The avirulent A7 strain was isolated in
Mozambique (Mcintosh et al., 1961).
SFV Pathogenesis
SFV strains can be divided into two groups, those that are virulent to both adult and
neonatal mice (virulent strains) and those that are solely virulent in neonates
(avirulent strains). Both types produce fulminant encephalitis in neonates, triggering
apoptosis in neurones and resulting in death within a few days (Zlotnik et al., 1972;
Gates et al., 1985; Fazakerley et al., 1993). In adult mice, virulent strain infections
are much the same; although neuronal death is most likely by necrosis (Atkins et al.,
1990; Fazakerley et al., 1993). Avirulent infections are confined to small foci
surrounding cerebral blood vessels; the virus is unable to spread efficiently between
neurones (Fazakerley et al., 1993). Microscopically infected cells contain 'viral core
aggregates' but no virions are observed. Around 6-10 days post-infection the virus
is cleared from the CNS, following which lesions appear in the myelin tracts similar
to those seen in multiple schlerosis (Suckling et al., 1978). This demyelination is
caused by CD8+ T cells (Fazkerley and Webb, 1987), most probably initiating
oligodendrocyte cell death. Experiments with severe combined immuno-deficient
mice (SCID) and nude mice have shown no and reduced demyelination respectively,
38
Introduction
indicating that these lesions are dependent upon the cellular immune system (Amor et
ah, 1996). In pregnant mice some avirulent strains, specifically the A7 ts22 mutant,
show teratogenesis, inducing defects in the skeleton, skin and neural tube (Mabruk et
ah, 1989).
Age-dependent Virulence
A distinct feature of the avirulent infection is age-dependent virulence. Experiments
have shown that up to 11 days of age neonates infected with an avirulent strain
develop panencephalitis and die, after 12 days of age infection is avirulent (Oliver et
ah, 1997; Oliver and Fazakerley, 1998). This pathology is not thought to be
associated with the adaptive immune system, as adult SCID mice display similar
infection patterns to adult immunocompetent mice, with small foci of virus infection
(Amor et ah, 1996). However, it could be attributed to CNS development. Mice
develop their CNS synaptic connections up until two weeks post-partum (reviewed by
Fazakerley, 2001). During this period, synaptogenesis and neuronal differentiation
involve a significant amount of smooth membrane vesicle production (reviewed by
Fazakerley, 2001). The importance of smooth membrane synthesis for viral
replication is demonstrated when A7(74) infected mice are pre-treated with
aurothiolates (gold containing compounds). This results in widespread infection and
high virus titres (Scallan and Fazakerley, 1999). These observations are not due to
toxic effects of the aurothiolates. It is suggested that the aurothiolates alter neuronal
physiology to increase smooth membrane proliferation and that this allows virus
replication (Mehta et ah, 1990). This implies that the avirulent strains of SFV hijack
lipid vesicles to spread throughout the developing CNS, but upon brain maturation are
confined to their initial foci of infection. An alternative explanation is that immature
neurones are more susceptible to apoptosis than adult neurones and that increased cell
death could facilitate virus spread. In the developing CNS, apoptosis is used to
remove incorrect or weak synapses. As the brain matures, surviving neurones become
more resistant to apoptosis. For example, SFV A7(74) infection of immature neurons
of the suckling mouse brain results in death by apoptosis, whereas SFV A7(74)
infection of the adult mouse brain results in a persistent infection (Allsopp et ah,
1998; Allsopp and Fazakerley, 2000; Fazakerley, 2002). Additionally, the rostral
migratory stream, which is an area of the brain where neurones are constantly being
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replaced and differentiating, is the only area of the adult mouse brain to show
apoptotic neurones upon infection with avirulent strains (Sammin et al., 1999).
SFV Replication
SFV entry into a cell is mediated by a yet unknown cellular receptor, although Sindbis
virus entry is mediated via interactions with the laminin receptor (Tsai et al., 2002).
During a virulent infection the enveloped virion enters the cell by endocytosis
(reviewed in Kielian and Jungerwirth, 1990). Fusion of the envelope with the
endosome membrane is dependent upon the acid pH altering the conformation of the
spike protein (Wahlberg and Garoff, 1992). The El spike protein mediates fusion
between the virus and the vesicle membrane resulting in nucleocapsid release into the
cytoplasm. The acidic conditions of the vesicle also promote conformational changes
in the capsid protein exposing ribosomal binding structures and uncoating of the viral
RNA (Grimley et al., 1968; Grimley and Freidman, 1970). Viral replication is
associated with cytopathic vacuoles (CPV) I and II (Kujala et al., 2001); these are
developed from endosomes and lysosomes. CPV I are covered in viral protein
complexes (sperules), containing the viral non-structural proteins and are the sites for
viral replication. Virus maturation occurs on CPV II, these vacuoles then translocate
to the plasma membrane for virion release (Pathak et al., 1976). Spikes protrude from
the budding SFV virion envelope and are comprised of three E1-E2 heterodimers per
spike. The C'terminal end of E2 associates with the capsid protein, which in turn is
associated with viral RNA. The interactions between the capsid and E2 proteins drive
virus budding and virion release (Suomalainen et al., 1992).
SFV is a single-stranded, positive-sense enveloped RNA virus. It has an 11 kb genome
composed of two open-reading frames, the non-structural genes (nsPl, nsP2, nsP3, nsP4)
and the structural genes (C, E2, E3, 6 kDa, El; Figure IE). The 5' non-structural proteins
(nsP) are translated into a polyprotein (Takkinen et al., 1986), nsPl, 2, 3 and 4, which is
processed by the viral protease nsP2. Together these proteins form the replicase complex
which synthesizes full length negative strands to be used as templates for the production of
more genomic and then sub-genomic transcripts. Cis cleavage at the nsP3:nsP4 junction
enables minus strand synthesis, further trans cleavage at the nsPl :nsP2 junction allows
both minus and positive strand synthesis and the final cleavage separating nsP2:nsP3
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terminates minus strand synthesis and switches the replicase to synthesis of the subgenomic
RNA (Lemm and Rice, 1993a; Lemm et al., 1993b; Shirako and Strauss, 1990; Shirako and
Strauss, 1994).
nonstructural proteins
5'ut| nspT nsP2 nsP3 nsP4
Promoter
structural proteins
c | ii~ El 3'UT
e3 6k
Figure IE: SFV genome
The non-structural proteins (nsP), which form the replicase complex, are encoded at the 5'
end of the genome. The structural proteins are encoded at the 3' end of the genome after a
sub-genomic promoter.
Roles of the Non-Structural Proteins
NsP1
NsPl is involved in the capping of viral RNAs, possesses methyl- and guanyl-transferase
activity, aids initiation of negative strand RNA synthesis, and localises the replicase
complex to cellular membranes (Ahola et al, 1997; Peranen and Kaariainen, 1991; Hahn et
ah, 1989). NsPl plasma membrane attachment is essential for its capping activities
(reviewed in Salonen et ah, 2005). NsPl attachment to membranes is mediated by an
amphipathic helix and reinforced by palmitoylation (Laakkonen et ah, 1996). Disruption of
palmitoylation attenuates the virus. If the nsPl threonine residue 538 of virulent SFV4 is
changed to isoleucine as found in avirulent strains this attenuates the virus (Heise et ah,
2003). The 538 residue forms part of the nsPl :nsP2 cleavage site, insertion of the
isoleucine residue enhanced processing of the cleavage but reduced virulence.
NsP2
NsP2 possesses ATPase and GTPase activity (Rikkonen et ah, 1994a) as well as RNA
triphosphatase and RNA helicase activities (Gomez de Cedron et ah, 1999). It is involved
in terminating negative strand production and in controlling subgenomic RNA synthesis
(Suopanki et ah, 1998). It also cleaves the non-structural polyprotein through its papain-
like protease domain (Merits et ah, 2001) and contains a nuclear targeting sequence which
induces nuclear translocation of approximately 50% of nsP2 (Rikkonen et ah, 1992;
Rikkonen et ah, 1994b). An nsP2 mutant, SFV4nsP2-RDR where the central arginine
residue of the nuclear translocation signal (RRR) is converted into an aspartic acid (D),
revealed that this sequence was not essential for viral replication but was a determinant of
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neurovirulence (Fazakerley et al., 2002; Rikkonen, 1996). In vitro, SFV4nsP2-RDR
replicated comparably to SFV4 with reduced protein synthesis. In vivo, mice inoculated
intracranially with SFV4nsP2-RDR survived whereas those infected with SFV4 virus died.
SFV4 infected mice had higher brain virus titres than the mutant virus. To determine the
role of the IFN response within this pathology, both viruses were inoculated into IFNAR_/~
mice; all mice succumbed to infection regardless of the inoculating strain and produced
similar virus titres (Fazakerley et al., 2002). This suggests several possibilities; firstly that
in vivo SFV4nsP2-RDR does not replicate as well as SFV4 and that this slower replication
allows time for control by the IFN response; secondly that SFV4 can suppress the IFN
response, or is not susceptible to it, whereas the SFV4nsP2-RDR virus cannot suppress the
response or is susceptible to it. Research with SV indicates that mutation of the nsP2 P726
residue, conserved throughout the alphaviruses, suppresses cytopathic effect and increases
IFN production (Frolova et al., 2002). Similar observations were made in vivo, suggesting
that nsP2 has a role in IFN suppression.
NsP3 and nsP4
NsP3 is a phosphoprotein involved in RNA synthesis (Peranen et al., 1988).
Experiments comparing the virulence of chimeric viruses containing segments from
virulent and avirulent strains, demonstrated that when virulent nsP3 and nsP4 proteins
were expressed in an avirulent genetic background, high virus titres were observed in
the brain and 95% of the mice died i.e. the virus was virulent. When only nsP3 was
replaced, widespread infection was still observed throughout the cortex and
cerebellum (Tuittila et al., 2000). The avirulent strain nsP3 protein possesses a 7
amino acid deletion at its C terminal end, which includes five hydrophobic amino
acids. However, when the deletion was replaced (with the virulent strain sequence),
the new virus was still unable to replicate efficiently and showed no clinical
symptoms in infected mice. The avirulent nsP3 also has an opal stop codon at the
3'end. When the opal codon was altered to arginine, virulence was increased; 1/20
mice died and 5 were paralysed (Tuittila et al., 2000). However, several other
neurovirulent alphaviruses possess an opal codon at the 3'end of nsp3 e.g. Ross River,
Eastern and Western equine encephalitis, Sindbis and Middelburg viruses,
questioning the importance of the opal codon in SFV virulence (Strauss et al., 1983).
NsP4 is the viral RNA polymerase (Keranen & Kaarianen, 1979).
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The Involvement of the Immune Response
Avirulent infections can be cleared from the blood of immunocompetent mice within
three days and from the brain within 8 days (Fazakerley, 1993). IgM can be isolated
from the blood within a few days and is followed by IgG2a and a slow
accummulation of IgGl (Fazakerley, 1993). By 4 days post-infection, plasma cells
can be detected within the brain. Initial production of IgM neutralises virus but
cannot completely clear the infection. A secondary wave of IgG2a is required for
complete removal of infection (Amor et al., 1996). In support of this, infected pMT
mice, which lack B cells, show continued cycling of viral RNA species over several
months (unpublished data, Rennos Fragkoudis). However, T-cells play a critical role
in SFV immune responses. T-cell deficient mice, nu/nu mice, clear infectious
avirulent A7(74) virus from their blood but cannot completely clear it from the brain.
The brain requires IgG antibodies to clear the virus infection. In the absence ofCD4+
T-cells, B cell Ig class switching is not induced and so no neutralising IgG antibody is
produced (Amor et al., 1996; Fazakerley and Webb, 1987). SCID mice, which lack
all forms of adaptive immunity, are unable to clear A7(74) infection, but they survive
for several weeks before succumbing to the infection (Amor et al., 1996). Passive
transfer of SFV specific IgM or IgG prevents death but does not entirely remove the
virus emphasizing the necessity of T-cells for complete viral clearance (Amor et al.,
1996). The major cerebral infiltrating cells are CD8+ T-cells with a few B cells
(Amor et al., 1996; Morris et al., 1997). Cytotoxic T-cells have been associated with
primary demyelination (Mokhtarian et al., 2003). IFN-y is released by T-cells and is
associated with neuronal SFV immune responses. IFNGR"7" mice demonstrate higher
levels of neuronal necrosis than wt mice; this is associated with increased viral
antigens and high numbers of macrophage and B cells (Keogh et al., 2003). No
difference is observed in the levels of demyelination between IFNGR"/_ and WT mice.
Following an i.p. infection, type I IFNs are released. Other cytokines such as IL-la, -
ip, -3, -6, -10 and TNF-a are also observed although their role has yet to be
determined (Moris et al., 1997).
Semliki Forest Virus and Interferons
During an SFV infection, blood levels of IFN correspond to levels of viraemia
(Bradish et al., 1975). When SFV-infected L-cells are treated with anti-IFN
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antibodies, larger plaques develop than when cells are untreated. In vivo, treatment of
mice with anti-IFN antibody increases brain virus titres and mortality (Fauconnier,
1969). In the CNS, SFV antigen expression is reduced when mice are treated with
IFN-a/p (Morris et al., 1986). Several other experiments provide evidence for the
protective effect of IFN against SFV. The protective effect of IFN, given prior to
virus infection, is proportional to the amount of IFN given (Finter et al., 1966).
Administration of a dose of IFN earlier than 48 hours prior to infection results in the
loss of the protective effect. Also, endogenous IFN induces a greater protective effect
than administered IFN, as mice previously infected with Newcastle Disease virus are
protected against an SFV challenge to a greater degree than those treated with high
doses of IFN (Finter et al., 1966). When IFN is administered 24 hours prior to
infection with L10 SFV it delays death; however, when mice are treated with poly I:C
4 hours prior to L10 SFV infection, the infection is rendered avirulent (Bradish and
Titmuss, 1981). Similar IFN concentrations from mixed samples of blood, muscle
and spleen are induced by the virulent VI3 strain and avirulent A7 strains (Smillie et
al., 1973). Mice infected with A7 are protected against VI3 challenge, 63 hours later
(Smillie et al., 1973), and mice infected with A7(74) three hours prior to challenge
with LI0 are protected against panencephalitis (Oliver, 1997). Only small foci of
brain infection are apparent, suggesting SFV A7(74) stimulates an antiviral response,
most likely IFN, that can control the SFV L10 infection. The importance of the IFN
response in containing an SFV infection is further demonstrated in IFNAR~/_ mice,
infection with all strains of SFV results in death within 2 days (Bradish et al., 1975;




The aim of this thesis is to further investigate the interactions between IFN and SFV.
To date studies have demonstrated SFV sensitivity to IFN and the ability of SFV to
induce IFN.
Questions to be addressed:
1) Does SFV4 induce IFN?
In vitro in cell cultures, the L10 and A7 strains of SFV are well-known inducers of
type I IFN responses; however, the IFN response to the molecularly cloned SFV4 has
not been studied.
2) Is the brain IFN system activated by SFV infection?
Recently, IFN-a mRNA transcripts have been detected in the brains of SFV4 infected
adult mice (McKimmie et al., 2005). The dynamics of the IFN response and its
relationship to the levels of virus have not been studied.
3) Do suckling mice induce differential levels of IFN in comparison to
adult mice?
In mice up to the age of 12 days, SFV A7(74) causes severe infection; in adult mice
the infection is avirulent (Fleming, 1977, Oliver et al., 1997). The pathology of the
infected adult mouse brain demonstrates foci of SFV A7(74) infection, implying that
the virus cannot spread between neurones. One explanation of this is that a host
defence mechanism is controlling the infection in adult mice, but that this does not
function or is impaired in suckling mice. This could be an impaired ability of
immature (post-natal) CNS cells to produce or respond to IFN.
4) What is the role of PKR in the IFN response to an SFV4 infection?
Induction of IFN-P requires the activation ofmultiple transcription factors, including
NF-kB. PKR is a cytoplasmic, dsRNA-activated kinase, which terminates host cell
translation and promotes inflammation by activating NF-kB. PKR is not essential for
IFN-P induction during several virus infections; however, the role ofPKR in IFN-P
induction during alphavirus infections has not been investigated.
5) Do virulent and avirulent strains induce different amounts of IFN?
There are several strains of SFV; these can be divided into two groups, those that
cause panencephalitis in adult mice and those that present a restricted neuronal
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infection. These differences in pathology could be attributed to differential induction
oflFN.
5) Does SFV4 antagonise the IFN response?
Viruses from many families have developed mechanisms to antagonise the IFN
system. Ross River virus antibody dependent enhanced infection of macrophages
suppresses the expression of IFN-P and TNF-a by reducing nuclear NF-kB and other
transcription factor complexes (Mahalingham and Lidbury, 2002). However, no area
of the alphavirus genome has yet been identified as an antagonist of IFN expression.
NsP2 mutants of Sindbis virus and SFV induce higher levels of IFN or induce less
neuropathology and lower virus titres than wt virus, respectively (Frolova et al., 2002;
Fazakerley et al., 2002). When the SFV nsP2 mutant is inoculated into IFNAR"'"
mice, the pathology and virus titres are equivalent to those induced by wt virus.
Possible explanations are that the nsP2 mutation affects replication and that the
reduced level of replication enables the host immune system to control the infection
or that wt virus can suppress the IFN response, or is not susceptible to it, whereas the
mutant nsP2 virus cannot suppress the response or is susceptible to it.
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Cell lines, culture conditions & virus strains
BHK-21 cells were kindly provided by Deborah Allen (CID, Edinburgh); the cells
were maintained in 10 % new born calf serum (NBCS, Invitrogen) Glasgows
modified essential medium plus 10 % tryptose phosphate broth (Invitrogen), penicillin
and streptomycin (P/S, final concentration 100 U/ml penicillin and 100 pg/ml
streptomycin, Merck BDH) and L-Glutamine (2 mM, Merck BDH). L-929 cells were
kindly provided by Deborah Allen (CID, Edinburgh) and cultured in 10 % foetal calf
serum (FCS) Dulbecco's modified Eagles medium supplemented with P/S (100 U/ml
/100 pg/ml) plus L-Glutamine (2 mM). PKR_/" and WT 129/Sv/Ev mouse embryo
fibroblasts (MEFs) were grown from 13.5 day old embryos; MEF preparation is
described in detail below. MEFs were maintained in 10 % FCS DMEM plus P/S (100
U/ml / 100 pg/ml) plus L-Glutamine (2 mM). The virus strains, SFV4, L10, A7(74),
SFV4nsP2RDR and SFV4nsP3A50 were kind gifts from Professor Leevi Kaariainen
(University of Helsinki, Finland). The SFV vectors pSFV10bl2A-NP and
pSFV10RDRbl2A-NP were kindly provided Pia Dosenovic (Karolinska Institutet,
Sweden); the IFN-(3 plasmid pSFV4-ifnb was kindly provided by Kathrina Quinn
(Trinity College Dublin, Ireland).
Passaging adherent cell lines
At confluence, the culture media was removed and the cells were washed with 0.02 %
Versene. Five ml trypsin / EDTA (Invitrogen) was incubated with the cells for
several minutes until they could be tapped free from the plastic. Trypsin was
inactivated by the addition of 25 ml 10% FCS / NBCS media; this cell suspension was
then centrifuged at 450 x g for 5 minutes to pellet the cells. The cell pellet was re-
suspended in 2 ml 10% FCS / NBCS media. Ten pi of cell suspension was added to
90 pi trypan blue. This mixture was placed on a haemocytometer so that the mean
number of cells per ml of cell suspension could be determined. The mean number of




Mean number of cells per square x dilution factor (10) x total volume of a square
(104) x final volume of cell suspension (2) = Mean number of cells per ml of cell
suspension
Approximately 3 - 5 x 106 cells, cell type dependent, were seeded into a T175 flask in
30 ml medium to facilitate continued growth of the cell line.
Mouse Embryo Fibroblast (MEF) production
Mice were sacrificed by cervical dislocation after 13.5 days of pregnancy. The dead
mice were sprayed with 70 % alcohol; two incisions were made at the base of the
peritoneum and the cuts were extended rostrally along the flank of the animal. The
exposed uterine horns were removed and washed in sPBS (150 mM; 2.5 mM KC1, 10
mM Na2HP04,1 mM KH2PO4 (pH 7.4)). Each embryo was released from its amniotic
sack and transferred into a separate dish containing sPBS. Neuronal and hepatic
tissues were removed by decapitation and extraction; the remaining embryonic tissue
was cut using a scalpel blade in 1 ml trypsin/EDTA. A further 1 ml trypsin/EDTA
was added to the tissue homogenate, which was then repeatedly triturated with a 1 ml
pipette and incubated at 37°C for 10 minutes. Following the incubation, another 2 ml
trypsin/EDTA was added and the homogenate re-triturated and re-incubated. The
digested tissue was transferred to a universal tube and the supernatant was removed
and placed in a separate universal tube, which was then topped up with media (10 %
FCS DMEM plus P/S plus L-Glutamine). This was centrifuged at 450 x g for 5
minutes; the cell pellet was resuspended in 10 ml of media and spun again. Following
the second wash the cell pellet was suspended in 10 ml of media and transferred to a
T80 cell culture vessel to facilitate cell growth.
Infection of cells for functional IFN studies
Chamber slides were seeded with 2x105 of either L-929 cells or MEFs in 10 % FCS
DMEM and incubated at 5 % CO2 and 35°C for 24 hours. At 80-90 % confluence the
growth media was removed and the cells were washed with sPBS. Each well was
inoculated for 1 hour at room temperature with 400 pi of virus suspension. After 1
hour, the inoculum was removed, the monolayers washed twice with sPBS and then
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covered with 1.5 ml of 0.5 % or 2 % FCS DMEM for L-929 cells or MEFs,
respectively. The chamber slides were incubated at 5 % CO2 and 35°C for 20 - 24
hours. Following incubation 700 pi of supernatant was collected for plaque assays
and 700 pi was collected for the CPERA to determine the levels of infectious virus
and functional IFN, respectively. Once the supernatant had been removed the
monolayers were washed twice with sPBS and fixed prior to SFV nsP3
immunostaining.
Infection of cells for RNA extraction
T20 flasks were seeded with approximately lxlO6 MEFs or lxl06 L-929 cells in 10 %
FCS DMEM. For each time point or virus strain investigated T20 flasks were set up
in triplicate. At confluence the culture media was removed and the monolayers were
infected as described in 'Infection of cells for functional IFN studies'.
Animal Experiments
Infection of mice
All of the adult mice used in this thesis were aged 4-6 weeks; wild type 129/Sv/Ev
mice and PKR_/" mice were inoculated intracranially with 5xl03 pfu in 0.2 pi PBSA or
• • • • T
with PBSA alone, Balb/c mice were inoculated intraperitoneally with 1x10 pfu of
SFV L10. Neonates, four days old (P4), derived from 129 mice were inoculated
intranasally; 50 pi of lxl0s pfu/ml SFV4 were placed on the nostrils and inspired.
Perfusion
Mice were deeply anaesthetised with halothane and the thorax opened to expose the
heart. A butterfly needle attached to a 50 ml syringe filled with sPBS was inserted
into the left ventricle and the sPBS was slowly perfused in. Maintenance of a pulse
during the procedure is necessary to pump the sPBS throughout the body to remove
all of the blood. The sPBS was continually passed through the heart until the skin




Animals were killed by exposure to CO2 according to the Home Office regulations;
the animals were scalped and an incision made into the base of the skull. This
incision was extended along the sides of the skull at the widest point up until the eye
socket. The skull was carefully lifted away from the brain; the top of the spinal cord
was cut and the hemispheres of the brain separated bilaterally down the midline and




Two pg RNA from an infected cell culture was made up to a total volume of 10.5 pi
with RNase free water. One pi of 50 pM of the 3'SFV4nsP2RDR or 3'SFV4nsP3A50
primer and 1 pi 40 pM dNTP mix (Promega) was added to the RNA then incubated at
65°C for 5 minutes. Following the initial denaturing phase, the samples were cooled
on ice for 5 minutes then incubated with 4 pi 5x buffer (Invitrogen), 2 pi 0.1 M DTT
(Invitrogen) and 40 U RNaseln (Promega) for 2 minutes at 42°C. Two hundred U of
superscript II Murine Moloney leukaemia virus reverse transcriptase (Invitrogen) was
added to the reaction mix and incubated for a further 58 minutes at 42°C. The
reaction was completed with 15 minutes at 70°C.
High fidelity PCR
Platinum Pfx DNA polymerase (Invitrogen) was used to clone fragments spanning the
SFV4nsP2RDR and SFV4nsP3A50 mutations for sequencing. Individual reactions
were set up as described below for 50 pi final volume.
10 X Pfx amplification buffer 5 pi
10 mM dNTP mix 1.5 pi
50 mM MgS04 1 pi
Primer A (50 pM) 1 pi
Primer B (50 pM) 1 pi







Tubes were briefly centrifuged and then the template DNA was denatured for 2 mins
at 94°C. Samples can directly enter the amplification cycles as the polymerase is
antibody bound, so does not require a 'hot start' for greater specificity. Samples were
processed through thirty rounds of 94°C for 15 seconds, 55°C for 30 seconds and
68°C for 2 minutes. Followed by 10 minutes at 68°C for the final extension stage.
TOPO® Cloning
One pi of PCR product, 1 pi salt solution, 3 pi sterile water and 1 pi pCR®II-Blunt-
TOPO® were added in the order described to set up the TOPO® cloning reaction
(Invitrogen) and were incubated at room temperature for 7 minutes. Two pi of the
TOPO® cloning reaction were added to a vial of chemically competent DH5a E.coli
cells and incubated on ice for 20 minutes. The cells were exposed to 42°C for 30
seconds and then transferred to ice. Two hundred and fifty pi of SOC media (lx LB
broth, 20 mM glucose, 20 mM MgCl2) was added to the vial, which was shaken for 1
hour at 37°C. Following the incubation, 50 pi or 100 pi of the bacterial suspension
were added to and spread across LB agar (1 x LB broth, 1.5 % (w/v) bacto-agar) plus
kanamycin plates (50 mg/ml), which were incubated overnight at 37°C. The next
morning three colonies were selected and transferred into 3 universals containing 5 ml
Luria Bertani broth (1 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 1 % (w/v) NaCl)
plus kanamycin and shaken at 37°C for 8 hours. Mini-preps following the Qiagen
mini-prep protocol were prepared for each culture and the extracted DNA was
sequenced in the Biomedical Sciences Molecular Pathology Unit, University of
Edinburgh.
DNA Extraction
DNA was extracted in accord with the Qiagen mini-prep protocol; briefly 5 ml of
bacterial culture was spun at 360 x g for 5 minutes. The pellet was resuspended in
250 pi of buffer PI, 250 pi of buffer P2 was added to the suspension which was then
gently inverted 4-6 times. To this, 350 pi of buffer N3 was added and the
suspension was inverted 4-6 times immediately afterwards. This was centrifuged at
maximum speed > 8000 x g for 10 minutes on a bench top centrifuge. Following the
spin, the supernatant was spun through a Qiagen spin column for 1 minute at
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maximum speed on a bench top centrifuge and the flow-through discarded. The
column was washed with 750 pi of buffer PE and centrifuged as before. The flow-
through was removed and the column spun for a further minute. The DNA was eluted
with 50 pi of buffer EB (10 mM Tris.Cl, pH 8.5); the buffer was added for 1 minute
and then the DNA was eluted by centrifugation.
Purification of SFV
Ten T175 flasks were seeded with BHK-21 cells, which were grown to confluence in
10 % GMEM. At confluence, the cells were infected at a moi 0.01 of virus in 2 ml
media for 1 hour at room temperature. Following infection, the monolayers were
incubated in 40 ml 10 % GMEM for 24 - 48 hours, until CPE was observed. The
supernatants were collected and clarified by centrifugation at 7,000 rpm (Sorvall GSA
rotor) for 20 minutes. To the supernatant, 23 g/L NaCl and 70 g/L PEG 8,000 were
added, the suspension was continually stirred overnight at 4°C. After the overnight
incubation, the suspension was centrifuged as before (7,000 rpm for 20 minutes) and
the pellet was resuspended in 8 ml of low salt buffer (0.15 M NaCl, 10 mM Tris pH
7.4). Sucrose gradients were prepared in SW41 centrifugation tubes ranging from 20
% to 70 % in increments of 10 %; 4 ml of the virus suspension was placed on top of
the gradients. The virus suspension was separated by overnight centrifugation at
35,000 rpm on an SW41 rotor. Two ml of material surrounding the virus band was
removed and each of the bands from all of the tubes were pooled and diluted with low
salt buffer. The purified virus was pelleted by centrifugation at 35,000 rpm on an
SW41 rotor for 1 hour at 4°C and the pellets were resuspended in 200 pi low salt
buffer.
Plaque assay
BHK cells were seeded at 4xl05 onto 6 well plates in 2 ml 10 % GMEM and
incubated at 5 % CO2 and 37°C until they reached 80 % confluence. At 80 %
confluence, the growth media was removed, the cells washed with sPBS and infected
with 400 pi of virus suspension. A series of ten-fold virus dilutions were prepared in
sPBS, each dilution of virus was tested in duplicate. Infected cells were incubated for
1 hour at room temperature in a damp tissue culture box. Two ml ofmolten,
approximately 45°C, 2 % FCS DMEM mixed at a 10:3 ratio with 4 % agar was added
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to the cells and allowed to set. The plates were incubated for 48 hours at 5 % CO2
and 37°C. After incubation, the cells were fixed with 2 ml 10 % neutral buffered
formaldehyde solution for 3 hours; this was removed along with the agar plug and the
cells were stained with 0.1 % Toludine blue for >1 hour. The stain was removed and
the plaques counted, to calculate the pfu per ml the following calculation was applied:
Mean pfu per well x dilution factor x 2.5 = pfu/ml
Cytopathic effect assay
L-929 cells were seeded at 3xl04 cells per well in a 96 well plate in 0.1 ml 10 % FCS
DMEM and incubated for 24 hours at 5 % CO2 and 37°C. At confluence, the culture
media was replaced with 100 pi 0.5 % FCS DMEM and a further 50 pi of virus
solution from a specific 10-fold serial dilution step was added in quadruplicate (see
Table 2A).
1 2 3 4 5 6
NEAT NEAT NEAT NEAT MEDIUM MEDIUM
10"' 10"1 10"' 10"' MEDIUM MEDIUM
10"' 10"' 10"' 10"' MEDIUM MEDIUM
10"' 10"' 10"' 10"' MEDIUM MEDIUM
10"4 10"4 10"4 10"4 MEDIUM MEDIUM
10"' 10"' 10"' 10"' MEDIUM MEDIUM
10"b 10"b 10"b 10"b MEDIUM MEDIUM
10"' 10"' 10"7 10"' MEDIUM MEDIUM
Table 2A: Cytopathic Effect plate design
Columns 1-4 contain quadruplicate repeats of virus dilutions and columns 5 and 6 were
incubated with media for controls. If the virus needed to be diluted further for quantification
the above set up was repeated across the remainder of the 96-well plate starting at dilution
10"8.
Plates were incubated at 5 % CO2 and 37°C, and checked after 24 hours for cytopathic
effect. The TCID50, the tissue culture infectious dose resulting in the death of 50 % of
cells, was determined by the number ofwells showing a cytopathic effect and
calculated by the Karber method:
Log10 TCID50 / 50 pi = L - d(s - 0.5)
Where L = log of the lowest dilution (-1)
d = difference between dilution steps




Detection of SFV nsP3 by NovaRED™
Monolayers were fixed for 20 minutes with 4 % paraformaldehyde and then washed
with sPBS. Cells were treated with 0.1 % Triton-XlOO for 5 minutes to permeate the
lipid membrane and then washed with sPBS. This treatment was followed with a 30
minute CAS block (Zymed) incubation; the block was not washed off prior to addition
of primary antibody. Excess block was drained off the slides. The primary antibody
was a monoclonal rabbit anti-SFVnsP3 antibody supplied by T. Ahola (Institute of
Biotechnology, University ofHelsinki). Four hundred pi of a 1:3000 dilution of
primary antibody in CAS block was incubated with the slides for 1.5 hours at room
temperature on a rocking platform. After incubation the cells were washed three
times for 5 minutes in PBS, again on the rocking platform. The secondary antibody
was a biotinylated goat anti-rabbit IgG (Vector Laboratories). Four hundred pi of a
1:400 dilution of the secondary antibody in CAS block was incubated with the slides
for 1 hour at room temperature on a rocking platform. The cells were washed as
before. Addition of the Vectastain Elite ABC reagents following incubation with the
secondary biotinylated antibody increased the sensitivity of the staining. The reagent
consisted of a preformed avidin and biotinylated horseradish peroxidase
macromolecular complex, which was prepared by the addition of 2 drops of reagent A
and 2 drops of reagent B to 10 ml PBS; the solution was mixed following the addition
of each reagent. This was allowed to stand at 4°C for 30 minutes prior to addition to
the slides. On completion of the three 5 minute washes in PBS the Vectastain reagent
was incubated with the slides at room temperature for 30 minutes and then washed as
before. To visualise the immunostaining, a NovaRED™ chromogen was used
(Vector Laboratories). NovaRED™ substrate was prepared immediately before use; 3
drops ofReagent 1 were added to 5 ml of distilled water and mixed, followed by 2
drops ofReagent 2, 2 drops of Reagent 3 and 2 drops of the Hydrogen Peroxide
Solution. The solution was mixed after the addition of each reagent. NovaRED™
was added to the slides and incubated in the dark for approximately 5 minutes and
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then rinsed immediately with water. Each of the slides was counter stained with
Haematoxylin (Vector Laboratories) at 1/10 dilution until appropriately stained and
then mounted in aqueous mounting media (Dakocytomation).






1 / 200 (T. Ahola, Elniversity ofHelsinki)
1/100 (Mauro D'Amato, Karolinska Institutet)
1 / 200 (Santa Cruz Biotechnology)
1 / 200 (T. Ahola, University ofHelsinki)
Secondary antibodies
Donkey a-goat Cy 3 1 /1000 (Jackson Immunoresearch)
Donkey a-mouse Cy 2 1 /100 (Jackson Immunoresearch)
Donkey a-rabbit texas red 1/200 (Jackson Immunoresearch)
Goat a-rabbit FITC 1 / 450 (Jackson Immunoresearch)
HOERST 1 /1000 (Molecular probes, Eugene, Oregon)
Cells were grown on coverslips, infected at moi of 1 and then fixed by washing in
sPBS and then incubating in 4 % paraformaldehyde for 8 minutes at room temperature
followed by ice-cold methanol for a further 8 minutes at - 20°C. The methanol was
washed offwith PBS prior to being blocked for 1 hour at room temperature with
serum (2.5 ml horse sera, 100 pi NaN3 (sodium azide, 10 % stock) and 47.5 ml PBS).
The block was drained from the cells and the specific primary antibody added at the
designated concentration diluted in the serum solution and incubated for 1.5 hours at
room temperature in the dark. The primary antibody was removed by washing the
cover slips 3 x with PBS; the secondary antibody was incubated on the cells for 1
hour in same blocking buffer. Excess secondary antibody was removed by washing
the cells 3 x in PBS then once with pure water. The coverslips were mounted using
vinol mounting media (Fukui et ah, 1987). Excess mounting media was washed away
and the slides were allowed to dry.
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Cytopathic Effect Reduction Assay (CPERA)
Production of Laboratory IFN Standards
Three T-175 flasks were seeded with 2xl06 L-929 cells in 50 ml 10 % FCS DMEM
and incubated at 5 % CO2 and 37°C until 48 hours post confluence (approximately
four days). The growth media was removed and the monolayers washed twice with
15 ml DMEM. The cells were infected with a moi 10 of either L10 SFV or A7(74)
SFV diluted in 2 ml serum free DMEM and incubated with the virus for 1 hour at
room temperature. The third flask was mock infected with serum free DMEM. After
one hour the virus was removed and the cells were washed twice with 15 ml DMEM,
then immediately covered with 50 ml protein free DMEM containing 1 mM
phenylmethylsuphyl fluoride (PMSF, Sigma), a protease inhibitor, and incubated for
approximately 24 hours at 37°C and 5 % CO2 until cells exhibited a clear CPE. At
this point, the culture fluid was harvested and centrifuged at 7,700 x g for 20 minutes
at 4°C to remove any cellular debris. To inactivate infectious virus, the supernatant
was left for 4 days at 4°C and pH 2. This was achieved by adding 1 M HC1 to the
culture fluid. After 4 days the fluid was neutralised with 1 M NaOH and stored at -
70°C in the presence of 1-3 mg/ml BSA and 1 mM PMSF.
Determination of the quantity of IRS IFN required to achieve 50 % cell
viability
A CPERA was performed for 5, two-fold dilution series of International Reference
Standard (IRS) IFN murine IFN alpha/beta (GU02-901511 Braton Biotech Inc,
NIAID). The average 50 % end point was determined. This is the amount of IFN
required to maintain 50 % cell viability during an EMCV infection and was calculated
to be 0.45 International Units (IU) IRS IFN.
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Preparation of samples for CPERA
In vitro supernatants
Supernatants were centrifuged at 8000 x g in a bench top centrifuge, acidified to pH 2
with 1 M HC1 and incubated at 4°C for 4 days. After incubation samples were
neutralised to pH 7 with 1 M NaOH and stored at -70°C.
In vivo - brain samples
The average weight of an adult half brain is 0.3 g. A 1:10 (weight: volume) dilution
was made by homogenising the brain in 2.7 ml sPBS and 1:1000 dilution of protease
inhibitor cocktail (Sigma); the homogenate was passed through a 21 G needle 5 times
to dissipate tissue clumps, then centrifuged at 8000 x g in a bench top centrifuge for 5
minutes; the supernatants were then collected and acidified as above.
CPERA
In a 96 well plate, 3xl04 L-929 cells were seeded per well in 0.1 ml 10 % FCS
DMEM supplemented with 1 % L-glutamine. The plates were incubated overnight at
5 % CO2 and 37°C until a confluent monolayer was formed. In a separate 96-well
plate, a 2-fold dilution series of the IFN samples was prepared (See Table 2B). To
each well, except wells A2 - A12, 0.1 ml 0.5 % FCS DMEM was added. To wells A2
and A6, 0.2 ml of 1:10 laboratory standard IFN: DMEM was added. Wells A3 - A5,
A7 - A9 and A10 - A12 contained 0.2 ml of three different samples repeated in
triplicate. A two-fold dilution series was then created down the test columns by
transferring and mixing 0.1 ml from row A into row B; this was repeated down the
plate. After tituration of row H, the extra 0.1 ml was discarded and the plates
incubated at 5 % CO2 and 37°C for 30 minutes to re-equilibrate the pH of the media.
The growth media from the cell plates was then removed and replaced with the
prepared dilution series, and the plates were re-incubated for a further 24 hours at 5 %
CO2 and 37°C. After incubation, the IFN samples were removed and replaced with a
challenge virus suspension. Encephalomyocarditis virus was added to the cells at 300
TCID50 per 0.1 ml 0.5 % FCS DMEM. Column 1 (no IFN standard or test sample)
served as cell and virus controls. Wells A1 - D1 received 0.1 ml 0.5 % FCS DMEM
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and wells El - HI, 0.1 ml challenge virus suspension. The plates were incubated at 5
% CO2 and 37°C until complete CPE was observed in the virus controls, usually after
approximately 48 hours. When complete CPE was observed in the virus controls, the
media was removed from all the wells and replaced with fresh 0.5 % FCS DMEM.
Ten pi ofWST-1 cell proliferation reagent (Roche) was then added to each well and
the absorbance read immediately at 420 - 480 nm on a MRX microplate reader
(Dynex Technologies). The plates were incubated in the dark at 5 % CO2 and 37°C
for three hours and then read again. Viable cells cleave the WST-1 tetrazolium salts
to formazan through their mitochondrial dehydrogenases; the activity of these
enzymes directly correlates to the number ofmetabolically active cells in the culture.
The level of formazan is determined by measuring absorbance values upon addition of
the WST-1 reagent and again 3 hours later. An advantage of this reagent is that
hydrolysis of tetrazolium salts to formazan is not accompanied by high background
readings which can be observed with traditional dyes.
To determine the amount of functional IFN within a test sample: Primarily a mean
value for each of the dilutions of the two-fold dilution series was obtained for each
sample, this data was graphically represented on a linear scatter graph, where the
absorbance readings were plotted against the two-fold dilution series. A threshold
was determined, the 50 % end point, which was equivalent to the halfway value
between the absorbance readings of the cell and virus controls. The point at which the
test sample crossed the threshold was determined from the graph (Figure 2A). This
was multiplied by its reciprocal dilution factor and 0.45 IU to determine the initial
amount of IFN added to the CPERA; the amount of IFN per ml of supernatant or g of
brain was then determined for each sample.
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40 80 120 160 200 240 280 320 360 400
Reciprocal dilution
Figure 2A: Graphical representation of the absorbance values of IFN standard
and test samples after incubation with WST-1 reagent for 3 hours
Each point for each graph is equivalent to a dilution within the two fold dilution series, the
blue line represents standard IFN and the pink and yellow lines represent two test samples.
The black horizontal line is the 50 % end point threshold; the point at which each sample
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Materials & Methods
Swedish IFN bioassay
(Miller and Anders, 2003)
L-929 cells were seeded at a density of 1.5 x 103 per well in a 96 well plate in 100 pi
10 % FCS DMEM and incubated for 24 hours at 5 % C02 and 37°C, until 90 %
confluent. At 90 % confluence, the media was removed by shaking the plate upside
down and replaced with 50 pi 10 % FCS DMEM. Samples were tested in duplicate
and diluted across the plate in a two-fold dilution series. The first and last rows were
excluded from the experiment and used as virus controls (Table 2C). Fifty pi of
sample was added to the first well of each row, mixed and then transferred into the
next well along the plate. This was repeated until the end of the row. An IFN standard
was included on each plate, supplied by the NIH reference centre. The samples were
incubated with the cells for 24 hours at 5 % C02 and 37°C.
1 2 3 4 5 6 7 8 9 10 11 12
A Virus Control
B Sample la 1 2 4 8 16 32 64 128 256 512 1024 2048
C Sample lb 1 2 4 8 16 32 64 128 256 512 1024 2048
D Sample 2a 1 2 4 8 16 32 64 128 256 512 1024 2048
E Sample 2b 1 2 4 8 16 32 64 128 256 512 1024 2048
F Sample 3a 1 2 4 8 16 32 64 128 256 512 1024 2048
G Sample 3b 1 2 4 8 16 32 64 128 256 512 1024 2048
H Virus Control
Table 2C: Swedish IFN bioassay plate set up
The top and bottom rows are left blank and used as virus controls to indicate 100 %
cytopathic effect. The six rows in between are used to assay two-fold dilutions of each sample
in duplicate. The numbers in the wells indicate the reciprocal dilution of the two-fold dilution
series. Where standards were included on the plate, one of the samples was replaced with 100
IU IRS IFN (stock - 10,000 IU/ml).
Following the 24 hour incubation, the media was removed and replaced with the
infectious challenge media. SFV4 was made up to a concentration of 1.5 x 104 pfu /
50 pi in infection media (MEM plus 0.2 % BSA, 2 mM glutamine, 20 mM Hepes).
Fifty pi of infectious challenge media was added to each well and incubated for 1
hour at 5 % C02 and 37°C. The media was removed and replaced with 100 pi 10 %
FCS DMEM and the plates were incubated for a further 48 hours until CPE was
visible. When total CPE was observed in the virus controls, the media was removed
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and 50 pi of 10 % MTT solution was added to each of the wells and incubated at 5 %
CO2 and 37°C for 4 hours.
10 % MTT solution: 5 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide) is dissolved in OPTImem (minus phenol red plus L-glutamine, 1 x
NEAA, 2 % FCS, P/S).
After the incubation, the MTT solution was discarded and replaced with 100 pi 0.1 M
HC1 in anhydrous isopropanol to solubilise the crystals. The plate was left on a
gyratory shaker for 1 hour and then read at 570 nm and normalised against the 630 nm
reading.
Polymerase Chain Reaction
Different conditions had to be established for different sets of primers. Here a general
description of the protocol used is given; specific conditions and primers are listed
below (Table 2D).
An individual reaction was set up as below
10 xPCR buffer 5 pi
25 mM MgCl2 3 pi
lOmMdNTPs 1 pi
Forward primer (50 pM) 1 pi
Reverse primer (50 pM) 1 pi
cDNA 2 pi
dH20 36.6 pi
Taq DNA polymerase 2.5 U
For each experiment a master mix was created for the total number of reactions,
including buffer, MgCl2, dNTPs, forward primer, reverse primer and dH20. Two pi
cDNA was added separately to each PCR 200 pi tube followed by 47.6 pi ofmaster
mix. Each tube was incubated for 3 minutes at 94°C, after which 0.4 pi Taq
polymerase was added. Samples were held at the annealing temperature, 62°C for 30
seconds and extended at 72°C for 2 minutes. After the initial reaction, samples were
cycled through 30 -35 reactions of
94°C for 15 seconds
62°C for 30 seconds
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72°C for 2 minutes
followed by 72°C for 10 minutes for the final extension phase. Products were






IFNP For 5' CACAGCCCTCTCCAT CAACT
Rev 5' GCATCTTCTCCGTCATCTCC
62°C 152
SFV4 El For 5' CGCATCACCTTCTTTTGTG
Rev 5' CCAGACCACCCGAGATTTT
62°C 173
PKR For 5' CAAAGCAGGAGGCAAGAAAC
Rev 5' GCTGACTGGGAAACACCATT
55°C 369
IFNa For 5' AGGACAGGAAGGATTTTGGA
Rev 5' GCTGCTGATGGAGGTCATT
62°C 186
P-actin For 5' CGTTGACATCCGTAAAGACC
Rev 5' CTGGAAGGTGGACAGTGAG
62°C 202
GAPDH For 5' AACTCCCACTCTTCCACCTT
Rev 5' GCCCCTCCTGTTATTATGG
62°C 269














For 5' GCTTTGTTACCTGTTGTAGC N/A N/A
NsP2RDR
Outer
For 5' GGACCACCTTCCTACATA N/A N/A
Table 2D: Primer sequence and annealing conditions
Transcription Shut Down Analysis
MEFs were seeded at 5 x 105 cells per well in a 6 well plate; the cells were infected at
a moi of 50 with SFV4 or SFV4nsP2RDR in 300 pi of media (MEM plus 0.2 % BSA,
2 mM glutamine, 20 mM Hepes). Virus was incubated on the cells for one hour and
then replaced with 2 ml of culture media; the cells were incubated in culture media for
4.5 hours at 37°C and 5 % CO2. After 4.5 hours 1 ml ofmedia containing 1 pg/pl
actinomycin D was added to specific wells. Following 30 minutes incubation with
actinomycin D, radioactive carbon-14 uridine was added to all wells, diluted in either
plain media or media containing actinomycin D (5 ml media plus 100 pi Uridine). At
8 hours post-infection, the media was removed, the cells washed in ice cold PBS and
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250 pi of lysis buffer (containing guanidine thiocyanate and 2-mercaptoethanol,
GenElute™ Mammalian Total RNA Miniprep Kit, Sigma-Aldrieh) was added per
well. The lysis buffer was prepared in accordance with the manufacturer's
instructions (Sigma). The cells were incubated on ice in the lysis buffer for 1 - 2
minutes and the lysates were collected and stored at -70°C. RNA was extracted as
described below and quantified by spectrometer.
To 1.8 pg RNA, 3 pi 10 x MOPS, 1.8 pi formaldehyde, 15 pi formamide, and 3 pi
water were added. The samples were incubated at 55°C for 15 minutes and then 2 pi
of Loading Buffer (Final concentrations: 95 % formamide, 0.025 % w/v bromophenol
blue, 0.025 % w/v xylene cyanol blue, 5 mM EDTA pH 8.0 and 0.025 % w/v SDS)
were added to each sample. For each test sample, 5 pi were loaded onto a
formaldehyde agarose gel.
Gel Preparation (25 ml total)
0.35 g agarose
36.5 ml DEPC water
9 ml formaldehyde (37 %)
5 ml 10 x MOPS buffer - 0.1 M MOPS
40 mM NaAc
5 mM EDTA (pH 8)
The gel was run at 60V for 20 minutes then 70V for 2 hours until the blue dye reached
the end of the gel. Following the run, the gel was placed in sodium salicylate for 30
minutes on a rocker and then dried. In a vacuum dryer, the gel was incubated for 1




Cells were incubated with virus for a specific time and collected for RNA extraction.
Briefly, monolayers were washed with versene, trypsinised and neutralised with 25 ml
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10 % FCS DMEM. The cells were centrifuged at 450 x g and the pellets were
immediately snap frozen on dry ice and stored at -70°C until RNA could be extracted.
RNA was extracted using the QIAGEN RNeasy Mini kit following the animal cells
protocol. Six hundred pi buffer RLT with (3-mercaptoethanol (10 pi (3-
n
mercaptoethanol per 1 ml buffer RLT) was added to the frozen cell pellet (< 1x10
cells). The pellet was vortexed in the buffer until cells were evenly distributed;
further membrane disruption was induced by passing the cells through a 21 gauge
needle 5 times. Seventy % ethanol was added to the lysate at a 1:1 ratio and 700 pi of
the suspension was placed in an RNeasy mini column. The column was centrifuged at
8000 x g in a microfuge for 15 seconds. All spins were carried out under these
conditions unless otherwise stated. The cell suspension was repeatedly added to the
same column in 700 pi aliquots until all of the lysate had been centrifuged. Three
hundred and fifty pi of buffer RW1 was added to each tube and spun, following which
the tubes were incubated at room temperature for 15 minutes with 80 pi RNase-free
DNase (Qiagen). A further 350 pi buffer RW1 was added to the tubes which were
then centrifuged; following this 500 pi buffer RPE (an ethanol solution) was added to
the column to precipitate the RNA and the tubes spun again. A second 500 pi of
buffer RPE was added to the tubes, which at this point were spun for 2 minutes. After
discarding the flow-through the tubes were spun at top speed for another 3 minutes.
Thirty pi RNase-free water was used to elute the RNA by centrifuging at 8000 x g for
1 minute. This final step was repeated using the first eluate to concentrate the RNA.
Brain samples
Following dissection, brain tissue for RNA analysis was stored in RNAlater (Sigma).
Forty pg was removed and homogenised in 600 pi RLT buffer (Qiagen RNeasy kit)
plus (3-mercaptoethanol (P-ME 10 pl/ml buffer) using a mortar and pestle. The
homogenate was then passed through a 20-gauge needle and syringe 10 times to
further disrupt the lysate. Each lysate was then centrifuged for 3 minutes at maximum
speed in a bench top centrifuge (> 8000 x g) and the supernatant transferred to a fresh
tube. To this 1 volume (1400 pi) of 70 % ethanol was added and mixed immediately





RNA was quantified on the Agilent bioanalyser (Agilent technologies) using the RNA
6000 Nano assay. Figure 2B shows an example of an Agilent chip.
10-12 i [ $
Figure 2B: Agilent RNA 6000 Nano assay chip
Wells numbered 1 - 12 are used to quantify test RNA samples; gel-dye mixture is inserted
A
into all wells represented by G and the well represented by ^ is used to quantity the test
RNA samples through addition of an RNA ladder.
Briefly, 1 pi dye concentrate was added to a 65 pi aliquot of gel matrix and spun for
10 minutes at 13,000 x g. Nine pi of gel-dye mixture was added to the well marked
®
, this was dispersed throughout the chip using a 'priming station' and 'plunger'.
Another 2 aliquots of gel-dye mixture were then added to the wells marked ® . Five
pi ofmarker solution was added to the ladder well ^ and to all sample wells. Test
samples and RNA ladder were held at 70°C for 2 minutes then placed immediately on
ice. One pi of ladder was added to the ladder well and 1 pi of each sample was added
to each test well. On completion, the chip was vortexed for 1 minute and read in the
bioanalyser by the total eukaryotic nano RNA electrophoresis assay.
For more details on the technology and procedure visit:
http:/Avww.chem.agilent.com/scripts/generic.asp?lPage=1565&indcol=N&prodcol=Y
Reverse transcription PCR
Two pg RNA from each sample was made up to a total volume of 10.5 pi with RNase
free water. Five hundred ng of oligo dT(15) (Promega) and 1 pi of a 40 pM dNTP
mix (Promega) was added to the RNA then incubated at 65°C for 5 minutes.
Following the initial denaturing phase, the samples were cooled on ice for 5 minutes
then incubated with 4 pi 5 x buffer (Invitrogen), 2 pi 0.1 M DTT (Invitrogen) and 40
U Rnaseln (Promega) for 2 minutes at 42°C. Two hundred U of superscript II Murine
Moloney leukaemia virus reverse transcriptase (Invitrogen) was added to the reaction
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mix and incubated for a further 58 minutes at 42°C. The reaction was completed with
15 minutes at 70°C.
Preparation of Standards
Plasmid Cloning
Two types of standard were used to normalise the qPCR assay and quantify mRNA
transcripts. PCR products were used as standards to quantify IFN-a, (3-actin and
GAPDH and plasmids were used as standards to quantify SFV4 (pSFV-GEMl) and
IFN-{3 (pSFVl-IFNb). Clive McKimmey kindly provided the PCR product standards;
the plasmid standards were amplified in E.coli cells and then extracted and purified.
Preparation of LB-Ampicillin plates
Five hundred ml Luria broth and 7.5 g agar were heated in a microwave until clear.
The suspension was allowed to cool and 1 ml (50 mg/ml) ampicillin was added before
the plates were poured.
Transformation of DH5a cells
Five hundred pg of control plasmid, (pUC19) was added to 100 pi of competent cells
(Life Technologies). To a further two aliquots of cells, 5 pi ofwater and 5 pi plasmid
(1 pg/pl) was added. The cells were incubated on ice for 30 minutes, heat shocked for
45 seconds at 42°C then transferred to ice for a further 2 minutes. Nine hundred pi
LB-AMP was added and the eppendorfs placed in universals, which were transferred
to the 37°C shaker for 1 hr at 225 rpm. Fifty pi of the cell suspension was added to
the LB-AMP plates and spread evenly across the surface. The plates were left for 5
minutes to absorb the solution, then incubated overnight at 37°C.
Purification ofplasmid
Single colonies were selected from the plates and cultured overnight in 5 ml LB-
AMP. One ml of broth was removed and spun at 360 x g for 5 minutes in a bench top
centrifuge. One ml 50 % glycerol in dFLO was added to the cell pellets, each sample
was vortexed, placed on dry ice and finally transferred to -70°C for storage. The
remaining 4 ml were processed through Qiagen miniprep columns to elute purified




The pSFVl-ifnb plasmid was incubated at 37°C with bovine serum albumin (BSA),
buffer 2 (New England Biolabs) and Spe I for approximately 1.5 hours. The reagents
were added as indicated below.
After incubation, the temperature was increased to 65°C for 20 minutes.
To linearise the SFV structural proteins plasmid, pGEMl-SFV, the plasmid was
incubated as above with Sph I (5 U). This enzyme does not require BSA and so was
incubated with 34 pi dFEO.
The Spe I and Sph I digestions gave, as expected, a single band of the correct size.
Both plasmids have the same SFV backbone and were also digested with Eco RI:
Eco RI buffer 2 pi
Eco RI 20 U
cDNA 1 pi
water 16 pi
Each reaction was incubated for 2 hours at 37°C and then run on a 1 % agarose gel to
visualise the bands. Three bands were produced for each plasmid, but pSFV4-ifnb
had larger band sizes due to the insert. Following confirmation, the standards were
quantified on the spectrometer and the copy number determined from the calculation
below:
Copies DNA / pi = (6.023 x 1023 x mass/pl) / molecular weight ofDNA
6.023 x 10 is Avogadro's number and is the number ofmolecules per mole; the
molecular weight is determined by gene length (base pairs) x 660 Daltons (660













Preparation of samples for real-time PCR
Following 1st strand cDNA synthesis samples were frozen at -20°C, thawed and
diluted in filtered water to 1:100 and 1:10 to measure SFV El transcripts and cellular
mRNA transcripts, respectively.
Quantitative PCR
A master mix was prepared for the total number of reactions. Each reaction consisted
The master mix was vortexed and 17.9 pi aliquots were dispensed into 100 pi tubes.
To each tube, 2 pi of cDNA or standard DNA was added in triplicate. The fast start
taq was activated by 5 minutes at 94°C, the PCR was then cycled through 94°C for 20
seconds, 62°C for 20 seconds and 72°C for 20 seconds for 40 cycles on a RotorGene
3000 (Corbett Research). At the end of each cycle SYBR green associates with
dsDNA and the PCR machine emitted fluorescence is recorded. A melt curve
analysis is carried out at the end of the cycling reactions in accord with
manufacturer's instructions; fluorescence is measured as the temperature is increased
from 65°C to 94°C in increments of 0.3 degrees.
of:
Primer A (50 pM)
Primer B (50pM)
40 mM dNTPs












1:20,000 SYBR Green (Biogene Ltd)







1 - Running gel
The gel cassette was set up and filled with a 10 % SDS gel, prepared as described
below,
Water 9.9 ml
30 % acrylamide/ bisacrylamide 8.3 ml
1.5 M TRIS (pH 8.8) 6.3 ml
10 % w/v SDS 0.25 ml
10 % w/v ammonium persulphate 0.25 ml
TEMED 0.01 ml
A 2 cm space was left at the top of the gel to add the stacking gel. Whilst the running
gel was setting, 100 pi of isopropanol was placed on the top of each gel within the
cassette to level the surface and the gel pack kept in humid conditions to avoid
desiccation.
2 - Stacking gel
The isopropanol was drained and the gel pack thoroughly washed to remove all traces
of the alcohol. The stacking gel was prepared as described below:
Water 6.8 ml
30 % acrylamide/ bisacrylamide 1.7 ml
1.0 M TRIS (pH 6.8) 1.25 ml
10% w/v SDS 0.1ml
10 % w/v ammonium persulphate 0.1 ml
TEMED 0.01 ml
Stacking gel was added to each individual gel within the cassette; when completed,
combs were inserted into each layer and the excess gel was removed.
Sample preparation
The protein content of each sample was determined and 25 mg was added per well for
both cytoplasmic and nuclear samples. The samples were mixed with the appropriate
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volume of 4 x sample buffer ((200 mM Tris-HCL (pH8.8), 20% (v/v) glycerol, 5 mM
EDTA, 0.02 % bromophenol blue) 70 % (v/v) ofwhich was added to 20 % (v/v) SDS
and 10 % 0.5 M DTT). The samples were heated to 95°C for five minutes then added
to the gel. The first well contained protein ladder.
Sample preparation and transfer
A set gel was transferred to the running equipment, which was pre-filled with 1 x SDS
running buffer and 20 pi of sample was loaded into each well. The samples were
initially run at 60 V for 30 minutes through the stacking gel and then at 100 V until
completion of the run. To visualize the separated proteins, the sample runs were
transferred onto a membrane. Cold transfer buffer (3 g TRIS, 14.4 g Glycine in 800
ml water plus 200 ml cold methanol) was prepared prior to the transfer. The transfer







The membrane was pre-soaked in methanol for 5 seconds and then placed in transfer
buffer for a further 5 minutes alongside the sponges and the filter paper. Gel transfer
was carried out in a Boehringer box which was kept on ice and filled with an ice block
to maintain a low temperature. The transfer was run in cold transfer buffer for 1.5
hours at 100 V.
Detection of transcription factors
An overnight incubation in TBS plus 0.1 % w/v Tween with skimmed milk powder (5
g/100 ml) at 4°C was used to block the membrane. To detect the transcription factors,
the membrane was drained and placed in a 50 ml Falcon tube, protein side facing
inwards, with 4 ml milk solution plus primary antibody. The primary antibody was





Rabbit a NF-kB p65 (SDS Biosciences) 1/300
Rabbit a eIF-2a (SDS Biosciences) 1/200
Mouse a nsP2 (two monoclonal antibodies 2C7 + 3B5) 1/500
(Kindly donated by Leevi Kaariainen, University ofHelsinki, Finland)
After the primary antibody incubation, the membrane was washed in TBS plus 0.1 %
Tween for 2 x 30 seconds, the excess liquid was drained off between each step, and
then washed a further 2x10 minutes in the same buffer. The same procedure was
followed for the secondary antibody which was bound to horseradish peroxidase
except that the secondary antibody was diluted in 4 ml 3 % BSA.
Secondary antibody concentrations
Goat a rabbit HRP (BD Biosciences) 1 / 5000
Goat a mouse HRP (DAKO) 1 / 5000
The secondary antibody was incubated for 1 hour on a rocker and then washed as
desccribed above. To detect any reaction the membrane was incubated with 2 ml of a
1:1 mix ofwestern immunoblot reagents (ECC Western Blotting analysis system,
Amersham Biosciences) for a minute. The membrane was drained completely and
transferred protein side down to a piece of clingfilm to develop on film.
Electromobility Shift Assay (EMSA)
Oligo design
Sequences derived from the literature describing NF-kB and IRF-3 binding sites on
the IFN-P promotor were used to develop probes for NF-kB and IRF-3. Each probe
was 29 nucleotides long, had 5' overhangs and enveloped the specified binding site.
It was necessary to include a G in the overhang so P32 could be incorporated into the
probe in a cysteine nucleotide.
NF-kB
FOR: 5' ACTGA AAGTGGGAAAT TCC TC TGAG




FOR: 5' AAATG ACAGAGGAAAACTGAAAGGG
REV: TGTCTCC T TT T GACT T TCCC TCTTG 5'
Preparation of oligomers
The oligomers were diluted to a final concentration of 100 pM/pl; 2.5 pi of each oligo
was made up to 100 pi with 10 x Boehringer buffer H and purified water.
The solution was brought to the boil for 2 minutes and left to cool slowly overnight.
The prepared oligos were stored at -20°C.
Nuclear Extractions
MEFs were seeded in 6 well plates at 4 x 10? cells per well in 10 % FCS DMEM until
confluent. At confluence, the cells were washed with PBS and then infected at moi of
50 with either SFV4 or SFV4nsP2RDR. The wells were incubated for an hour at 37°C
and rocked every 10 minutes. After an hour, virus was removed and the cells were
washed and incubated in 600 pi 10 % FCS DMEM. A low volume was used so that
the supernatant could be collected and tested in the bioassay. After 4, 5, 6 or 7 hours,
250 pi of supernatant was collected to test in the IFN bioassay. This was acidified
with 40 pi 1M HC1. The cell monolayer was then trypsinised in a volume of 300 pi
until the cells could be tapped free from the culturing wells and then treated with 1 ml
10 % FCS DMEM to inactivate the trypsin. The cell suspension was centrifuged (300
x g, 5 minutes) and the pellet collected in 1.5 ml eppendorfs. The pellet was washed
twice in ice-cold PBS and centrifuged between each wash.
Two buffers were required for the extraction of nuclear proteins:








10 mM HEPES (pH 7.9)
10 mM KC1
0.1 mM EDTA
10 mM HEPES (pH 7.9)
0.4 M NaCl
1 mM EDTA
0.1 mM EGTA 1 mM EGTA
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The following were added immediately before use:
Leupeptin 0.5 pg/ml (final)
Aprotinin 0.5 pg/ml (final)
DTT 1 mM (final)
PMSF 0.5 mM (final)
Cells were resuspended in 300 pi Buffer A and placed on ice for 15 minutes. Twenty
pi of 10 % NP-40 was added to the cell suspension and vortexed for 10 seconds and
then left on ice for 2 minutes. The suspension was centrifuged at 1,677 x g for 5
minutes at 4°C; the supernatant was removed and transferred to another eppendorf
labeled cytoplasmic fragment. The cell pellet was washed in buffer A and centrifuged
again. Eighty pi of Buffer B was added to the pellet and vortexed; this was left on ice
for 60 minutes and intermittently vortexed. Following the hour incubation, the
suspension was centrifuged at 11,337 x g for 5 minutes at 4 °C and the supernatant
(nuclear fragment) aliquoted in 25 pi and stored at -70°C.
Protein assay
Both the cytoplasmic and nuclear fractions were assayed for protein content in the
BIO-RAD DC protein assay (Bio-Rad Laboratories, US). Following the microplate
protocol, 20 pi of reagent S was added to each ml of reagent A needed for the run
(A'). A 2-fold dilution series was prepared of a BSA standard of 1.41 pg/pl in both
buffer A and buffer B for the cytoplasmic and nuclear extractions respectively. Five
pi from each of the dilution steps of the standards and 5 pi of each sample were added
to a dry microtitre plate. To these 25 pi of reagent A' was added, followed by 200 pi
reagent B. The wells were mixed and then transferred to another plate to avoid any
bubbles generated from the mixing. The plates were left for 15 minutes then read at
750 nm.
Gel preparation (1)














The above were mixed together and then poured in between two glass plates.
Probe labelling
To an eppendorf the following were added:
10 x Klenow buffer 2 pi
dNTPs 1 pi
Oligo duplex 2 pi
Water to make volume to 20 pi
Alpha- 32P - dCTP 1 pi
Klenow fragment 1 pi
The reaction was incubated at room temperature for 30 minutes; then stopped by
adding TE (10 mM Tris-HCl (pH 8.0), 1 mM EDTA) up to 50 pi. Oligos were
purified through Amersham spin columns-G50. First the columns were spun at 800 x
g for 1 minute to dry them, the labelling reaction was then added and the columns
recentrifuged at 800 x g for 2 minutes. The eluted oligos were checked using a Geiger
counter to verify counts per second (CPS), which were expected to be in the range of
200-300.
Gel Preparation (2)
The gel was set up with 0.5 x TBE (0.44 M Tris-borate, 0.44M Boric acid, 12 mM
EDTA) and pre-run at 200 V, 4 °C for 30 minutes prior to addition of samples.
During this period the samples were incubated with the hot oligos in the binding
reaction described below.
Binding reaction:
3 pi purified oligo
5 pi sample = 1 pg
8 pi 2 x binding buffer
[2 x binding buffer: 50 pi polydhdC (lpg/pl)





4 x buffer 40 mM HEPES
4 mM EDTA/ 4 mM EGTA]
This reaction was incubated at room temperature for 10 minutes and then loaded onto
the gel. A total of 4.66 pg of nuclear protein was added to each well, at a
concentration of 0.233 pg/pl. The running dye was in column 1 and the test samples
were placed in the subsequent columns. None of the test samples were loaded with
dye due to different refraction coefficients of glycerol and water and consequently
could not be visualised. The samples were added at 4 °C and then run for
approximately 2 hrs at 200 V. The position of the running dye was monitored and
used to indicate the position of the test samples on the gel to determine when the gel
run had completed. On completion of the run, the gel was removed and dried at 80°C
for 1 hour, then put under film for several hours and exposed.
Translational shut-off experiment
BHK cells were seeded in 24-well plates at lxlO5 cells per well; at 90 % confluence
the cells were infected at a moi of 10 with pSFV10bl2A-NP or pSFV10RDRbl2A-
NP. At each of the following time-points post-infection 2, 2.5, 3, 3.5, 4, 4.5 and 5
hours, a well was starved of methionine and then incubated with S labelled
methionine as follows: Media was removed and the monolayers washed with PBS.
500 pi of starvation media (Methionine-free medium (MP Biomedicals), P/S, Hepes
(Gibco) and L-Glutamine) was incubated with the cells for 10 minutes at 37°C. This
-2 r
was removed and replaced with 90 pi of pulse media (10 pi S-methionine (Redivue
L-35S-methionine, >1000 Ci/mmol (#AG1094, Amersham Biosciences) per ml in
starvation medium) for 10 minutes at 37°C. The pulse media was removed and the
cells washed with PBS; to collect the cells, monolayers were incubated on ice with
300 pi lysis buffer (Tris-HCl (pH 7.6) containing 1 % NP-40, 150 mM NaCl, 2 mM
EDTA (and protease inhibitors)) for 5 minutes. The lysate was collected and spun for




All statistical analysis was carried out using Microsoft excel and Prism. Viral titre,
qPCR and CPERA data were analysed with the non-parametric Mann-Whitney and
Kruskal Wallis tests.
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Development of assays to quantify IFN
Objectives
1) Develop a quantitative PCR assay to determine levels of viral RNA
species and IFN-(3 and IFN-a transcripts in an infected sample.
2) Develop a quantitative bioassay to determine functional IFN levels in an
infected sample.
Development of assays to quantify IFN
Quantitative PCR and the cytopathic effect reduction assay (CPERA) were developed
as a means to establish levels of IFN gene expression and protein activities.
Transcript copies of IFN-P and IFN-a were compared to copies of virus RNA to
determine the amount of IFN gene transcription induced per unit of virus RNA. The
CPERA quantified functional IFN by determining the dilution that induced an anti¬
viral state, determined by protection of L-929 cells from a set amount of cytopathic
virus.
Quantitative (q) PCR
Transcript analysis ofmRNA was a four step process; (i) RNA was extracted from
infected cells or tissues, (ii) it was quantified and its quality assessed, (iii) the RNA
was reverse transcribed into cDNA and (iv) the cDNA was quantified by qPCR.
RNA Extraction
Adherent cell monolayers were collected and immediately snap frozen on dry ice to
reduce exposure to RNases. Each sample was initially handled individually to
minimise RNase degradation. RNA was extracted from cell monolayers using the
RNeasy kit (Qiagen) according to the manufacturer's instructions. Briefly, samples
were triturated with RLT buffer containing P-mercaptoethanol to inactivate RNases.
The homogenate was mixed with 70 % ethanol to precipitate nucleic acids and
purified through a Qiagen mini column, where it was also DNase treated to remove
contaminating DNA. The RNA was eluted from the column with RNase-free water
and immediately frozen. Mouse brain samples were handled slightly differently due
to the high lipid content of the brain. Only 40 mg of brain were used, to prevent
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blockage of the spin column membrane. RNA was extracted from the brain using an
RNA lipid kit (Qiagen). Briefly, the brain was homogenised in QIAzol lysis reagent
and then mixed with chloroform. This suspension was centrifuged and the upper
aqueous phase removed and mixed with 70 % ethanol to precipitate nucleic acids.
Following precipitation, RNA purification and elution was carried out as described
above.
RNA Quantification
The quality and quantity ofRNA was assessed using Agilent technology. For qPCR,
the quality of the RNA needs to be high. This microchip technology, RNA 6000
Nano assay, runs 12 samples ofRNA against a quantified standard on a micro gel.
The number ofRNA bands in each sample is indicative of the quality of the RNA.
An ideal sample produces two visible bands, representing the 18 S and 28 S ribosomal
RNA species (Figure 3A (ii)); these comprise 95 % of the total RNA. Samples of
poorer quality produce many bands. A completely degraded sample produces a smear
down the gel. The Agilent software generates a graphical representation of the RNA
species in each sample; the quantity ofRNA is determined by integrating the area
under the curve. A typical yield ofRNA from cultured cells grown in a T20 flask,
approximately 2 - 5 x 106 cells, is 30 pg. For each RNA sample to be analysed by
qPCR, 2 or 5 pg RNA (tissue culture or brain samples, respectively) were reverse
transcribed into cDNA using separate reactions with oligo-dT primers.
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Figure 3A: Quality and quantity assessment of RNA.
RNA was extracted from tissues or cell monolayers, 1 pi of each sample was run on an
Agilent microchip and compared to a pre-quantified RNA ladder, (i) A typical sample
electrogram, the two major peaks represent the (1) 18 S and (2) 28 S ribosomal RNA species.
The y-axis indicates the level of fluorescence and the x-axis the time in seconds. The amount
of RNA present in a sample is calculated from the area under the curve, (ii) The gel bands
give an indication of RNA degradation, the ladder bands are shown in the first column
marked L. The numbered columns (1 - 12) are test samples; these all show two main bands,
which are equivalent to the two peaks on the graph and represent the ribosomal RNA species.
The numbers along the length of the gel indicate the size of the bands (bp).
Quantification of cDNA by qPCR
Two pi of a 1:100 dilution of each cDNA sample to be tested for SFV transcripts and
2 pi of a 1:10 dilution of each cDNA sample to be tested for IFN-P, IFN-a, P-actin
and GAPDH transcripts were assayed as standard. Samples were diluted to reduce the
concentration of the cDNA, which if too concentrated can inhibit the qPCR reaction.
To allow quantification, a 10-fold serial dilution of a pre-quantified standard was run
in each assay. Each dilution produces a sigmoid curve, where the fluorescence
emitted from the dsDNA-bound SYBR green is plotted against PCR cycle number.
As the PCR cycle number increases, the number of amplicons increases and so the
emitted fluorescence is higher. After several PCR cycles, all dilutions of standard can
be detected. A threshold is determined to create a standard curve; the point at which
the dilutions cross the threshold gives their Ct values. Plotting the Ct against the
logarithm of the copy number corresponding to that Ct should, using linear regression
2 •
analysis, produce an R" value of 1. Using this standard curve, the Ct values of the test
samples can be transformed into transcript copy numbers. Figure 3Bi (b) depicts a
10-fold serial dilution of standard; the line on the graph represents the threshold.
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An important factor regarding quantification of cellular transcripts or viral RNA is the
efficiency of the qPCR. In an optimal PCR reaction the number of amplicons would
be expected to double after each elongation step in the PCR; this equates to 100 %
efficiency. QPCR efficiency can be affected by several factors, including annealing
temperature, primer specificity, primer dimer formation, NTP concentration and
magnesium levels. Indications of efficiency are the gradient and regression co¬
efficient of the standard curve. Under ideal conditions the standard curve has an R2
value of 0.98 and a gradient of-3.3 (Nolan, 2004). At the time when this work was
carried out greater emphasis was given to the R value. In all experiments presented
in this thesis the R value exceeded 0.98. Greater emphasis is now given to the
gradient of the standard curve as a better indicator of efficiency. From analysis of the
gradient, all of the experiments presented in this thesis have an efficiency of > 90 %,
which is the minimal efficiency cut-off value recommended within the Laboratory of
Clinical and Molecular Virology, University of Edinburgh. However, the IFN-(3
qPCR data experiments had an efficiency of >100 %, all of the efficiencies of these
experiments are within 10 %. This increase in efficiency was not associated with the
normal factors related to high efficiency e.g. non-specific products and primer dimer
as demonstrated by the single phase melt curve.
Validation of qPCR
For a qPCR assay to be valid, it must be specific and sensitive. Quantitative PCR is
particularly powerful as an assay as it is known to be quantitative over a large
dynamic range and can differentiate between sub-types of the same gene e.g. IFN-a,
with appropriate primers under optimal conditions.
Specificity and Sensitivity of qPCR
To determine the specificity and sensitivity of the qPCR, levels of five transcripts
were investigated: SFV RNA species (genomic and sub-genomic), IFN-P, IFN-a, P-
actin and GAPDH. To detect each transcript a set ofPCR primers was developed.
The specificity of the primer pair was determined by a melt curve and BLAST
analysis and the sensitivity by analysis of a ten-fold serial dilution of a pre-quantified
standard. The latter enabled limits of detection to be set for each gene transcript
assayed and demonstrates the dynamic range for each primer pair (Figure 3B (b)).
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DNA plasmids were used as standards for SFV and IFN-P transcript analysis and PCR
products were used as standards for IFN-a, P-actin and GAPDH transcripts. The
plasmids and PCR products were quantified by spectrometry. The primers used are
listed in table 2D (Materials & Methods). The melt curves and the qPCR
amplification curves generated by the serial dilutions are shown in figure 3B.
Each melt curve (Figure 3B (a)) for the five primers produced a single peak; this
indicates that a PCR product of one size was produced from each primer pair. No
peaks at lower temperatures were produced, demonstrating that primer dimer was not
an issue for any of the sets of primers. During the design process for each set of
primers, a BLAST analysis was performed. This tests the primer sequence against all
known mouse gene sequences. None of the primers cross-matched with other mouse
genes and so are assumed to be specific for the gene of interest. The range of
sensitivity varied for each primer pair; for example SFV species could be quantified
between 102 and 108 copies, the IFN-P primers were less sensitive and could quantify
samples in the range of 103 and 106 copies. All of the standard curves generated were
analysed with linear regression and produced an R value of 0.99. No subsequent
extrapolation of the curve was required to quantify any of the experiment samples.
85
Development of assays to quantify IFN
86
Development of assays to quantify IFN
Figure 3B. The specificity and sensitivity of the primers
Ten-fold serial dilutions of pre-quantified standards for each gene of interest were assayed by
qPCR. Melt curves were produced for each primer set; these demonstrated the range of
product sizes generated by each primer pair. The 10-fold dilution series indicates the range of
sensitivity of each qPCR. The y-axes are arbitrary fluorescence measurements; the x-axes
represent degrees of temperature and cycle number for the melt curve and serial dilution
respectively, (i) SFV El primers show the levels of viral genomic and sub-genomic species
(a) melt curve, (b) 10-fold serial dilution of pSFV4 (pre-quantified standard can be detected
from 102 - 108 copies of virus RNA). (ii) IFN-P primers (a) melt curve, (b) 10-fold serial
dilution of pSFV-IFNb (pre-quantified standard can be detected from 103 - 106 copies of IFN-
P transcript), (iii) IFN-a primers (a) melt curve, (b) 10-fold serial dilution of IFN-a PCR
product (pre-quantified standard can be detected from 101 — 107 copies of IFN-a transcript),
(iv) P-actin primers (a) melt curve, (b) 10-fold serial dilution of P-actin PCR product (pre-
quantified standard can be detected from 102 — 106 copies of P-actin transcript), (v) GAPDH
primers (a) melt curve, (b) 10-fold serial dilution ofGAPDH PCR product (pre-quantified
standard can be detected from 103 - 106 copies ofGAPDH transcript).
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Normalisation
Standard practise when using qPCR would be to normalise to a housekeeping gene
such as P-actin or GAPDH. This is based on the concept that these genes are
expressed at the same level across the same cell type under the same conditions.
However, this may not be the case in virally infected cells where infection often
affects cellular transcription. To investigate the feasibility of normalisation using P-
actin and GAPDH, transcript levels for these genes were determined over a 12-hour
period (Figure 3C (i; ii). In two primary cell cultures, P-actin transcript levels at 8
and 12 hours post-infection were significantly reduced relative to mock-infected cells
and infected cells at 4 hours post-infection (p < 0.05, Mann-Whitney). Each time
point was significantly different to mock-infected cells (p < 0.05, Kruskall Wallis
test). A significant decrease in GAPDH transcript levels was also observed between
mock-infected cells and SFV4 infected cells sampled at 12 hours post-infection (p <
0.05, Mann-Whitney) (Figure 3C (iii)). These three sets of data indicate that
housekeeping genes were affected during SFV infection precluding their use for
normalisation. This was not unexpected as IFN induces anti-viral gene expression,
including RNase-L and ADAR-1, which both induce degradation of cellular and viral
transcripts (Samuel, 2001).
An alternative method for normalisation is to quantify the amount of ribosomal or
total RNA. The majority of total RNA is ribosomal and should not vary with virus
infection. This can be achieved by PCR assay using 18S rRNA primers or by direct
quantification of the total RNA prior to qPCR. It was decided to quantify the total
RNA using the Agilent mini gel system. Total RNA was quantified prior to qPCR
and all transcripts assayed were normalised to 1 pg RNA.
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Figure 3C: p-actin and GAPDH down regulation during SFV infection of Mouse
Embryo Fibroblasts.
Two cultures of primary cells (i) and (ii) were infected with a high moi SFV4; cell cultures
were harvested at 4, 8 and 12 hours post-infection. The data was grouped as indicated to
enable Mann-Whitney analysis and the two groups compared for levels of P-actin transcripts,
(iii) Cells were infected with a high moi of SFV4 or mock infected with PBS, at 12 hours
post-infection the cell cultures were harvested and assayed in triplicate for GAPDH
transcripts by qPCR. Each point represents an individual cell culture, which was assayed in
triplicate by qPCR; * indicates a significant difference (p < 0.05, Mann-Whitney). The x-axis
crosses the y-axis at the limit of detection of the assay.
Assessment of Variation
Quantification of total RNA using the Agilent bioanalyser, does not directly quantify
mRNA levels since quantification is based on the size of the peaks produced by the 18
S and 28 S ribosomal RNA species. It has been observed that the levels ofmRNA
within an RNA sample when normalised to total RNA can vary by up to 7 % (Solanas
et al., 2001).
To investigate the variability of the qPCR in virus infected cells, two transcripts, SFV
and IFN-P, were selected for detailed analysis. RNA isolated from SFV4 infected
cells was quantified on the Agilent bioanalyser and 2 pg was added to each of five
separate RT-PCR reactions. The cDNA generated from each reaction was quantified
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in triplicate by qPCR and is presented in tables 3A and 3B. The number of viral
copies or IFN-P transcripts per pg was calculated (second column), and used to
determine the mean, standard deviation and from these the coefficient of variance
(VAR) for each sample. The coefficient of variance demonstrates the percentage
variation of the mean.
Variation in q PCR
Sample SFV Transcripts
Copies / pg
RNA Mean SD VAR Log 10 Mean SD
SFV 1a 288,622,686 1.44E+11 1.11E+11 2.93E+10 0.26 11.16 11.03 0.108
b 188,680,818 9.43E+10 10.97
c 185,887,618 9.29E+10 10.97
SFV 2a 110,292,346 5.51E+10 6.81E+10 1.13E+10 0.17 10.74 10.83 0.076
b 151,987,220 7.60E+10 10.88
c 146,424,534 7.32E+10 10.86
SFV 3a 162,537,984 8.13E+10 8.42E+10 4.09E+09 0.05 10.91 10.93 0.021
b 177,753,679 8.89E+10 10.95
c 164,980,326 8.25E+10 10.92
SFV 4a 153,124,864 7.66E+10 6.12E+10 1.33E+10 0.22 10.88 10.78 0.090
b 109,472,927 5.47E+10 10.74
c 104,682,688 5.23E+10 10.72
SFV 5a 223,983,778 1.12E+11 1.10E+11 2.83E+09 0.03 11.05 11.04 0.011
b 223,983,778 1.12E+11 11.05
c 214,182,853 1.07E+11 11.03
Mean 8.69E+10
Variation in RT-PCR SD 2.50E+10
VAR 0.27
Table 3A: SFV transcripts quantified from the same RNA sample
The table demonstrates the amount of variation intrinsic to the SFV qPCR assay; one RNA
sample was reversed transcribed in five separate reactions, the cDNA generated from each
reaction was then quantified in triplicate by qPCR. The mean and standard deviation were
calculated and from these the coefficient of variation (VAR) was determined. VAR is
indicative of the percentage variation about the mean.
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Variation in qPCR









































































Table 3B: IFN-p transcripts quantified from the same RNA sample
The table demonstrates the amount of variation intrinsic to the IFN-p qPCR assay; one RNA
sample was reversed transcribed in five separate reactions, the cDNA generated from each
reaction was quantified in triplicate by qPCR. The mean and standard deviation were
calculated and from these the coefficient of variation (VAR) was determined. VAR is
indicative of the percentage variation about the mean.
The complete qPCR assay consists of two main stages, RT-PCR and qPCR; it would
be expected that most of the variation would be introduced at these stages. Tables 3A
and 3B demonstrate this variation. Each of the triplicate repeats (SFV 1 - 5 (a, b, c)
or IFN-P 1 - 5 (a, b, c)) indicates the variation in the final qPCR stage. The variation
within the triplicate repeats never exceeds 2-fold. Considering the dynamic range of
the assay (> 1,000,000) this 2-fold difference is inconsequential. However,
differences of less than 2-fold need to be interpreted with caution. Given the large
dynamic range of the assay, data of this type is often expressed logarithmically (Table
3A and 3B). Taking the mean of the triplicate repeats (Column 4) indicates the
average viral RNA or IFN-P transcript copy per pg total RNA generated from each
RT-PCR (SFV 1 - 5). Comparing these values demonstrates the variation within the
RT-PCR stage. Again the difference between the means never exceeds 2-fold. The
range of the triplicates and means is shown in figure 3D. Most biological systems
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demonstrate a large variation with a normal distribution. Given the small sample
size, no conclusion about the distribution of the data can be made, whereas the data
would be expected to have a normal distribution this cannot be assumed and all the
PCR results in this thesis have been analysed with a non-parametric test, Mann-
Whitney (p < 0.05). Due to the requirements of this test some of the data has been
grouped, where data has been grouped, this is indicated in the figures. Where Mann-
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Figure 3D: The range of data from the qPCR assay.
RNA from a single infected cell culture was reverse transcribed into cDNA in five separate
reactions (1 - 5); each of these cDNAs was quantified in triplicate by qPCR. The scatter plots
indicate the range of the data for (i) SFV transcripts, (ii) IFN-P transcripts; the total range of
data is indicated in the first column (Total), the three values for the samples labelled 1 - 5
represent the triplicate qPCR repeats of the cDNA from each RT-PCR. In the 'Mean'
column, the points represent the mean values of viral RNA or IFN-P transcripts for each RT-
PCR.
Cytopathic Effect Reduction Assay - Interferon Bioassay
The cytopathic effect reduction assay (CPERA) is a standard cell-based assay used to
assess the total IFN content of a sample. Samples of supernatant taken from virus
infected cells are incubated on a monolayer of L-929 mouse fibroblasts for 24 hours.
Any IFN in the sample stimulates the L-929 cells anti-viral response so that upon
subsequent virus challenge (with encephalomyocarditis virus, EMCV) the cells are
protected from death. After virus challenge the viability of the cells is assessed (using
the WST-1 cell viability reagent). For each sample, a two-fold dilution series was
assayed. The amount of IFN was determined by comparison to a standard curve run
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in the same assay. The standard curve was produced from a two-fold serial dilution of
a laboratory standard. The amount of type I IFN in this laboratory standard was
quantified using an International Reference Standard for murine total IFN (NIAID).
Assessment of Variation
To assess the level of variation within the CPERA three replicate plates, each
containing 11 two-fold dilution series of the laboratory standard were assessed in each
of two separate but identical experiments A and B (run on separate days). For each
experiment, the reciprocal dilution of laboratory standard IFN correlating with 50 %
cell death was determined for each of the 11 serial dilutions on each of the 3 plates.
The inter-experiment, inter-plate and intra-plate variations were then determined.
The variation in the absorbance readings of the serial dilutions generated from
laboratory standard IFN from the two experiments is shown in figure 3E (i). The
optical density:dilution curves generated in experiment A (blue) clearly localise
differently to the optical density:dilution curves generated in experiment B (red).
Box-whisker representation of the data demonstrates the difference between the
ranges of values (Figure 3E (ii)). Using Mann-Whitney test the average 50 % cell
death end point produced in the two experiments (run on different days) were
significantly different with a p value of < 0.05. For many bioassays day to day
variation is an important variable. To deal with this, assays are conventionally
normalised by running a standard or a series on standards to create a standard curve
on each assay. Laboratory standard IFN quantified by comparison to international
reference standard IFN was used to normalise between experiments.
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e
Reciprocal dilution Experiment
Figure 3E: The range of the serial dilutions and 50 % end points produced from
laboratory standard IFN run in two experiments.
(i) Serial dilutions of laboratory standard run 33 times in two experiments, experiment A -
blue, experiment B - red. (ii) Box whisker plots indicate range of the 50 % cell death end
points for each experiment; * indicates a significant difference of p < 0.05, Mann-Whitney.
The optical densityrdilution curves from the 3 different plates run in parallel within
the same experiment are shown in figure 3F (i) and 3F (ii). The curves from different
plates overlap each other and have a smaller range of 50 % end points in comparison
to experiments A and B. In figure 3F (iii) the data is depicted in box-whisker format.
The medians of the 50 % cell death end points of the two experiments were different
(Figure 3E (ii)), whereas the medians of the 50 % cell death end points from different
plates in the same experiment were similar (Figure 3F (iii)). To ascertain if samples
run at the same time but on different plates could be analysed together, sample and
population variance was determined by ANOVA. Although the distribution of the
data is unknown, ANOVA is a strong statistical analysis and can withstand slight
deviations from normal distribution. ANOVA assesses the likelihood of several
samples being from the same population by determining whether the variance within
samples is comparable to the variation within the population. The significance of
ANOVA analysis is determined by calculating the F value and comparing this to the F
distribution chart. All 3 plates assessed in the same experiment produced low F
values, so they were not within the critical region of the F distribution and hence were
not significantly different from each other. Consequentially, data obtained from
different plates run at the same time can be analysed together without normalisation.
However, serial dilutions of standard were assayed with each plate to further reduce
the variation.
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Figure 3F: Comparison of serial dilutions (i) and (ii) and median 50 % cell death
end point values (iii) of the 3 plates assessed per experiment.
Laboratory IFN standard was run 11 times per plate and 3 plates were run per experiment.
Samples run in a single plate, experiment A (i) and experiment B (ii) are represented by the
same colour. Individual plate medians and data ranges (1-3, experiment A; 4 - 6,
experiment B) are displayed as box whisker plots (iii). The central horizontal bar represents
the median value of the 50 % cell death end point for each plate; data within the box equates
to data within the inter-quartile range, the whiskers indicate the total range of the data.
The range of dilution curves within each plate is shown in figure 3G; the variation
between the dilution curves in each plate is quite narrow. This demonstrates the
reproducibility of the assay within a plate. From these figures the 50 % end point of
each dilution curve was determined and is shown in table 3C. The range of the data
from table 3C is shown in figure 3H (See also figure 3E (ii)).
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Experiment A Experiment B
(i) (a) (ii) (a)
32 64 128 256 512 1024 20484096
Reciprocal dilution
-p 4-r
32 64 128 256 512 1024 20484096
Reciprocal Dilution
(i) (b) (ii) (b)
Reciprocal dilution Reciprocal Dilution
(0 (c) (ii) (c)
Reciprocal dilution Reciprocal dilution
Figure 3G: Assessment of intra-plate variation of two-fold serial dilutions of
laboratory standard IFN.
Two-fold serial dilutions of laboratory standard IFN were run 11 times in each plate, (i) -
(a), (b) and (c) represent the 3 plates run in experiment A, (ii) - (a), (b) and (c) represent the 3
plates run in experiment B.
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50% End Point (Reciprocal Dilution)
Experiment A Experiment B
Plate 1 2 3 4 5 6
31 34 32 61 46 57
32 35 32 63 52 59
34 35 32 66 58 63
34 35 33 67 60 65
35 35 33 68 63 65
35 36 33 68 64 66
39 36 34 71 64 67
49 36 36 71 66 67
50 36 37 76 66 71
51 37 40 76 69 80
62 38 49 74
Table 3C: 50 % cell death end point values for laboratory standard IFN run on 6
plates
Laboratory standard IFN was run 11 times per plate in a two-fold serial dilution, the 50 % cell
























Figure 3H: Distribution of 50 % end points
The 50 % end points of experiment A and B were plotted to determine their distribution
dynamics.
The 50 % end points generated during Experiment B demonstrate a normal
distribution, however, the 50 % end points generated during Experiment A
demonstrate a heavily skewed distribution pattern. As a consequence of the different
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distributions of the two experiments no assumptions were made about the data and so
it was decided to analyse results by the non-parametric Mann-Whitney test (p < 0.05).
Discussion
Two assays were developed to quantify type I IFN at the transcript and functional
protein level. The variation within each assay was assessed. Assessment of standards
suggested that both assays should be analysed with non-parametric assays i.e. Mann-
Whitney analysis.
Quantitative PCR is a well-developed research tool; it has a huge dynamic range and
the ability to rapidly analyse many samples and all mRNA species. However,
normalisation needs to be established for each experimental model. The variability
of qPCR is closely tied to the efficiency of polymerisation at both the RT step and the
qPCR step. Several factors are known to affect amplification efficiency including low
template copy numbers, RT-PCR primers and qPCR primers. Low template copy
numbers adversely affect the efficiency ofRT-PCR; all of the mRNA species
investigated in this assay are likely to be relatively numerous in virus infected cells.
Oligo-dT primers were used to prime the RT-PCR reaction. Oligo-dT is more
specific for mRNA than random primers and generates a more reliable cDNA
representation of the original mRNA population. However, good quality mRNA is a
pre-requisite for oligo-dT priming as full length mRNA is required. All of the RNA
samples used were assessed on the Agilent bioanalyser and any poor quality samples
were discarded. Other considerations when using oligo-dT primers were the position
of the upstream primers and the secondary structure of the transcript; the RT-PCR
may fall short of the upstream qPCR primers, particularly if the transcript forms
multiple secondary structures. These are clearly not major issues in this analysis as
all of the transcripts investigated were reproducibly detected.
A primary consideration in qPCR primer design, with regard to amplification
efficiency, was minimal annealing between primer pairs. Amplicons were detected
by SYBR green fluorescence, which non-specifically binds to dsDNA; therefore
specificity of the primers was paramount. Non-specific binding to template or to
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other primers would have led to false positives and primer dimer formation would
have severely diminished the amplification efficiency. These effects are indicated in
the melt curve analysis for each primer pair; as only a single peak was observed in the
melt curve for each primer pair, no primer dimer formed and only a single product
size was amplified suggesting that the primers were specific to a single locus.
Normalisation is necessary to account for the variation of amplification efficiencies
between reactions and differences between samples. However, given virus infection,
target gene transcripts could not be normalised to housekeeping genes, as the
expression of p-actin and GAPDH was significantly reduced compared to mock
infected cells by 12 hours post-infection. Bustin et ah, (2005) reviewed the most
plausible methods for normalisation in any system and recommended normalising
against total RNA mass, providing that the RNA sample was of high quality and
accurately measured. This method of normalisation was applied to all of the qPCR
experiments. It was also noted that for the assessment of cytokines, only when the
data was normalised to rRNA were the results biologically relevant (Bas et ah, 2004).
The CPERA was found to have a range of variation from 3 - 20 %. This variation
could have arisen at any of the multiple stages; differences in the number of L-929
cells seeded per well, day-to-day differences in the incubator environment, differences
in the volume aspirated by each tip of the multi-channel pipette whilst generating the
two-fold dilution series, as well as differences in the number of challenge virions.
Each of these aspects was controlled as tightly as possible; cells were counted and
single cell suspensions produced to ensure an even distribution of cells within the
seeding suspension, the same incubator was used for each experiment, the multi
channel pipette was observed constantly to maintain comparable levels of aspirate and
the titre of the challenge virus was checked regularly. When all of the standard curves
were analysed for variation at each point of the dilution series, the variation increased
down the plate. This was expected since the distance between two points doubles as
the dilution series is extended, thereby increasing the potential error. This effect
emphasizes the need for consideration of the practical limitations of the assay whilst
interpreting the results.
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For experimental analysis, ANOVA indicated that plates assessed on the same day
could be directly compared; however, to further control variation between plates and
to allow comparisons between experiments, duplicate runs of IFN standard were
included on each plate to enable normalisation. This same method was used to
normalise between experiments. However to ensure minimal variation, in this thesis
experimental comparisons were always run in the same CPERA.
Summary
The objectives of this chapter were to develop assays which would allow
quantification of IFN-P and IFN-a transcripts as well as functional IFN. Quantitative
RT-PCR for virus and IFN transcripts and an IFN bioassay were established,
validated and the level of variation determined.
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Chapter 4: Does SFV4 infection induce IFN expression
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Does SFV4 infection induce IFN expression in vitro
and in the brains of adult and neonatal mice?
Objectives
1) Determine whether SFV4 induces type I IFN transcripts in mouse L929
fibroblasts.
2) Quantify type I IFN transcripts and functional IFN in the brains of SFV
infected adult and neonatal mice.
3) Determine whether passive administration of IFN can protect adult mice
against virulent SFV infection.
Introduction
In vitro in cell cultures, the LI 0 and A7 strains of Semliki Forest virus (SFV) are
well-known inducers of type I IFN responses. Anti-IFN antibodies increase the SFV
plaque size in infected L-cells and exacerbate SFV pathogenicity in mice (Fauconnier
et ah, 1969). Blood IFN levels correlate with SFV viraemia levels (Bradish et ah,
1975) and IFN can be detected in blood, muscle and spleen samples of SFV infected
mice (Smillie et ah, 1973). Recently, IFN-a mRNA transcripts have been detected in
the brains of SFV4 infected adult mice (McKimmie et ah, 2005). An interesting
aspect of SFV encephalitis is the age-dependent outcome of infection. Avirulent
strains, such as A7(74), induce fulminant encephalitis in neonates and suckling mice
infected at up to 12 days of age whereas infection after 14 days of age results in a
restricted CNS infection (Fleming et ah, 1977; Oliver et ah, 1997). Virulent strains
induce pan-encephalitis following ip inoculation regardless of age (Fazakerley et ah,
1993). One possible explanation of age-dependent virulence would be an impaired
ability of immature (post-natal) CNS cells to produce or respond to IFN. The
literature suggests that there may be age-related differences in type I IFN responses to
RNA viruses. Adult human peripheral blood mononuclear cells and cord blood
mononuclear cells were compared in their abilities to induce IFN-a in response to a
viral infection. Infection with either Sendai virus or Newcastle Disease virus (NDV)
resulted in production of lower levels of IFN-a from cord blood cells in comparison to
adult blood cells; the most dramatic difference was observed in NDV infection. The
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number of IFN producing cells was quantified for both adults and neonates and found
to be comparable, 1 %, suggesting that neonate mononuclear cells are impaired in
their ability to produce IFN- a (Neustock et al., 1993). Coxsackie B1 virus also
induces differential IFN levels in the tissues of mice of different ages (Heinenberg et
al., 1964).
To assess IFN production in neonatal and adult mice infected with SFV, groups of
adult and neonatal mice were inoculated with SFV4. SFV4 is a cloned virulent virus,
which is readily engineered, making it a powerful system for genetic analysis of SFV.
Given this tool for genetic analysis of virus it was decided to use SFV4 over SFV LI 0
and SFV A7(74) to determine adult and neonate mouse IFN levels, despite the history
of literature. Since the IFN response to SFV4 had not previously been studied,
cultured cells were infected with SFV4 to determine, if like L10 and A7(74), SFV4
induced IFN.
Does SFV4 induce IFN in mouse fibroblasts?
Continually cultured mouse L-929 fibroblasts were infected with SFV4 and analysed
for IFN-P transcripts. L-929 cells were used as these are known to be IFN competent.
Other cell lines commonly used in virology, such as Vero cells and baby hamster
kidney (BHK) cells, have impaired IFN systems which makes them useful for viral
growth and replication studies, but not for assessing IFN responses (Diaz et al., 1988).
To determine the level of IFN induced during an SFV4 infection, L-929 cells were
infected at a multiplicity of infection (moi) of 10. The moi represents the average
number of virus plaque forming units per cell when infecting a culture. Using the
Poisson distribution, the fraction of cells infected with 0, 1 or more virus particles can
be calculated. The moi required to infect 99 % of cells in a culture can also be
calculated and is 4.6 plaque-forming units (pfu) per cell. To study the kinetics of IFN
gene induction and IFN protein production ideally requires a single step infection, in
which all of the cells are infected synchronously, and therefore a relatively high (>
4.6) moi. Monolayers of L-929 cells were infected with SFV4 at a moi of 10 for 1
hour at room temperature and then incubated in 5 % CO2 at 35°C for 2, 3, 4 or 6
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hours. Low volumes of inoculate were used to increase the efficiency of infection.
At each of the specified time points, cells from three infected and one mock-infected
(PBS alone) culture were collected. RNA was extracted, quantified on an Agilent
bioanalyser and 5 pg was reverse transcribed into cDNA. Each sample was assessed
for levels of SFV RNA and IFN-P transcripts by qPCR. No viral RNA or IFN-P was
detected in the mock-infected controls (data not shown). Figure 4A (i) shows the
copies of SFV RNA at 2, 3, 4 and 6 hours post-infection. A steady rise in SFV RNA
occurs over time, approximately a ten-fold rise per hour. The levels of IFN-P
transcripts over the 6-hour time course are indicated in figure 4A (ii); IFN-P
transcripts could only be detected at 4 and 6 hours post-infection. At both time points
the levels of IFN-P transcripts were equivalent. No direct correlation was observed
between the levels of SFV RNA and IFN-P transcripts (Figure 4B), suggesting that
IFN-p gene transcription was either on or off. Although virus RNA levels continued
to increase (10-fold) between 4 and 6 hours, IFN-P transcripts did not increase over
this time. This is consistent with synchronous infection of the majority of cells in the
culture and for each cell a maximum level of IFN gene transcription which cannot be
exceeded (Figure 4B). However, Figure 4B(ii) may also indicate that IFN-P
transcription has been abolished after 4 hours post-infection and that the maintenance
of transcripts at the same level at 6 hours post-infection is indicative of the stability of
IFN-p mRNA.
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Figure 4A: Production of IFN-p transcripts in mouse L-cells following an SFV4
infection.
Mouse fibroblasts were infected with SFV4 at a moi of 10 and assayed for (i) SFV4 RNA and
(ii) IFN-p transcripts at 2, 3, 4 and 6 hours post infection. The y-axis for each figure
commences at each assay's limit of detection; each point represents an individual cell culture
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Figure 4B: IFN-p transcripts do not increase with increasing levels of virus
RNA
L-929 cells were infected with SFV4 at a moi of 10 and assayed for SFV RNA species and
IFN-P transcripts at 2, 3, 4 and 6 hours post-infection. Only cultures that produced detectable
IFN-P transcripts are plotted; green symbols are cultures assayed at 4 hours post-infection and
red symbols are cultures assayed at 6 hours post-infection.
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To determine whether functional IFN could be detected in L-929 cells and to
determine whether a moi of 10 was achieving maximum levels of infection, L-929
cells were seeded into chamberslides and at confluence infected with SFV4 at a moi
10 or 100 (in quadruplicate) or mock infected with PBS. Supernatant samples were
taken at 24 hours to compare the amount of IFN and infectious virus in each sample
(Figure 4C). The monolayers were then washed and stained with anti-nsP3 antibodies
to ascertain the percentage of cells infected. Fifteen cell counts were carried out on
different areas across the monolayer. No functional IFN or virus proteins were
detected in the mock-infected cells. For both a moi of 10 and a moi of 100 the
percentage infection was between 90 % and 100 % demonstrating that moi 10, as
expected, achieved the maximum level of infection. All of the cultures produced
similar amounts of infectious virus and functional IFN, indicating that once maximum
infection had been achieved excess virus had no further effect. In conclusion, SFV4
infects L929 fibroblasts and establishes infection of > 90 % cells at moi 10; infected

















Figure 4C: Production of functional IFN by a mouse fibroblast cell line (L-929)
Chamberslides were seeded with L-929 cells and infected with SFV4 at a moi of 10 or 100.
Supernatant samples were collected after 24 hours and assayed for levels of (i) infectious
virus and (ii) functional IFN. Each point represents a single cell culture.
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Adult 129/Sv/Ev mice were intracranially (ic) inoculated with 5x10 pfu SFV4 in 20
pi PBSA or mock infected with PBSA alone. Ic inoculation was used in preference to
intraperitoneal (ip) since in pilot experiments SFV4 was found to be less
neuroinvasive than other strains of SFV; ip inoculation of SFV4 resulted in
encephalitis in only 1:3 cases (data not shown). Three mice were sampled for brain
tissue at the following time points, 12, 24 and 40 hours post-inoculation. Before the
brain was extracted, each mouse was perfused with PBS to remove blood from the
cerebral blood vessels. This facilitated quantification of IFN produced within the
brain by minimising any contribution from blood IFN. Plalf brains from each animal
were stored in RNALater to prevent degradation ofRNA. Forty mg of tissue was
taken at random from each half brain and the RNA extracted. The RNA was reverse
transcribed into cDNA and quantified for copies of SFV RNA, IFN-p, IFN-a and P-
actin transcripts. In contrast to the high moi in vitro experiments, which resulted in
synchronous infection of all cells and differentially downregulated cell housekeeping
genes which are normally used for normalisation, in vivo infections are essentially
low moi infections and therefore are not expected to affect global levels of cell
housekeeping genes. Consequently, the levels of virus RNA and IFN transcripts can
be normalised to housekeeping genes such as P-actin. All of the transcript data
generated from in vivo studies was normalised to 100,000 P-actin copies. No viral
RNA or IFN transcripts were detected in the mock-infected brains (data not shown).
Figure 4D (i) indicates the level of SFV RNA in each mouse brain. No SFV RNA
was detected for two of the mice at 12 hours post-inoculation. Levels were variable
between mice but showed an increase between 12 and 24 hours. At 12 hours post-
inoculation not all of the brain would have been infected; the negative samples at this
time may have come from an uninfected area of the brain.
IFN- P transcripts were only detected at 24 and 40 hours post-infection, and only in
two of the three mice sampled at each time point (Figure 4D (ii)). Only mice with
greater than 1 x 106 copies SFV RNA / 100,000 P-actin copies produced detectable
IFN-P transcripts. IFN-P gene transcript levels were similar at 24 hours and 40 hours
107
IFN induction by Semliki Forest virus
post-infection. A strong correlation (R2 = 0.91) was observed between levels of SFV4
RNA and levels of IFN-P transcripts (Figure 4E); this suggests that IFN-p gene
transcription in the brain was driven by virus RNA. IFN- a transcripts could only be
detected in mice when IFN-p transcript levels were greater than 1.2 x 103 transcript
copies / 100,000 p-actin copies (Figure 4D (iii)). Levels of IFN-a transcripts were
similar at 24 and 40 hours post-infection. Levels of IFN-a transcripts were
proportional to both levels of IFN- P transcripts and SFV RNA; linear regression
• 9
analysis indicated R values of 0.99 and 0.94, respectively.
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Figure 4D: Production of IFN-p transcripts in mouse brains following SFV4
infection
Adult 129/Sv/Ev wild type mice were inoculated ic with SFV4, after 12, 24 or 40 hours post-
inoculation brains were sampled and assayed for (i) viral RNA species, (ii) IFN-P and (iii)
IFN-a transcripts. All of the data was normalised to the level of 100,000 P-actin transcripts.
Each bar represents one animal and the order of presentation is kept the same in each figure.
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Figure 4E: Levels of IFN-p transcripts increase with increasing levels of virus
RNA
Adult 129/Sv/Ev wild type mice were inoculated ic with SFV4, after 12, 24 or 40
hours post-inoculation brains were sampled and assayed for viral RNA species and
IFN-P transcripts. Only brains that produced detectable amounts of IFN-|3 transcripts
are plotted, dark blue symbols represent 24 hours post-infection and light blue
symbols represent 40 hours post-infection, each point represents one mouse. Linear
regression analysis produced an r2 value of 0.91.
Does SFV4 induce type I IFN transcripts in neonatal mouse
brains?
One hypothesis for the greater virulence of SFV in neonates versus adults is that
immature CNS cells are impaired in their ability to produce type I IFNs in response to
SFV infection. To test this, the levels of type I IFN transcripts induced by SFV4
infection in the neonate brain were determined. Neonatal mice (129/Sv/Ev) aged 4
days were intranasally (in) infected with approximately 50 pi of 1 x lO* pfu /' ml
SFV4 or mock infected with PBSA. Widespread neonatal brain infection is expected
to occur between 24 and 40 hours post-infection (Oliver et al., 1997). At 30 hours
post-inoculation mice were sampled and brains were removed and stored in
RNALater until the RNA was extracted. The levels of SFV4 virus RNA detected in
each neonate brain are shown in figure 4F (i). No virus RNA was detected in the
negative controls (data not shown). All of the SFV4 infected mice had > 1 x 104
copies virus RNA / 100,000 P-actin copies. The level of virus RNA produced by each
mouse varied by 2 Logio- IFN-P transcripts were detected in all of the infected mice
except one (Number 5), which showed the lowest level of SFV RNA (1 x 104 SFV4
RNA copies / 100,000 P-actin copies) (Figure 4F (ii)). All negative controls produced
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low but detectable levels of IFN-P transcripts, consistent with very low level
contamination of these samples. To allow for the possibility that the samples from the
virus infected mice were also contaminated (although the negative result from mouse
5 suggests this was not the case) the limit of detection was raised to the highest
negative control value. The levels of IFN-p transcripts were similar for all 5 animals
in which they were detected. Only three of the neonates produced detectable IFN-a
transcripts, these mice also produced the highest levels of IFN-P transcripts
(approximately >1x10 transcript copies / 100,000 P-actin copies) (Figure 4F (iii)).
Linear regression analysis indicated that the levels of IFN-P and IFN-a did not
correlate to the levels of virus RNA, however, the levels of IFN-a did correlate to the
levels of IFN- p with an R2 value of 0.99.
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Figure 4F: Production of IFN-p transcripts in neonatal mouse brains following
SFV4 infection.
Four-day-old neonates were infected in with SFV4; brain RNA was extracted at 30 hours
post-inoculation and assayed for (i) SFV RNA, (ii) IFN-P transcripts and (iii) IFN-a
transcripts. All of the data was normalised to 100,000 P-actin transcripts. Each bar represents
one mouse and the x-axis crosses the y-axis at the limit of detection of the assay.
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Do neonatal and adult mouse brains produce functional IFN in
response to an SFV4 infection?
To determine if the IFN transcripts detected in both neonatal and adult mouse brains
resulted in functional IFN, half brains were assessed in the bioassay (Figure 4G). IFN
was detected at both 24 and 48 hours in neonates and levels increased over this time.
Functional IFN was only assessed at 40 hours post-inoculation in adult brains; the
amount detected was comparable to the amount detected in neonates at 24 hours.
24 48 40
Neonate Adult
Figure 4G: Neonatal and adult mouse brains produce functional IFN.
129/Sv/Ev wt neonatal mice were inoculated in with SFV4 and half brains sampled at 24 and
48 hours. Wild type 129/Sv/Ev adult mice were inoculated ic with SFV4 and half brains were
sampled at 40 hours post-inoculation. The amount of IFN present in each sample was
quantified by CPERA. Each bar represents one mouse.
In conclusion, high levels of SFV4 RNA induce IFN-p and IFN-a gene expression in
both adult and neonate mouse brains and functional IFN is produced in adult and
neonate brains in response to SFV4 infection.
Is human interferon protective against SFV
encephalitis?
SFV is a positive sense, single-stranded RNA virus, which targets the CNS and
induces virus encephalitis. It belongs to the alphavirus family and is transmitted by
mosquitoes (Weaver et al., 2000). Thirty-seven alphaviruses are known to cause
human disease, including Eastern Equine Encephalitis virus (EEE), Venezuelan
Equine Encephalitis virus (VEE), Ross River virus and Chikungunya virus. The
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alphaviruses are endemic across the Americas, Africa and Australia (reviewed in Tsai
et al., 2002) and the majority target the CNS. Other viruses, which commonly cause
human encephalitis include Japanese encephalitis virus, rabies virus and measles
virus. SFV can be used as a model to study the pathogenesis of neurotropic
infections. For many viral encephalitides no vaccines are available and both vaccines
and alternative prophylactics are desired. The SFV model system may have potential
in evaluating human IFN preparations. This was determined by evaluating the ability
of a new interferon product to affect the course of SFV encephalitis. The compound
if*) • • • •
Multiferon ' is being developed by Viragen Ltd (Edinburgh) and contains multiple
types and sub-types of IFN. It was hypothesised that treatment with a broad range of
IFNs would maximise the potential of an anti-viral effect and would be less likely to
promote pathogen resistance.
This study investigated the protective effect ofMultiferon1 (Viragen), on SFV L10
infection. LI 0 is an extremely virulent strain of SFV; ip inoculation normally results
in death (100 % of animals) within 3-4 days (Fazakerley, 2002).
Does Multiferon® protect adult mice against SFV L10
infection?
Six groups of six female Balb/c mice aged 4-6 weeks were inoculated ip with 1 x 103
pfu of SFV LI 0; each group was given a different Multiferon treatment regime and
assessed twice daily for survival. SFV L10 is extremely neurovirulent and is
representative of a naturally acquired virulent arboviral encephalitis. Each treatment
regime is described in table 4A. Where IFN was administered, 1x10 IU Muliferon
diluted in 0.1 ml PBS were inoculated ip.
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Time post virus inoculation
Group -24 hr 0 5 hr 26 hr Day 2 Day 3 Day 4 Day 5
A - L10 - - - - - -
B - - IFN IFN IFN IFN IFN IFN
C IFN L10 IFN IFN IFN IFN IFN IFN
D - L10 IFN IFN IFN IFN IFN IFN
E - L10 - IFN IFN IFN IFN IFN
F - L10 IFN IFN - - - -
Table 4A: Multiferon treatment regime.
Six groups of Balb/c mice were inoculated with SFV L10 and treated with IFN where
indicated. L10 represents ip inoculation of 1 x 103pfu L10 / 0.1 ml PBSA; IFN indicates the
ip administration of 1 x 105 IU Multiferon® / 0.1 ml PBS.
This experiment was carried out under the auspices of a UK Home Office licence. In
accordance with these regulations, mice that had substantial clinical signs were
euthanised. Mice first presented with clinical signs at day 3 when 4 of the mice in
Group A became ill; 2 had signs of substantial disease (Figure 4H) and all mice in
Group E appeared unwell with ruffled coats and slow, shaky movements. By day 4, 5
of the animals in Group A had died; the remaining mouse had a ruffled coat, an early
sign of infection. Four of the animals in Group E were dead; another had hind limb
paralysis and was consequently put down, the surviving animal showed the early
signs of infection. By day 5 post-inoculation, one mouse was found dead in Group F,
2 more showed signs of poor grooming and 3 were asymptomatic. The infection in
the surviving mice from Groups A and E had progressed; both mice had ruffled coats
and displayed minimal movement, when stimulated their movements were shaky. At
day 6, all of the mice in Groups A and E had succumbed to SFV encephalitis or had
reached substantial clinically defined terminal end points and had been put down. A
further 2 mice from Group F had died, but the 3 surviving mice were still
asymptomatic. One mouse was found dead in Group C, the remaining 5 mice were
asymptomatic. Another mouse was found dead in Group D and a further mouse was
put down due to complete hind limb paralysis. Four remaining mice ofGroup D
showed initial signs of infection. By day 7 another mouse from Group D was put
down and the following day a mouse in Group C died. The experiment continued
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until 12 days post-inoculation; however, after day 8 no more mice died. Healthy mice
• (^) • • • • • •
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Figure 4H: Mouse survival (days) after SFV L10 inoculation and treatment with
Multiferon©
Six female mice aged 4-6 weeks were assigned to each group. Each group received a different
treatment regime: A - Inoculated with LIO, B - Given Multiferon' at 5 and 26 hours post-
inoculation and PID 2, 3, 4, 5, C - Inoculated with LIO and given Multiferon' at-24, 5, 26
hours post-inoculation and PID 2, 3, 4, 5, - Inoculated with L10 and given Multiferon0 at 5
and 26 hours post-inoculation and PID 2, 3, 4, 5, E- Inoculated with LIO and given
Multiferon' at 26 hours post-inoculation and PID 2, 3, 4, 5, F - Inoculated with LIO and
given Multiferon' at 5 and 26 hours post-inoculation only.
In conclusion, Multiferon' reduced the virulence of SFV L10 infection when
administered 24 hours prior to virus or 5 hours after virus. However, Multiferon®
administered 26 hours post-inoculation had no effect (GroupE had the same mortality
rate as the positive controls, Group A). Following treatment 24 hours before or 5
• • • • • • • •
hours after inoculation additional doses of Multiferon did not have any additive
value.
These results demonstrate the applicability of the SFV model system to study the anti¬
viral efficacy of human IFN preparations.
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Discussion
Many virus infections are more severe in neonates than in adults; it has been
postulated that this is related to an impaired ability of neonates to induce IFN
responses. Neustock et al., (1993) demonstrated that cord blood mononuclear cells
produced less IFN in comparison to adult blood cells following a virus infection. The
experiments described in this thesis investigated the levels of IFN produced by
neonatal and adult mouse brains in response to SFV4 infection. SFV4 induced IFN-J3
and IFN-a transcripts and functional IFN in both adult and neonates. Levels of IFN
transcripts detected in neonatal mouse brains were approximately 10-fold lower than
in adult brains; however, this corresponded to 10-fold lower virus RNA titres. This
could be a consequence of the different inoculation sites (adults, ic and neonates, in).
The ratio of IFN-P transcripts: 1 x 106 virus RNA is approximately the same for
adults and neonates (3 and 3.25, respectively), demonstrating that adult and neonate
brains produce equivalent levels of IFN-P in response to a certain virus RNA level.
Given that neonates produce IFN and make a similar response to adult mice, indicates
that lack of IFN in neonates is not the explanation for age-related virulence. This
result is in agreement with those of Labrada et ah, (2002) who demonstrated that high
levels of Sindbis virus (SV) induce high levels of IFN and inflammation. Alternative
explanations for the increased SFV virulence in neonates include 1) the stress
hyporesponsive period, which is defined by the absence of a stress-induced
adrenocortical response to mild stimuli between post-natal day 4 and 14 (Schapiro et
ah, 1962; Schoenfeld et ah, 1980). It has since been shown that the developing CNS
can produce a strong adrenocorticotrophin hormone (ACTH) response to multiple
stimuli, for example, histamine (Kent et ah, 1996), endotoxin (Witek-Janusek L,
1988), and IL-1 (Levine et ah, 1994). 2) CNS maturation, neuronal maturation
coincides with acquirement of resistance to SFV infection (Oliver et ah, 1997; Oliver
and Fazakerley, 1998). SFV replicates on smooth membranes. During CNS
development high levels of smooth membrane production occur to support
synaptogenesis. When smooth membrane production in adult mice was induced with
aurothiolates, a normally avirulent SFV infection was able to spread throughout the
brain (Mehta et ah, 1990; Scallan and Fazakerley, 1999). Another factor that changes
with CNS maturation is the propensity of CNS cells to undergo apoptosis. Neurons of
the developing CNS are more susceptible to apoptosis (Levine et ah, 1996; Havert et
117
IFN induction by Semliki Forest virus
al., 2000) and forced expression of anti-apoptotic proteins such as Bcl-2, Bax and
CrmA, all reduce mortality of neonatal mice following infection with alphaviruses
(Levine et al., 1996; Lewis et al., 1999; Nava et al., 1998). 3) Other differential
immune responses, reduced NK cell activity in neonates has been observed (Nair et
al., 1985). Adaptive immune responses are suppressed in neonates; however, SCID
adult mice, which are deficient in their T and B cell responses, show a restricted
infection with avirulent strains of SFV (Wesselingh et al., 1994; Fazakerley
unpublished), suggesting that other factors play a role in SFV age-dependent
pathology. Gene expression analysis revealed that during an SV infection only ISG-
12 is expressed at greater levels in adult mice compared to neonates and enforced
expression of ISG-12 in neonates delayed mortality (Labrada et al., 2002).
The adult and neonate in vivo data show that IFN-a transcript levels correlate to IFN-
(3 transcript levels. This suggests that IFN-a transcript production is driven by IFN-P
and is consistent with the two-phase IFN induction theory (Marie et al., 1998), which
states that IFN-P is expressed initially and signals through the IFNAR to induce
expression of anti-viral genes, including the transcription factor IRF-7. IRF-7 is
required for the induction ofmany IFN-a subtypes. IFN-P expression is activated by
virus and in the adult brain IFN-P levels correlate to SFV4 RNA levels. During a low
moi infection such as this, as the virus spreads throughout the brain, increasing
numbers of cells are infected. This enables greater levels of virus replication, which
induces increasing numbers of cells to express IFN-P.
Interestingly when IFN-P transcripts were detected, the corresponding levels of SFV4
RNA were particularly high. When cultured cells were infected with SFV4, virus
RNA was detected from 2 hours post-infection and virus levels continued to increase
until 6 hours post-infection. However, IFN-P transcripts were not detected until 4
o
hours post-infection when virus RNA levels were >1x10 RNA copies / pg total
RNA. IFN is one of the first anti-viral responses, but virus RNA levels were high
before this crucial primary response was detected. Possible explanations are that (i)
IFN-P transcripts are induced earlier but at levels below the limit of detection of the
assay (< 1000 copies); (ii) a certain level of virus replication needs to be present per
cell to induce IFN gene expression; (iii) SFV4 is able to suppress, or at least delay,
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induction of IFN gene expression. To address each in turn, qPCR is a very sensitive
assay, but for IFN-P transcript detection the limit of detection is 1000 copies per pg
total RNA. However, given that the levels of IFN-p increase 50-fold from below the
limit of detection (< 1000 copies) within an hour, it is unlikely that transcripts have
not been detected. The high moi in vitro experiment indicates that approximately 109
SFV4 RNA copies / pg total RNA were detected at 4 hours post-infection.
Approximately 30 pg RNA were extracted from 2 x 106 cells, therefore 3 x 1010 SFV4
RNA molecules were produced by 2 x 106 cells, equating roughly to 10,000 SFV4
RNA molecules per cell at 4 hours, the time when IFN-P is first detected. The 4-hour
delay between infection and IFN-P transcript detection could represent the minimal
delay between virus detection and initiation of gene transcription. However, crg-2,
the murine equivalent of IP-10, which is an immediate early expressed gene (like
IFN-P) and is induced by IFN-y, poly I:C and viruses, can be detected within 2 hours
following IFN- y induction and within 3 hours following NDV infection (Vanguri and
Farber, 1994). Poly I:C treatment of primary tamarin hepatocytes induces a 12-fold
increase in IFN-p transcripts within 2 hours (Lanford et ah, 2003). In addition to
virus replication, IFN expression is induced by non-replicating SFV as a result of
virus entry into the cell, which might be expected to result in rapid IFN gene
expression (Hidmark et ah, 2005). Alternatively, the 4 hour delay before detectable
IFN gene transcription could represent SFV4 suppression of IFN-p expression. Many
viruses have developed mechanisms to antagonise the IFN response so this is a
plausible concept.
SFV4 infection ofmouse fibroblasts resulted in a continual increase in SFV RNA
copies / pg total RNA over 6 hours; however after induction at 4 hours, even though
the levels of virus RNA increased 100-fold, IFN-P transcript levels maintained a
constant level until 6 hours. As this was a high moi infection, IFN-P expression
should have been induced in all cells synchronously but whereas virus RNA levels
would be expected to increase as the number of potential transcription templates
increased with time there are only two copies of the IFN-P gene and so transcript
levels reach a plateau. However, this may also suggest that IFN-P transcription has
been abolished after 4 hours post-infection and that the maintenance of transcripts at
the same level at 6 hours post-infection is indicative of the stability of IFN-P mRNA.
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The sensitivity of SFV to IFN is examined in the second section of this chapter;
however, in figure 4A (i) there is a decline in the rate of virus RNA accumulation
between 4 and 6 hours post-infection and this correlates to the time of IFN-P
expression suggesting that SFV is sensitive to the effects of IFN.
Mice inoculated ic displayed considerable variation in the levels of virus RNA. SFV
is known to infect neurons, oligodendrocytes, meningal, ependymal and choroid
plexus cells but infection of astrocytes has not been observed (Balluz et ah, 1993;
Pathak et ah, 1983). Inoculation into a particularly brain area may result in
predominant infection of a certain cell type for example, oligodendrocytes in the
corpus callosum or neurons in the thalamus, and different cells may be better at
supporting SFV infection and may respond to SFV infection by producing different
levels of IFN. To date, IFN production in the CNS has been mostly attributed to
astrocytes (Ogata et ah, 2004), however neurons have recently been identified as
major IFN producers and IFN has been detected in resident macrophages and brain
epithelial cells (Delhaye et ah, in press; Barber et ah, 2004). The variability between
animals inoculated ic in the levels of both virus RNA and IFN transcripts is likely to
reflect the variability in cell types and brain regions infected in different animals.
Mice inoculated in also demonstrated variability in the levels of virus RNA detected
in the brain. Following in inoculation, neurotropic viruses can invade the brain by
infecting vomeronasal chemosensory neurons e.g. HSV-1 and HSV-2 (Mori et ah
2005). These viruses do not induce apoptosis in the infected neurons; it is believed
that this may facilitate viral transmission to the CNS. H5N1 influenza A virus
induces CNS pathology by travel from the nasal cavity along the cranial nerves
(Iwasaki et ah, 2004). In inoculation of SFV results in SFV spread along neurites in a
circuit-specific manner throughout the olfactory bulb (Oliver and Fazakerley, 1998).
By in inoculation the virus is not directly inoculated into the brain, and must traverse
one of several nerves to enter the CNS. The time at which it infects the CNS may
vary between animals.
Is IFN protective against an SFV infection?
The L10 strain of SFV, which is highly virulent in adult mice was shown to be
sensitive to a human IFN preparation (Multiferon' ). This effect was conditional upon
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the time prior / post infection that IFN was administered. Only mice treated with IFN
5 hours post-infection (ip) had an improved survival rate. By 5 hours virus would
have started to spread from the originally infected cells of the peritoneal cavity.
Administration of IFN at this time should have stimulated an antiviral state in
uninfected cells and greatly reduced the second and subsequent waves of virus
production. IFN administered at or after 26 hours post-infection was ineffective. By
this time the virus would have established infection in many tissues. This is
consistent with the observation that in the mouse, IFN levels are high by 24 hours
post-infection, but this fails to prevent virulence of L10 virus (Bradish and Titmuss,
1981). Mice given IFN treatment 24 hours in advance of the L10 infection
demonstrated the highest percentage of survival. Advance IFN treatment would have
established an anti-viral state in all cells prior to infection. In the clinical setting, the
use of IFN as preventative treatment for virus infections would be of little value as the
induced anti-viral state is downregulated within a few days if an infection is not
detected. Finter, (1966) observed that the antiviral state can only be stimulated 1-2
days in advance of infection to still be protective against SFV.
These studies demonstrate that the mouse:SFV L10 system can be used to screen
human IFN preparations. However, the results also demonstrate the potential
problems of IFN as an anti-viral therapy for an acute infection. In this study the time
window for effectiveness was very small (hours before and after the infection). In a
clinical setting, this would be of little value as most patients would not realise they
had been infected until they presented symptoms by which time IFN treatment could
be of no value. However, IFN treatment could be useful as a post-exposure therapy
following for example laboratory infection with a dangerous virus. Venezuelan equine
encephalitis virus (VEE), an alphavirus related to SFV has been associated with over
20 laboratory infections resulting in clinical illness (Koprouski and Cox, 1947).
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Summary
The objectives of this chapter were to determine whether SFV4 induced type I IFN
gene expression in mouse fibroblasts; to quantify type I IFN responses in the brains of
SFV4 infected adult and neonatal mice and to assess the efficacy of passive IFN
administration to treat a neurovirulent infection. As with other strains of SFV and as
expected, SFV4 induced type I IFNs in cultured mouse (L-929) fibroblasts. Similar
levels of type I IFN transcripts and functional IFN were induced in both adult and
neonatal mouse brains following SFV4 infection. It is therefore unlikely that
differences in the generation of IFN contribute to SFV induced age-dependent
virulence. Type I IFN is a potent anti-viral response, however the ability of the
Multiferon preparation to protect against lethal SFV encephalitis was very dependent
upon the time at which the IFN was administered. Mice had an increased chance of
survival if IFN was given prior to, or at 5 hours post-infection, but not if given 26
hours post-infection. However, these results do demonstrate the applicability of this
mouse model for the testing of human IFN preparations.
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A Role for PKR in IFN induction
Does Protein Kinase R (PKR) have a role in IFN
induction during SFV infection
Objectives:
1) Does PKR affect IFN-P transcript production in the mouse brain in
response to SFV infection?
2) Does PKR affect functional IFN production in the mouse brain in response
to SFV infection?
3) Does PKR affect IFN-P transcript production in vitro in response to SFV
infection?
4) Does PKR affect functional IFN production in vitro in response to SFV
infection?
Introduction
PKR (Clemens et ah, 1993) is an IFN induced antiviral protein, with two domains, the
N-terminal regulatory domain, composed of two dsRNA binding motifs (dsRBM),
and the C-terminal catalytic domain, which encompasses the protein kinase function
(Meurs et ah, 1990). Attachment of dsRNA to the dsRBM induces a conformational
change resulting in autophosphorylation and activation ofPKR. The dsRBM may also
be responsible for PKR ribosomal targeting (Zhu et ah, 1996). Following
autophosphorylation, PKR forms a homodimer and this active PKR targets several
proteins for phosphorylation. The best known target is eIF-2a, although other roles in
growth factor (platelet derived growth factor) and calcium-mediated signal
transduction as well as in transcription regulation have been defined (Mundschau and
Faller, 1995; Srivastava et ah, 1995; Kumar et ah, 1994). PKR is expressed
constitutively in all cell types (Baier et ah, 1993) and its antiviral effect can be
activated immediately following virus infection; other antiviral proteins (e.g. Mx) are
induced following IFN expression and therefore act less rapidly. PKR
phosphorylation of eIF-2a locks eIF2 in a complex with GDP; this prevents guanine
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nucleotide exchange factor cycling ofGDP and GTP which is required for continued
initiation of translation (Merrick, 1992). The inability of a cell to initiate translation
effectively culminates in protein translation shut-off. The role of PKR in transcription
regulation is linked to the phosphorylation of inhibitory kappa B kinase (IkK);
phosphorylation and activation of IkK results in IkK phosphorylation of IkB and
ultimately targets IkB for proteosome degradation. Under non-inflammatory
conditions, IkB maintains NF-kB within the cytoplasm in an inactive form.
Degradation of IkB releases NF-kB, which forms a homodimer and enters the
nucleus. Within the nucleus NF-kB associates with several promoters including the
IFN-p promoter.
The previously assumed pivotal role for PKR in IFN-P expression is now questioned
by the recent discovery of several other cytoplasmic dsRNA-activated, IFN inducing
proteins such as RIG-I and mda-5 and experimental evidence which has indicated that
PKR mutant mice do not display increased sensitivity to certain viral infections e.g.
vaccinia virus and EMCV (Yang et al., 1995; Zhou et al., 1999). Yang et al.
demonstrated that MEFs without functional PKR (PKRo/o) stimulated with poly I:C
did not express IFN-P or IFN-a mRNA, where as wt cells expressed both. However,
when PKRo/o and wt cells were infected with Newcastle Disease virus (NDV),
comparable levels of both IFN-P and IFN-a transcripts were detected. This implies
that cells contain a multitude of sensors which can stimulate the IFN response and
possibly that viruses differ in their requirement for PKR to activate the IFN response.
The mechanism of IFN induction in an SFV infection has not been investigated.
Dendritic cell (DC) cultures with defective PKR and RNase L proteins were infected
with Sindbis virus, an alphavirus related to SFV; these demonstrated a dependence
upon PKR for early but not late suppression of viral protein synthesis (Ryman et al.,
2002). In Sindbis virus infection, both PKR-dependent and PKR-independent
pathways participate in host cell translational shut-off; the most likely major pathway
was the independent pathway (Gorchakov et al., 2004), leaving open the question, is
PKR required for IFN-P gene expression in alphaviruses infections? Early in
infection the main role of PKR is probably to enhance IFN-P expression. It has also
been suggested that PKR is required for the induction of interferon regulatory factor
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(IRF) -1 expression (Kirchhoff et al., 1995), allowing IFN-a induction or expression
of other antiviral genes.
In the following experiments, the importance of PKR for IFN-p and IFN-a induction
in SFV infection ofmurine brain tissue and MEFs was studied.
Is PKR required for the mouse brain IFN response to SFV?
To determine whether PKR has a role in IFN induction during SFV infection,
129/Sv/Ev mice carrying a mutated PKR gene, PKRo/o (Yang et al., 1995), control
129/Sv/Ev mice, and mouse embryo fibroblasts (MEFs) derived from these, were
assessed for their ability to induce IFN-P transcripts and functional IFN following
SFV infection. The PKR0/0 mice were created by insertion of a neomycin resistance
gene in an antisense orientation with an upstream transcription termination sequence,
between and partially overlapping exons 2 and 3 of the PKR gene. The mutated PKR
gene was inserted into 129/Sv/Ev embryonic stem cells by homologous recombination
and then injected into C57BL/6 blastocysts. The transcription termination sequence
was not effective but the mRNA expressed by the mutant mice lacked exons 2 and 3
resulting in a frame shift and deletion of the first 17 amino acids including the
initiation codon (Yang et al., 1995). A C-terminal fragment ofPKR mRNA can be
expressed but is not functional. To confirm the PKR gene status, all cells and animals
investigated were characterised by PCR; RNA was extracted from ear clippings or
cell cultures and transcribed into cDNA from oligo dT primers. cDNA was assessed
for the presence of the deleted section of the PKR gene by PCR. The primers and
conditions are described in the Materials and Methods, Table 2D; figure 5A
demonstrates the presence or absence of the sequence overlapping exons 2 and 3 of
the PKR gene.
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1 23456789 Lane Primers Strain Sample
1 - - 100 bp ladder
2 PKR PKR0/0 Brain
3 P-actin PKR°'° Brain
4 PKR WT Brain
5 P-actin WT Brain
6 PKR WT MEFs
7 P-actin WT MEFs
8 PKR PKR0'0 MEFs
9 P-actin PKR0/0 MEFs
Figure 5A: Genetic confirmation of PKR0/0 or wild type mouse strains and
MEFs.
RNA was extracted from PKRo/o or wt strains and reverse transcribed into cDNA; the cDNA
was assessed for a sequence partially overlapping exons 2 and 3 of the PKR gene (PCR
product = 369 bp). This was absent in PKR00 and present in wt mice and cells. Each sample
was also assessed for P-actin (PCR product = 202 bp) to ensure that the PCR was valid.
Annealing was carried out at 55°C. The lane order is indicated in the table.
To determine whether PKR has a role in IFN induction in the mouse brain, three
strains ofmice were compared for their ability to induce functional IFN in response to
SFV infection - Balb/c, 129/Sv/Ev and PKRo/o. Balb/c and 129/Sv/Ev mice both
possess a functional PKR gene. Groups of four adult mice aged 4-6 weeks were
inoculated ic with 5x103 pfu SFV4 in 0.02 ml PBSA or with PBSA alone. After 24
hours the mice were sampled; half brains were snap frozen in dry ice and assessed for
infectious virus and functional IFN by plaque assay and CPERA, respectively (Figure
5B).
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Figure 5B: Functional IFN in the brains of SFV4 infected (/c) wild type and
PKR0/0 mice at 24 hours.
Balb/c, 129/Sv/Ev and PKR00 mice were ic inoculated with SFV4 and their brains sampled
and assessed for levels of (i) infectious virus and (ii) functional IFN at 24 hours post-
inoculation. Each point represents a single mouse brain.
Levels of infectious virus and functional IFN were not significantly different (p >
0.05, Kruskal Wallis test or Mann-Whitney) between the three strains of mice. No
infectious virus or functional IFN was detected in the brains of control mice
inoculated with PBSA alone (data not shown). This data clearly demonstrates that
PKR is not required for functional IFN induction in the brain. Furthermore, the
equivalent brain virus titres in the PKRo/o and wt mice suggest that PKR has no effect
on brain virus, at least at 24 hours post-infection. However, the functional IFN assay
detects all subtypes of IFN and most studies suggest that PKR is involved in IFN-P
induction.
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Does PKR affect IFN-p transcription in the mouse brain in
response to SFV?
To determine IFN-{3 gene expression and relate this to levels of virus and functional
IFN in the brain, 129/Sv/Ev wt and PKRo/o mice were inoculated ic with 5xl03 pfu
SFV4 in 20 pi of PBSA or with PBSA alone. Brains were sampled at 12, 24 or 40
hours post-inoculation; animals were perfused with sPBS to remove contaminating
blood prior to dissection. Half brains were stored in RNALater to prevent RNA
degradation. RNA was extracted, transcribed into cDNA and assessed by qPCR for
levels of IFN transcripts and SFV RNA species (Figure 5C). The other half of each
brain was assayed for functional IFN and infectious virus (Figure 5F).
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Figure 5C: IFN-p and IFN-a transcripts in wt and PKR°/0 mouse brains after
SFV4 infection.
129/Sv/Ev wt and PKRo/o mice were infected with SFV4. At 12, 24 or 40 hours post-
inoculation brains were sampled and assessed for (i) SFV RNA, (ii) IFN-P transcripts, and
(iii) IFN-a transcripts. The data was normalised to 100,000 P-actin copies. A single bar
represents an individual mouse brain and the sample order is maintained in each panel so the
data can be compared; mean values were not determined due to the variation between mice.
The x-axes intersect the y-axes at the limit of detection of the assay.
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No SFV RNA or IFN transcripts were detected in any of the mouse brains inoculated
with PBSA alone (data not shown). SFV RNA was detected in all virus inoculated
mouse brains except for two of the wt mice sampled at 12 hours post-inoculation. At
this early time point it is likely that large areas of the brain would still be uninfected.
Only approximately % of the brain is used for virus titration so the negative samples
at this time may have come from an uninfected area of the brain. Virus RNA levels
increased approximately 100-fold between 12 and 24 hours post-infection. At 24 and
40 hours post-infection there was no significant difference in the levels of virus RNA
in the brain between the two strains of mice (p > 0.05, Kruskal Wallis test). IFN-P
transcripts were not detected in the brains of either wt or PKRo/o mice until 24 hours
post-infection. There was no significant difference in the levels of IFN-p transcripts
detected in the two mouse strains at 40 hours post-infection (p > 0.05, Kruskal Wallis
test). In conclusion, absence of functional PKR did not affect the levels of virus RNA
or the levels of induced IFN-P transcripts.
For both mouse strains, IFN-P transcripts were only detected in brains when levels of
viral RNA > 1 x 106 copies / 100,000 P-actin copies. Where IFN-P transcripts were
detected, levels strongly correlated with virus RNA copies (wt cells R2= 0.91, PKRo/o
9 • • •
R' = 0.9, Figure 5D), suggesting that virus RNA levels drive IFN-P gene expression
in both wt and PKRo/o mouse brains. IFN-a transcript levels were also investigated.
PKR has been suggested to be required for IRF-1 induction (Kirchhoff et al., 1995).
Presence or absence ofPKR did not affect the level of IFN-a expression. At 40 hours
there was no significant difference in the levels of IFN-a transcripts between wt and
PKRo/o mice (p > 0.05, Kruskal Wallis test). IFN-a transcripts were only detected in
mouse brains when SFV4 RNA levels were > 1 x 106 copies / 100,000 P-actin copies
and IFN-P transcript levels were > 2 x 103 copies / 100,000 P-actin copies. The level
of IFN-a transcripts in wt mice strongly correlated with the levels of SFV RNA and
IFN-P transcripts with R values of 0.94 and 0.99, respectively. The level of IFN-a
transcripts also correlated with the levels of SFV RNA and IFN-P transcripts, with R
values of 0.845 and 0.99, respectively, in PKRo/o mice (Figure 5E). This suggests that
for both strains ofmice virus and IFN-P expression drive IFN-a transcription.
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Figure 5D: Levels of IFN-p transcripts correlated with levels of SFV RNA.
(i) 129/Sv/Ev wt and (ii) PKRo/o mice were infected with SFV4. At 12, 24 and 40 hours post-
inoculation brains were sampled and assessed for SFV RNA and IFN-P transcripts. Each
point represents an individual mouse brain. The linear regression co-efficient produced by
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Figure 5E: Levels of IFN-a transcripts correlated with levels of SFV RNA.
(i) 129/Sv/Ev wt and (ii) PKRo/o mice were infected with SFV4. At 12, 24 and 40 hours post-
inoculation brains were sampled and assessed for SFV RNA and IFN-a transcripts. Each
point represents an individual mouse brain. The linear regression co-efficient produced by
plotting the levels of IFN-a against virus RNA levels was R2 = 0.94 and 0.845, wt and
PKRo/o, respectively.
The other half brain from each of the mice sampled at 40 hours was assayed for
infectious virus and functional IFN (Figure 5F).
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Figure 5F: Functional IFN and infectious virus levels in 129/Sv/Ev and PKR0/0
mice infected with SFV4.
129/Sv/Ev wt and PKRo/o mice were inoculated ic with 5xl03 pfu SFV4 in 20 pi of PBSA. At
40 hours post-inoculation mice were perfused with sPBS and the brains removed. Brains
were assayed for (i) infectious virus and (ii) functional IFN. Each point represents an
individual mouse brain.
There was no significant difference in the levels of either infectious virus or
functional IFN between wt and PKRo/o mouse brains (p > 0.05, Kruskal Wallis test).
This supports the previous data (Figure 5B) and again demonstrates that PKR is not
required for IFN expression and does not enhance or suppress viral replication, at
least within 40 hours post-infection (Table 5A).
wt PKR°/0
1 2 3 1 2 3
Log10 infectious virus (pfu / g brain) 9.09 - - 8.98 9.02 8.32
Log-io virus RNA copies 8.01 6.50 5.59 7.63 7.38 -
Log10 IFN-p transcripts 4.31 3.26 0.00 4.12 4.02 -
Log-io IFN-a transcripts 3.28 2.55 0.00 3.21 3.08 -
Log-io functional IFN (III / g brain) 5.03 - - 5.08 5.32 5.24
Ratio PFU : virus RNA 1.14 - - 1.18 1.22 -
Ratio virus RNA : IFN-p 0.31 0.33 - 0.31 0.31 -
Ratio virus RNA : IFN-a 0.41 0.42 - 0.40 0.40 -
Ratio virus RNA : functional IFN 0.27 - - 0.25 0.23 -
Table 5A: A comparison of virus and IFN levels between wt and PKR0/0 mouse
brains.
The levels of infectious virus, virus RNA, IFN-P and IFN-a transcripts and functional IFN
detected in wt and PKRo/o mouse brains at 40 hours post-infection. Each mouse brain assayed
from each strain is indicated numerically. The ratios were determined per 106 pfu infectious
virus or 106 virus RNA copies. - indicates no data available.
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Does PKR affect IFN-J3 transcript production in vitro in
response to SFV infection?
Given the surprising result that PKR had no detectable affect on SFV replication, IFN
gene transcription or IFN functional activity in the brain, at least at 24 and 40 hours
post-infection, it was decided to investigate the role of PKR at earlier time points and
in a less complex in vitro system. Wild type and PKRo/o MEFs were grown to
confluence and infected at a moi of 10 with SFV4 or mock infected with sPBS. At 4,
8 and 12 hours post-infection, 3 cultures each ofwt and PKRo/o cells were collected,
RNA extracted and reverse transcribed into cDNA. The cDNA was assessed for SFV



























Figure 5G: IFN-p transcripts in wt and PKR0/o MEFs after SFV4 infection.
129/Sv/Ev wt (blue) and PKRo/o (pink) MEFs were grown to confluence in T20 flasks and
infected with SFV4 at moi 10 or mock-infected with sPBS. At 4, 8 and 12 hours post¬
infection cells were harvested, RNA extracted and reverse transcribed into cDNA to
determine levels of (i) SFV RNA species and (ii) IFN-P transcripts. Each point represents an
individual cell culture assayed in triplicate by qPCR; the limit of detection of each assay is at
the intersection of the axes. * indicates a significant difference (p < 0.05, Kruskal Wallis test)
between 129/Sv/Ev wt and PKRo/o groups.
No IFN-P transcripts were detected in the negative controls; however, low levels of
virus RNA (106 copies / pg RNA) were detected, suggesting that contamination had
occurred. This was most likely due to SFV4 plasmid contamination of the PCR assay.
SFV4 RNA levels remained relatively constant over the 12 hour period for both cell
types. A high moi (10) was used, which should have resulted in complete monolayer
infection and an early high and thereafter constant level of virus replication as is
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shown by the data. There was no difference observed between the two cell types in
their ability to support virus replication. In both cell types, the levels of IFN-P
transcripts increased approximately 100-fold between 4 and 8 hours post-infection
and then remained at a constant level up until 12 hours post-infection. There was no
significant difference in the levels of IFN-P transcripts between cell types at 4 or 12
hours post-infection (p > 0.05, Kruskal Wallis). However, at all of the time points
investigated, PKRo/o cells appeared to produce slightly lower amounts of IFN-P
transcripts. At 8 hours post-infection PKRo/o cells produced slightly but significantly
lower levels of IFN-P transcripts than wt cells (p < 0.05, Kruskal Wallis).
The experiment was repeated twice (II, III) and similar results were obtained (Figure
5H). In these experiments, no SFV RNA or IFN-P transcripts were detected from
MEFs mock-infected with sPBS (data not shown). In experiment II, levels of virus
RNA species increased slightly from 4 to 8 hours post-infection, perhaps suggesting
that not all cells were initially infected (Figure 5H (i)). No significant difference was
observed in either repeat experiment between the two cell types in their ability to
support virus replication (p > 0.05, Kruskal Wallis). In experiment II, IFN-P
transcripts steadily increased over the 12 hours post-infection for both cell types. At
all three time points, PKRo/o cells induced significantly lower levels of IFN-P
transcripts (p < 0.05, Kruskal Wallis) than wt cells (Figure 5H (ii)). To determine
significance, data from all three time points were grouped into wt and PKRo/o cells to
allow Kruskal Wallis analysis. In experiment III the PKRo/o cells also appeared to
produce less IFN-P transcripts than wt cells, but this difference was not significant (p
> 0.05, Kruskal Wallis, data not shown). In conclusion, SFV4 infection in the
absence of PKR induces lower levels of IFN-P transcripts, at least during the first 12
hours of infection.
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Figure 5H: Experiment II: IFN-p transcripts in wt and PKR0/0 MEFs after SFV4
infection.
129/Sv/Ev wt (blue) and PKRo/o (pink) MEFs were grown to confluence in T20 flasks and
infected with SFV4 at moi 10 or mock-infected with sPBS. At 4, 8 and 12 hours post¬
infection cells were harvested, RNA extracted and reverse transcribed into cDNA to
determine the levels of (i) SFV RNA and (ii) IFN-P transcripts. Each point represents an
individual cell culture assayed in triplicate by qPCR; the limit of detection of each assay is at
the intersection of the axes and * indicates a significant difference (p < 0.05, Kruskal Wallis)
between groups.
Are the levels of IFN-a influenced by PKR?
It has been suggested that PKR may be required for IRF-1 expression. IFN-a
transcript induction does not need the multitude of transcription factors required for
IFN-P transcription. IRFs are sufficient to induce IFN-a expression. To assess the
levels of IFN-a induced, the cDNA samples generated to determine the levels of SFV
RNA and IFN-P transcripts (Figure 5G; Figure 5H) were assayed for IFN-a
transcripts with redundant primers based on IFN-a4 (Figure 51).
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Figure 51: IFN-a transcripts in wt and PKR0/0 MEFs after SFV4 infection.
129/Sv/Ev wt (blue) and PKR0 0 (pink) MEFs were grown to confluence in T20 flasks and
infected with SFV4 at moi 10 or mock-infected with sPBS. At 4, 8 and 12 hours post¬
infection cells were harvested, RNA extracted and reverse transcribed into cDNA to
determine the levels of IFN-a transcripts. IFN-a transcripts were detected in (i) experiment I
and (ii) experiment II. Each point represents an individual cell culture assayed in triplicate by
qPCR; the limit of detection of each assay is at the intersection of the axes. * indicates a
significant difference (p < 0.05, Kruskal Wallis) between 129 wt and PKR0'0 groups.
No IFN-a transcripts were detected in the mock-infected controls (data not shown) or
in either experiment at 4 hours post-infection. In experiment I, IFN-a transcripts
were detected in both wt and PKR00 cells at 8 and 12 hours post-infection (Figure 51
(i)). The level of IFN-a transcripts detected in PKRo/o cells was significantly lower
than wt cells at 8 hours post-infection (p < 0.05, Kruskal Wallis). This correlates with
the level of IFN-p transcripts, which was also significantly lower in PKRo/o cells than
wt cells at 8 hours post-infection (Figure 5G (ii)). In experiment II, the levels of IFN-
a transcripts detected appeared lower in PKRo/o cells than wt cells at both 8 and 12
hours post-infection and pooling both time points, this difference was significant (p <
0.05, Kruskal Wallis, Figure 51 (ii)). Again this correlated with the IFN-P transcripts
(Figure 5H (ii). Experiment III also demonstrated that IFN-a transcript levels were
significantly lower in PKRo/o cells than wt cells at both 8 and 12 hours post-infection
(p < 0.05, Kruskal Wallis, data not shown).
To determine whether there was any correlation between IFN-a and IFN-P
transcripts, samples from 8 and 12 hours post-infection were compared (Experiment
I). For each cell type there was no correlation between IFN-a and IFN-p transcript
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levels; R2 values were < 0.3. This was supported by experiment III, which also
produced very low R values; however, experiment II contradicted both of these sets
of data and demonstrated a strong correlation between IFN-a and IFN-p transcripts
for both cell types with R2 values of 0.99. Experiments which demonstrated no
correlation between IFN-a and IFN-P expression also showed constant levels of IFN-
a and IFN-P transcripts at 8 and 12 hours post-infection; this implies that IFN gene
expression had reached a maximum level. Where IFN-P levels increased between 8
and 12 hours post-infection (Experiment II), the levels of IFN-a transcripts also
increased. In conclusion, these results suggest that PKR does not affect the level of
IFN-a transcripts independently of an affect on IFN-P gene expression.
What accounts for the observed reduction in IFN
transcription?
The reduced levels of IFN-a and IFN-P transcripts in SFV4 infected PKRo/o MEFs
(Figure 5G; Figure 5H; Figure 51) relative to wt MEFs are not associated with
differences in virus replication (Figure 5G (i); Figure 5H (i)) and most likely result
from a specific reduction in IFN gene activation. However, this difference could also
result from a general decrease in gene transcription, increased transcript degradation
or increased cell death. PKR is associated with regulation of the cell cycle through
interactions with NF-kB. Reduced activation ofNF-kB, a transcription factor
involved in prolonging cell viability, could for example, cause increased cell death in
PKR0/0 MEFs resulting in lower levels of IFN transcripts. To assess cellular
transcription, the cDNA generated to determine the levels of SFV RNA, IFN-P and
IFN-a transcripts, was assayed for levels of P-actin transcripts (Figure 5J). p-actin
transcription decreased after infection in both wt and PKRo/o cells. In experiment I,
wt cells produced significantly lower levels of P-actin transcripts than mock-infected
controls at 4, 8 and 12 hours post-infection (p < 0.05, Kruskal Wallis); in PKRo/o cells,
P-actin levels were only significantly lower than mock-infected cells at 12 hours post¬
infection (p < 0.05, Kruskal Wallis) (Figure 5J (i)). Levels of P-actin in PKRo/o cells,
but not wt cells, were also significantly lower than mock-infected cells at 12 hours
post-infection in experiment II (p < 0.05, Kruskal Wallis) (Figure 5J (ii)). This
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demonstrates that virus infection does result in degradation or shut-off of host gene
transcription or cell death.
In experiment I, wt cells produced significantly lower levels of p-actin transcripts
than PKRo/o cells at 8 and 12 hours post-infection (p < 0.05, Kruskal Wallis) and in
experiment II, PKRo/o cells produced lower levels of P-actin transcripts at 12 hours
post-infection than wt cells. Overall the data suggests neither cell type has a greater
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Figure 5J: p-actin transcripts in wt and PKR0/0 MEFs after SFV4 infection.
129/Sv/Ev wt (blue) and PKRH/o (pink) MEFs were grown to confluence in T20 flasks and
infected with SFV4 at a moi of 10 or mock-infected with sPBS. At 4, 8 and 12 hours post¬
infection cells were harvested, RNA extracted and reverse transcribed into cDNA to
determine the levels of p-actin transcripts. P-actin transcripts were detected in (i) experiment
I and (ii) experiment II. Each point represents an individual cell culture assayed in triplicate
by qPCR; the limit of detection of each assay is at the intersection of the axes. * indicates a
significant difference (p < 0.05, Kruskal Wallis) between 129 wt and PKR00 groups.
To determine whether the decline in cellular transcription observed by 12 hours was
related to cell death, MEFs grown to 90 % confluence in 96 well plates were infected
(moi = 10) with SFV4, in replicates of 12 and at 6, 8, 10 and 12 hours post-infection
were incubated with WST-1 reagent for 3 hours to determine viability (Figure 5K).
No difference in cell viability was detected with time or between the cell types. The
decrease with time in p-actin transcripts cannot be attributed to cell death.
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Figure 5K: MEF percentage survival after SFV4 infection
Wild type (Blue square) and PKRo/o (Pink triangle) MEFs were infected, in replicates of 12,
with SFV4 (dark blue or dark pink) at a moi of 10 or mock-infected with PBS (light blue or
light pink). At 6, 8, 10 or 12 hours post-infection cells were assayed for viability. Each point
represents the mean of 12 replicates.
Does PKR affect functional IFN production in vitro in
response to SFV infection?
Differences in the levels of transcripts for IFN-P and IFN-a observed between wt and
PKRo/o MEFs should translate to differences in the levels of functional IFN. To
investigate this, wt and PKRo/o MEFs were seeded at 2 x Kf cells per well in
chamberslides, grown to confluence and infected (moi 10) with SFV4 or mock-
infected with sPBS. Supernatant samples were collected at 24 hours post-infection to
assess levels of infectious virus and functional IFN (Figure 5L). No infectious virus
or functional IFN was detected for the mock-infected controls (data not shown).
Equivalent levels of infectious virus were detected in supernatant samples taken from
wt and PKRo/o MEFs (Figure 5L, i-a). However, the level of functional IFN in the
infected PKRo/o cells was significantly reduced (p < 0.05, Mann-Whitney) in
comparison to infected wt cells (Figure 5L, i-b). In a repeat experiment, (Figure 5L,
(ii)), supernatant samples were taken at 18 and 24 hours post-infection and assayed
for infectious virus (Figure 5L, ii-a) and functional IFN (Figure 5L, ii-b). Levels of
infectious virus were similar in both cell types at 18 and 24 hours post-infection;
however, no functional IFN could be detected from PKRo/o cells at either time point.
Levels of functional IFN produced in wt cells were similar at both 18 and 24 hours.
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Figure 5L: Functional IFN levels in wt and PKR0/0 cells after SFV infection.
129/Sv/Ev wt (blue) and PKR0 0 (pink) MEFs were grown to 90 % confluence in
chamberslide wells and then infected at a moi of 10 with SFV4. At (i) 24 hours and (ii) 18
and 24 hours post-infection supernatants were sampled and assayed for (a) infectious virus
and (b) functional IFN. Each point represents an individual cell culture mean and * indicates
a significant difference (p < 0.05, Mann-Whitney) between 129 wt and PKRo/o groups.
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Summary of findings
In vivo,
• There were no significant differences in SFV4 infectious virus titres at 24
hours post-infection or virus at 12, 24 or 40 hours post-infection in the
brains ofwt and PKRo/o mice.
• At 24 and 40 hours post-infection there were no significant differences in
levels of functional IFN between 129/Sv/Ev wt and PKRo/o mouse brains.
• IFN-P transcripts were detected in both mouse strains by 24 hours. At 24
and 40 hours transcript levels were similar. IFN-P transcripts were only
detected in mouse brains with viral RNA titres of > 1 x 106 copies /
100,000 P-actin copies. IFN-P transcripts strongly correlated with SFV4
RNA levels in wt and PKR0/0 cells (R2 = 0.91 and 0.9, respectively).
• IFN-a transcripts were detected in both wt and PKRo/o mice after 24 hours,
but only when IFN-P transcript levels > 2 x 103 copies / 100,000 P-actin
copies. In both cell types, IFN-a transcripts were proportional to SFV4
RNA (R2= 0.94 and 0.85, wt and PKRo/o respectively) and IFN-P
transcripts (R2 = 0.99 and 0.99, wt and PKRo/o respectively).
In vitro,
SFV4 infectious virus titres and virus RNA copies demonstrated no
significant difference between 129/Sv/Ev wt and PKRo/o MEFs.
IFN-P transcripts were consistently lower in PKR00 cells than 129 wt cells
at 4, 8, and 12 hours post-infection and were significantly lower at 8 hours
(p < 0.05, Kruskal Wallis test).
IFN-a transcripts were detected by 8 hours post-infection in both wt and
PKR0 0 cells. IFN-a transcripts were significantly lower in PKRo/o cells
than in 129 wt cells (p < 0.05, Kruskal Wallis test).
Reduced IFN transcript levels in PKRo/o cells was not associated with
greater cell death, increased transcript degradation or greater transcription
shut-off.
At 24 hours post-infection, functional IFN levels in the supernatants of
cultured PKRo/o MEFs were 10-fold lower than in 129 wt MEF
supernatants (p < 0.05, Mann-Whitney test).
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Discussion
The role of PKR in IFN induction has not been defined in alphavirus infections.
Investigations into the role of PKR in SFV4 infected mouse brains demonstrated that
there was no significant difference in the levels of IFN-a transcripts, IFN-P
transcripts or functional IFN between wt and PKRo/o strains at 24 or 40 hours post-
inoculation and that the virulence of SFV4 infection did not alter between the strains.
However, comparisons between SFV4 infected wt and PKRo/o MEFs at 4, 8 and 12
hours post-infection demonstrated that relative to wt, PKRo/o cells produced
consistently lower levels of IFN-a transcripts, IFN-P transcripts and functional IFN.
This decrease in IFN expression was not related to differences in virus replication,
transcript degradation, transcription shut-off or cell death.
In vivo infections showed considerable variation between mice, due to the variability
of the site of inoculation, the resulting cell types infected and a low moi of infection.
Small differences resulting from the ablation ofPKR function would be unlikely to be
observed in this in vivo system. In contrast, in vitro experiments used cultured
primary cell lines infected at a high moi to allow for a synchronous infection ofmost
cells; this resulted in synchronous induction of IFN-P gene expression and allowed
detection of small differences resulting from the presence or absence of PKR.
Previous experiments, which compared the same wt and PKRo/o mice, showed that
NDV infection induced similar levels of IFN-a and IFN-P transcripts in the spleen,
lung and liver of both wt and PKRo/o mice and that EMCV infection induced similar
IFN serum levels in both strains of mice (Yang et al., 1995). In contrast to the results
found in this chapter, NDV also induced similar levels of IFN-a and IFN-P transcripts
in wt and PKR0 0 MEFs. However, the northern blot technique described in Yang et
al. (1995) would have been unlikely to have detected subtle differences in the level of
IFN-p or IFN-a transcripts, whereas the qPCR used here is a very sensitive assay and
so can distinguish small differences. The in vitro data described here suggests that
PKR contributed to IFN-P gene expression during the early stages of SFV4 infection.
PKR is continuously and constitutively expressed in cells (Baier et al., 1993) and as
such it is likely that it is a first-line sentinel of infection. Loss ofPKR would
therefore be expected to reduce the rate of virus detection resulting in a delay in the
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induction of IFN. PKR is an upstream inducer of IFN-P gene expression during
reovirus infection of primary myocyte cardiac cultures (Stewart et al., 2003) and
during EMCV infection ofU-937 cells (Der and Lau, 1995). U-937 cells over-
expressing PKR antisense RNA or dominant negative PKR and then infected with
EMCV did not produce IFN-P transcripts by 6 hours post-infection and only produced
variable levels of IFN after 16 hours. Additionally, PKR inhibitors ablate poly I:C
gene induction in intestinal epithelial cells. Localisation of this inhibition is identical
to that of pharmacological inhibition of gene expression responses to rotavirus,
suggesting that PKR has a role in activating gene expression in response to rotavirus
infection (Vijay-Kumar et al., 2005). It has also been suggested that RNase-L and
PKR induced transcriptional and/or translational shut offmay be required to prevent
the expression of inhibitors ofMKK4 and c-jun N-terminal kinase (JNK) (Iordanov et
al., 2001). JNK phosphorylates and activates the transcription factor c-jun, a
component of AP-1, one of the transcription factors required to induce IFN-p
expression. Consequently, the loss of PKR may enable continued expression of these
kinase inhibitors, reducing the amount of IFN-P expressed.
PKR is an intracellular dsRNA activated protein kinase. Recently several other
intracellular dsRNA activated proteins have been described, e.g. RIG-I and mda-5,
which induce IFN-P gene expression. This complementarity in the detection of
dsRNA may provide an explanation for the partial but not complete reduction of IFN-
P expression observed in PKRo/o cells.
Mice lacking PKR do not have a defective immune response (Yang et al., 1995), but
many viruses show increased virulence in PKRo/o cells (Streitenfeld et al., 2003;
Balachandran et al., 2000). Only IFN-y responses are reduced in PKRo/o mice
(Abraham et al., 1999; Yang et al., 1995). This is possibly associated with PKR
interactions with STAT-1. The IFN- y receptor signals through STAT-1 homodimers.
PKR modulates the ability of STAT-1 to induce transcription (Wong et al., 1997);
PKRo/o cells demonstrate reduced STAT-1 serine 727 phosphorylation and
transactivation (Koromilas et al., 1992; Ramana et al., 2000). Despite several viruses
demonstrating increased virulence in PKRo/o cells (Bunyamwera virus (Streitenfeld et
al., 2003), VSV and influenza virus (Balachandran et al., 2000)), SFV produced
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similar levels of virus RNA at 4, 8 and 12 hours post-infection and of infectious virus
at 24 hours post-infection in wt and PKRo/o cells. SFV4 was able to establish an
infection more rapidly in PKRo/o cells than in wt cells (unpublished data provided by
Gerald Barry). 129 wt and PKRo/o cells were infected with SFV4-eGFP, an SFV4
vector encoding enhanced green fluorescent protein (eGFP). At 3 hours post¬
infection eGFP was observed in the PKR0/0 cells whereas eGFP was only observed in
the wt cells at 7 hours post-infection. These results suggest that PKRo/o cells replicate
SFV4 more rapidly than do wt cells. In PKR°/0 cells virus may not be detected as early
as in the presence ofPKR, allowing replication to progress further before IFN-(3 gene
expression is initiated. In the presence of PKR, host translation is shut off by the
phosphorylation of eIF-2a. eIF-2a phosphorylation induces the formation of stress
granules which sequester mRNA and pre-initiation complexes (Kedersha et al., 1999;
2002; Gilks et al., 2004). Maintaining components of translation in the stress granules
inhibits virus access to translation initiation complexes and may account for the delay
in eGFP detection. Alternatively, SFV has some resistance to PKR and so the lack of
functional PKR does not promote virus replication. Recently a highly stable hairpin
loop, downstream of the translation start site of Sindbis virus 26 S mRNA has been
implicated in resistance to eIF-2a phosphorylation (Ventoso et al., 2006). This
structure stalls the ribosome at the correct start site enabling translation to bypass the
requirement of an initiation complex. Bovine viral diarrhoea virus (BVDV)
modulates PKR activity; the non-cytopathic strain (ncpBVDV) does not induce PKR
and challenge with a poliovirus does not initiate PKR phosphorylation (Gil et al.,
2005); infection with poliovirus alone would normally result in PKR phosphorylation,
therefore ncpBVDV prevents PKR activation.
Interestingly, the increased virulence of some virus infections of PKRo/o mice is
associated with the site of inoculation. VSV and WSN strain of influenza virus
infections following in inoculations of PKRo/omice are much more virulent than iv
inoculations (Balachandran et al., 2000). It is possible that this form of inoculation
allows these viruses access to the CNS through the olfactory nerves, although PKR
may be important in respiratory immune responses. Basal PKR levels are higher in
pulmonary tissues (Krust et al., 1982); this supports the role ofPKR as a sentinel for
infection, as respiratory epithelia are directly exposed to invading pathogens.
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Summary
This chapter determined whether there was a role for PKR in IFN-P induction and
functional IFN expression in mouse brains and primary cell lines during an SFV4
infection. No significant differences were observed in the levels of IFN transcripts or
functional IFN between wt and PKRo/o mouse brains. However, PKRo/o mouse
embryo fibroblasts consistently produced significantly lower levels of type I IFN
transcripts and functional IFN in comparison to wt cells. This was not explained by
changes in cell death or RNA degradation.
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Chapter 6: Differential dynamics of IFN induction by
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Differential Induction of IFN by different strains of SFV
Differential dynamics of IFN induction by different
strains of SFV
Objectives
1) To determine whether virulent (SFV4) and avirulent (SFV A7(74),
SFV4nsP2RDR and SFV4nsP3A50) strains of SFV induce different
levels of IFN-(3 transcripts.
2) To determine whether virulent (SFV4) and avirulent (SFV4nsP2RDR)
strains of SFV induce different amounts of functional IFN.
3) To determine whether SFV antagonises the IFN response and if so, by
what mechanism.
Introduction
There are several strains of SFV, which can pathologically be divided into two
groups, those that cause panencephalitis in adult mice and those that have a restricted
CNS infection. Following virulent infection, virus antigen can be detected throughout
the brain; following an avirulent infection, virus can only be detected in small foci of
cells around blood vessels (Fazakerley et ah, 1993). A possible explanation for the
differential pathology could be that the virulent SFV strains induce less IFN or delay
IFN expression. This would allow greater virus replication and spread. To study the
affect of SFV infection on IFN induction, several different SFV strains, virulent and
avirulent, were investigated, SFV4, SFV4nsP3A50, SFV4nsP2RDR and SFV A7(74).
The 'prototype' strain of SFV was derived from SFV L10 and like L10 is virulent in
adult mice. SFV4 is an infectious molecular clone of the prototype virus (Liljestrom
et ah, 1991). SFV4nsP3A50 and SFV4nsP2RDR are engineered mutants of SFV4;
SFV4nsP3A50 has a 50 amino acid deletion at the C-terminal end, which includes a
hyperphosphorylated region. NsP3 has yet to be assigned any particular roles; it is
part of the replicase complex and other mutational studies have implicated it to be
important in virulence (Tuitilla et ah, 2001); no function has been determined for the
hyperphosphorylation. SFV4nsP2RDR possesses a single amino acid mutation
(RDR) in the nuclear localisation signal (RRR) of the non-structural protein (nsP) 2
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(Rikkonen et al., 1992). There are several defined functions for nsP2; these include
helicase activity, papain-like protease activity and triphosphatase activity (Rikkonen
et ah, 1994). In addition, 50 % of nsP2 enters the nucleus during an infection
(Rikkonen, 1996), although currently there is no known function for nuclear nsP2.
The SFV4nsP2RDR mutation completely disrupts the ability of nsP2 to translocate
into the nucleus (Rikkonen, 1996). SFV A7(74) is an avirulent strain of SFV.
In vivo investigations comparing SFV4nsP2RDR and SFV4 inoculated ip into
wildtype 129 mice show that SFV4nsP2RDR only establishes a restricted infection
whereas, SFV4 establishes a panencephalitis; however, when inoculated into IFNAR""
mice, SFV4nsP2RDR also produces a panencephalitis (Fazakerley et al., 2002).
Disruption of the type I IFN receptor renders IFNAR"7" mice unresponsive to type I
IFN. This result suggests that whereas type I IFN controls the CNS spread of
SFV4nsP2RDR preventing panencephalitis, it does not effectively limit the spread of
SFV4. Possible explanations for this result and the differential pathology between the
two strains could be: 1) that the SFV4nsP2RDR mutation reduces the rate of virus
replication enabling the establishment of the IFN anti-viral response and control of the
infection. This could also be a factor in other avirulent infections (SFV A7(74) and
SFV4nsP3A50); 2) that avirulent strains of SFV are more sensitive to the effect of
IFN and 3) that SFV4 but not SFV4nsP2RDR or SFV A7(74) is able to evade the IFN
response. These possibilities were investigated by characterising and comparing the
level of IFN induction between SFV4, and avirulent SFV4nsP2RDR, SFV A7(74) and
SFV4nsP3A50.
Comparison of IFN induction by SFV4, SFV4nsP2RDR and
SFV4nsP3A50
To investigate IFN induction between molecularly defined virulent and avirulent
viruses, IFN levels induced by SFV4, SFV4nsP2RDR and SFV4nsP3A50 were
compared. Stocks of SFV4nsP2RDR and SFV4nsP3A50 were analysed to confirm
the phenotype and genotype prior to use. In SFV4 infected cells, nsP2 was located
both in the cytoplasm and the nucleus. Cells infected with SFV4nsP2RDR, as
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expected, showed no nuclear staining for nsP2 (Figure 6A). Both viruses were
sequenced to confirm their mutations; T80 flasks ofBHK cells were infected at a moi
of 10 with SFV4, SFV4nsP2RDR or SFV4 nsP3A50 and incubated for 11 hours.
RNA was extracted from the infected cell cultures and quantified on an Agilent
bioanalyser. Five pg ofRNA were transcribed into cDNA using a specific primer
outside the mutated region (Table 2D, Materials & Methods). A high fidelity PCR
reaction was performed and the product size confirmed on a gel. Each of the PCR
products were cloned into TOPO vectors, which were then transformed into E.coli
and grown overnight on LB- Kanamycin plates. Three colonies from each plate were
selected and grown as cultures. DNA was extracted by mini-prep and sent for
sequencing (VBS, University ofEdinburgh). All sequences were as expected.
Several studies with SFV4nsP3A50 demonstrated that, regardless of the moi, only 50
- 60 % infection of cell monolayers was ever observed. This effect was observed in
two separate laboratories. To study the affects of IFN induction, a high level of
infection of the cell monolayers is necessary for uncomplicated data interpretation.
Consequently, further studies of SFV4nsP3A50 interactions with the IFN response
were terminated.
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Figure 6A: Localisation of nsP2 during an SFV4 or SFV4nsP2RDR infection
MEFs were infected with (i) SFV4 or (ii) SFV4nsP2RDR virus (A, B) or non-replicating
vectors (C). MEFs were infected at a moi of 1 with either strain and stained for nsP2 with
Novared chromogen (A. B) or immunofluoresence (C). (C) was kindly donated by Gerald
Mclnerney (Karolinska Institutet, Sweden).
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Comparison of growth of SFV4 and SFV4nsP2RDR in BHK
cells and MEFs
The growth of these two viruses was compared in BHK cells and in MEFs in multi-
step growth curves. This data was generated in collaboration with Pia Dosenovic
(Karolinska Institutet, Sweden). BHK cells have impaired IFN responses, whereas
MEFs are IFN competent. For each cell type, in duplicate, T25 flasks were infected
with either SFV4 or SFV4nsP2RDR at a moi of 0.05. Cells were infected at a low
moi (0.05) to produce a multi-step growth curve; this infection should reveal any
differences in the ability of the viruses to replicate and spread across the cell
monolayer. In contrast, high moi infections (> 10) enable investigations into cellular
responses or virus protein function, independent of virus replication and spread.
Supernatant samples were taken at 4, 8, 12, 24 and 48 hours post-infection and the
levels of infectious virus were determined by plaque assay (Figure 6B). Similar titres
of infectious virus were present at each time point in BHK cell supernatants. This
was also observed in infected MEFs up until 12 hours post-infection. After 12 hours
the levels ofRDR infectious virus remained approximately 0.5 logio lower than the
levels of SFV4 infectious virus.
(i) (ii)
Hxrs pc6t-infectkn Hours post-irfectkn
Figure 6B: Growth curves of SFV4 and SFV4nsP2RDR in BHK cells and MEFs.
Cultures of (i) BHK cells or (ii) MEFs were infected with SFV4 (Blue) or SFV4nsP2RDR
(Red) at a moi of 0.05. Supernatant samples were collected at 4, 8, 12, 24 and 48 hours post¬
infection and assayed for infectious virus. Each point represents the mean of two supernatant
samples. Data provided in collaboration with Pia Dosenovic (Karolinska Institutet, Sweden).
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Comparison of virus RNA and IFN-p transcript levels in SFV4,
SFV4nsP2RDR and SFV A7(74) infected L-929 cells and MEFs
To determine whether levels of IFN induction varied between SFV4, SFV4nsP2RDR
and SFV A7(74) infections, levels of virus RNA and IFN-P transcripts were
measured. T20 flasks were seeded with either L-929 cells or MEFs and incubated
until confluent. At confluence, triplicate cultures of cells were infected with either
SFV4, SFV4nsP2RDR or SFV A7(74) at a moi of 50 or mock infected with PBS.
Initially, SFV4nsP3A50 was included in these experiments, but was only observed to
infect 50 - 60 % of the monolayer at a moi of 10, consequently the moi was raised to
50. Despite increasing the moi, SFV4nsP3A50 still only infected approximately 50 %
of cells and so was removed from the experiment. To maintain consistency with the
preliminary experiments the moi was kept at 50. At 12 hours post-infection, cells
were harvested and the RNA extracted and reverse transcribed into cDNA. The levels
of virus RNA and IFN-P transcripts were quantified from the cDNA by qPCR (Figure
6C). No virus RNA or IFN-P transcripts were detected in the mock infected cell
cultures (data not shown). Similar levels of virus RNA were produced by all three
virus strains in both cell types (Figure 6C (a)). SFV4 and SFV A7(74) induced
similar levels of IFN-P transcripts in both L-929 cells and MEFs (Figure 6C (b));
however, SFV4nsP2RDR induced significantly higher levels of IFN-P transcripts
compared to SFV4 in both cell types (p < 0.05, Kruskal Wallis test). This correlated
to a 50 - 200 fold increase in the duplicate experiments in L-929 cells (Figure 6C (c))
and a 5-fold increase in MEFs. The two cell types both demonstrated that
SFV4nsP2RDR induces more IFN-P gene expression than SFV4.
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Figure 6C: IFN-p transcript induction by SFV4, SFV4nsP2RDR and SFV A7(74).
Cultures of (i; ii) L-929 cells or (iii) MEFs were infected at a moi of 50 with SFV4,
SFV4nsP2RDR or SFV A7(74). At 12 hours post-infection, RNA extracted from the cultures
was assayed for (a) virus RNA and (b) IFN-P transcripts. Each point represents the mean
value from a cell culture assayed in triplicate by qPCR; * indicates that the IFN-P transcript
levels induced were significantly different to IFN-P transcripts induced by SFV4 (p < 0.05,
Kruskal Wallis test). Bars represent the fold increase in the levels of IFN-P transcripts per 106
SFV4nsPRDR virus RNA copies compared to the levels of IFN-P transcripts per 106 SFV4
RNA copies.
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In conclusion, SFV4nsP2RDR induces more IFN-(3 transcripts per 1 x 106 virus RNA
copies than SFV4 or SFV A7(74). The observed increase of IFN-(3 transcripts during
an SFV4nsP2RDR infection could be specific to IFN-P or could reflect lack of
downregulation of all cellular transcripts.
Comparison of p-actin and GAPDH transcript levels in SFV4,
SFV4nsP2RDR and SFV A7(74) infected L-929 cells and MEFs
To determine whether the effect of increased transcript expression was specific to
IFN-P in an SFV4nsP2RDR infection, two housekeeping genes P-actin and GAPDH
were also investigated. Confluent T20 flasks of L-929 cells and MEFs were infected
at a moi of 50 with SFV4, SFV4nsP2RDR, SFV A7(74) or mock infected with PBS.
At 12 hours post-infection the cell cultures were harvested and RNA extracted and
reverse transcribed into cDNA. The level of P-actin and GAPDH transcripts in the
cDNA was determined by qPCR (Figure 6D). For both P-actin and GAPDH,
transcript levels were similar between the two cell types for mock infection, with
GAPDH transcript levels approximately 10-fold lower than p-actin transcript levels
(Figure 6D (a; b). Both L-929 cells and MEFs infected with all three viruses
expressed similar levels of P-actin transcripts, approximately 106 / pg total RNA
(Figure 6D (a)). This was a 10-fold decrease in the levels of P-actin transcripts from
the duplicate experiments in L-929 cells and a 3-fold decrease in the levels of P-actin
transcripts in MEFs (Figure 6D (c)). These levels were all significantly lower than
mock infected cultures (p < 0.05, Kruskal Wallis test). The levels ofGAPDH
transcripts were similar between cultures infected with all three viruses in 2 out of 3
experiments. This correlated to a 5-fold decrease in the levels ofGAPDH transcripts
in both cell types (Figure 6D (c)). In all three experiments the levels ofGAPDH
transcripts were significantly lower in virus infected cells than in mock infected cells
(p < 0.05, Kruskal Wallis test) (Figure 6D (b).
155
(i-a)







































































PBS SFV4 RDR A7(74) PBS SFV4 RDR A7(74) (Factin GAPDH
(iii-a)
a 8'



















Figure 6D: p-actin and GAPDH transcript levels in PBS, SFV4, SFV4nsP2RDR
and SFV A7(74) infected cell cultures.
Cell cultures of (i; ii) L-929 cells and (iii) MEFs were infected at a moi of 50 with SFV4,
SFV4nsP2RDR, SFV A7(74) or mock infected. At 12 hours post-infection the cultures were
assayed for levels of (a) P-actin and (b) GAPDH transcripts. Each point represents the mean
value from a cell culture assayed in triplicate by qPCR; * represents transcript levels were
significantly lower than mock infected cells (p < 0.05, Kruskal Wallis test). Bars represent
the fold-increase in the levels of transcripts compared to SFV4 infected cell cultures.
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To summarise, at 12 hours post-infection the levels of P-actin and GAPDH transcripts
in virus infected cells were significantly less than in mock infected cells. This
reduction in cellular mRNA could result from virus induced cellular transcription
shut-off and mRNA degradation. There was no difference between the reduced levels
of cellular transcripts between the three virus strains. This suggests that the higher
levels of IFN-P transcripts observed in SFV4nsP2RDR infected cells relative to SFV4
infected cells was specific to IFN-P gene expression. However, it could be argued
that only two cellular transcripts were investigated. As another test, MEFs were
seeded onto a 6 well plate and infected in triplicate at a moi of 50 with SFV4,
SFV4nsP2RDR or mock infected with PBS, (this experiment was carried out by Pia
Dosenovic, Karolinska Institutet, Sweden). Two of the three wells were used to
assess RNA replication; the remaining well was used to ascertain the level of
infection. To determine the level of infection, the infected monolayer was stained for
SFV envelope 2 antigen and 15 separate areas from the monolayer were counted for
infected cells. For both viruses the level of infection was approximately 95 - 100 %.
To assess RNA replication, actinomycin D was added to one of the infected wells at
4.5 hours post-infection and incubated for 30 minutes prior to the addition of
[l4C]Uridine. After a further 3 hours, at 8 hours post-infection, the cells were lysed
and RNA extracted. 1.8 pg of each RNA sample was run on a gel and exposed on
film (Figure 6E). Actinomycin D prevents cellular transcription; therefore all
actinomycin D positive wells only showed virus RNA species. These include the 42
S genomic RNA and the 26 S sub-genomic RNA. Actinomycin D positive, mock
infected cells showed no detectable bands (Figure 6E - column 1); however, SFV4
and SFV4nsP2RDR infected cells showed the two virus RNA species and no cellular
RNA transcripts (Figure 6E - columns 2 and 3). In contrast, actinomycin D negative
wells showed both cellular and virus RNA species. Several bands of cellular
transcripts are observed in mock infected cells (Figure 6E - column 4); however,
SFV4 and SFV4nsP2RDR infected cells show the two virus RNA species and
dramatically reduced levels of cellular RNA transcripts compared to mock infected
cells (Figure 6E - column 5 and 6). Together with the qPCR data (Figure 6D), this
suggests that during an SFV infection cellular transcription is reduced and that this is
not obviously different for these two viruses.
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Figure 6E: Reduction of cellular transcripts in SFV infected cells.
MEFs were infected at a moi of 50 with SFV4 (WT), SFV4nsP2RDR (RDR) or mock
infected with PBS (M). MEFs were incubated with or without actinomycin D (Act D) and
then cultured in media containing [l4C]Uridine. At 8 hours post-infection the cells were
harvested and RNA extracted. Bands labelled as 42 S and 26 S correspond to virus genomic
and sub-genomic RNA species; unlabelled bands represent cellular RNA transcripts. Kindly
provided by Pia Dosenovic (Karolinska Institutet, Sweden).
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Comparison of IFN levels in SFV4 and SFV4nsP2RDR infected
L-929 cells
Functional IFN levels were determined, as virus induced host translation shut-off
could alter the IFN protein levels so that they did not correlate with the IFN transcript
levels. SFV4 and SFV4nsP2RDR were compared for their ability to induce
functional IFN in L-929 cells. SFV4nsP2RDR induced higher levels of IFN-P
transcripts than SFV4 in L-929 cells, and should induce higher levels of functional
IFN in comparison to SFV4. To assess the levels of functional IFN induced by these
two viruses, chamber slides were seeded with L-929 cells and at confluence were
infected at a moi of 50 with SFV4, SFV4nsP2RDR or mock infected with PBS. After
24 hours, supernatant samples were taken and assayed for infectious virus and
functional IFN by plaque assay and the IFN bioassay, respectively. No infectious
virus or IFN was detected in mock infected cells (data not shown). The titres of
infectious virus were similar between the two strains (Figure 6F (i)). However, the
levels of functional IFN induced by SFV4 were consistently lower than the levels of
IFN induced by SFV4nsP2RDR (Figure 6F (ii)). This 3-fold difference in the levels
of functional IFN induced by SFV4 and SFV4nsP2RDR was also observed in a repeat













Figure 6F: Functional IFN induced by SFV4 and SFV4nsP2RDR in L-929 cells.
Chamber slides were infected at a moi of 50 with SFV4 or SFV4nsP2RDR (RDR);
supernatant samples were taken at 24 hours post-infection and assayed for levels of (i)
infectious virus and (ii) functional IFN. Each point represents an individual cell culture.
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SFV4nsP2RDR induced more functional IFN in L-929 cells than SFV4; to determine
whether the same effect would be observed in a different cell type, MEFs were
infected at a moi of 50 with SFV4, SFV4nsP2RDR or mock infected with PBS.
Supernatant samples were collected at 4, 8, 12 and 24 hours post-infection and














Figure 6G: Functional IFN induced by SFV4 or SFV4nsP2RDR infected MEFs
over 24 hours.
MEFs were infected at a moi of 50 with SFV4 (Blue) or SFV4nsP2RDR (Red); supernatants
were collected at 4, 8, 12, and 24 hours post-infection and assayed in duplicate for functional
IFN by the Swedish IFN bioassay. Each bar represents the mean of the duplicate tests.
No functional IFN was detected in the negative controls (data not shown). The extent
of infection in the MEFs was the same between the two viruses, as determined by
immuno-fluorescence detection of virus envelope antigen. IFN was detected from 8
hours post-infection in SFV4nsP2RDR infected cell cultures and the levels of IFN
continued to rise until 24 hours post-infection (Figure 6G). In contrast, IFN was
initially detected at 12 hours post-infection in SFV4 infected cells. At all time points
the level of IFN induced by SFV4nsP2RDR was higher than the level of IFN induced
by SFV4. A repeat experiment, supported the data in figure 6G. IFN was detected at
12 hours post-infection in SFV4 infected MEFs and at 8 hours post-infection in
SFV4nsP2RDR infected MEFs. IFN levels induced by SFV4nsP2RDR virus were
between 5-10 times higher at 24 hours post-infection than those induced by SFV4
(data not shown).
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Comparison of translation shut off kinetics between SFV4 and
SFV4nsP2RDR infected BHKs
Cellular transcription was shut-off in both SFV4 and SFV4nsP2RDR infected cells
(Figure 6E). To determine whether cellular translation was shut off similarly by both
strains, BHKs were seeded into 24 well plates and at confluence were infected at a
moi of 10 with SFV4 or SFV4nsP2RDR non-replicating vectors, (This experiment
was carried out by Pia Dosenovic, Karolinska Institutet, Sweden). Non-replicating
vectors do not encode the virus structural proteins; they infect similarly to replicating
viruses, but are unable to produce progeny. In this experiment the structural proteins
were replaced with influenza nucleoprotein (NP) attached to the SFV enhancer
element. The enhancer element is fused with foot and mouth disease virus (FMDV)
2A cleavage peptide, which is cloned in frame with NP. This cleavage peptide is
approximately 90 % effective; consequently, two proteins are expressed - influenza
NP and enhancer-FMDV 2A tagged influenza NP (M-2A-NP). At 2, 2.5, 3, 3.5, 4,
4.5 and 5 hrs post-infection cells were starved and then incubated with media
• . TS • • • •
containing [ S]Methionine. After this incubation, the cells were lysed and the lysate
run on an SDS-PAGE gel (Figure 6H). In both infections the majority of cellular
translation was shut-off after 3.5 hours post-infection, only influenza NP and
enhancer FMDV 2A tagged NP under the control of the SFV sub-genomic promoter
and low levels of P-actin were observed after 3.5 hours (Figure 6H). In conclusion,
both viruses induce cellular translation shut-off at a similar time post-infection.
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Figure 6H: Cellular translation shut-off in SFV4 and SFV4nsP2RDR infected
MEFs.
BHKs were infected at a moi of 10 with non-replicating vectors of SFV4 (WT),
SFV4nsP2RDR (RDR) or mock infected with PBS (M); at 2, 2.5, 3, 3.5, 4, 4.5 and 5 hours
post-infection the cells were starved and then incubated with [35S]Methionine. Each column
represents the proteins translated at that particular time point. NP-nucleoprotein, M-2A-NP -
enhancer-FMDV 2A tagged nucleoprotein. Kindly provided by Pia Dosenovic. (Karolinska
lnstitutet, Sweden).
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Comparison of NF-kB and IRF-3 nuclear translocation
between SFV4 and SFV4nsP2RDR infected MEFs
Cell cultures infected with SFV4nsP2RDR produced higher levels of IFN-P
transcripts and functional IFN in comparison to SFV4 infected cells (Figure 6C;
Figure 6F; Figure 6G). This increase in gene expression was specific to IFN-p as
both viruses reduced cellular transcription (Figure 6D; Figure 6E) and translation
(Figure 6H) equally. A combination of transcription factors is required to induce
IFN-p expression, NF-kB, IRF-3 and AP-1. NF-kB is maintained in the cytoplasm in
association with IkB; cellular detection of virus infection activates a cascade of
kinases which ultimately ubiquitinate IkB, targeting it for proteosome degradation.
Release ofNF-kB enables its translocation into the nucleus and binding to the IFN-P
promoter. IRF-3 shuttles in and out of the nucleus, but once a virus infection is
detected in the cell, IRF-3 is phosphorylated and is maintained within the nucleus
where it associates as a dimer with the IFN-P promoter. To determine whether NF-
kB and IRF-3 translocate into the nucleus during SFV4 and SFV4nsP2RDR
infections, MEFs were infected at a moi of 1; a low moi was used so that infected and
uninfected cells could be observed and compared under the microscope. MEFs were
infected with SFV4, SFV4nsP2RDR, SFV4nsP3A50 (a mutant with a functional
nsP2) or mock infected with PBS. At 6 hours post-infection, monolayers were fixed
and stained for NF-kB p65 subunit, IRF-3 and SFV envelope protein 2 (E2) (Figure
61). No virus antigen was detected in the mock infected cells; virus infected cells
were detected in all virus infections. For all three virus strains, virus infection
resulted in nuclear translocation ofNF-kB and IRF-3. Interestingly, cultures infected
with SFV4nsP3A50 demonstrated NF-kB translocation in cells where E2 protein
could not be detected. In conclusion, both NF-kB and IRF-3 entered the nucleus in
SFV4, SFV4nsP2RDR and SFV4nsP3A50 infected MEFs, demonstrating that these
cells detected the presence of all three viruses and initiated signalling events.
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Figure 61: Nuclear translocation of NF-kB and IRF-3 in SFV infected MEFs.
MEFs were infected at a moi of 1 with SFV4 (WT), SFV4nsP2RDR (RDR),
SFV4nsP3A50 (A50) or mock infected with PBS (Mock). At 6 hours post-infection
cells were fixed and stained for virus envelope protein (green), (i) NF-kB p65 subunit
(red) or (ii) IRF-3 (red).
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Comparison of NF-kB IFN-p promoter binding in SFV4 and
SFV4nsP2RDR infected MEFs
Following activation and nuclear translocation, NF-kB and IRF-3 associate with the
IFN-P promoter. As both accumulated in the nucleus in both SFV4 and
SFV4nsP2RDR infected cells, any virus interference with IFN gene activation is most
probably down stream of this event. To establish whether the ability ofNF-kB and
IRF-3 to bind to the IFN-P promoter differed in cells infected with the two virus
strains an electromobility shift assay (EMSA) was set up to measure binding. EMSA
probes representing the regions of the IFN-P promoter that bind to NF-kB or IRF-3
were designed. A 5' overhang containing a guanine residue was incorporated into
99
each of the probes so that [ P]CTP would be present after probe labelling, enabling
visualisation on film. MEFs were infected at a moi of 50 with SFV4, SFV4nsP2RDR
or mock infected with PBS. At 5 and 7 hours post-infection, cells were harvested and
• ... 99
nuclei extracted. Equal amounts of nuclear protein were incubated with [ P]CTP
labelled probes for 10 minutes and then run on an acrylamide gel. At completion, the
gel was dried and exposed to film (Figure 6J). No bound IRF-3 could be detected,
suggesting that the assay conditions were sub-optimal (data not shown). There was no
probe bound to NF-kB in nuclear extracts from mock infected cells (Figure 6J (i) -
column 5). At 5 hours post-infection, levels of probe bound to NF-kB were similar in
both SFV4 and SFV4nsP2RDR infected cells; by 7 hours post-infection very little
probe bound to NF-kB was detected in SFV4 infected nuclear extracts whereas,
SFV4nsP2RDR infected nuclear extracts showed higher levels of probe bound to this
transcription factor, although this was reduced in comparison to the levels observed at
5 hours post-infection (Figure 6J (i)). To clarify that the band presumed to be probe
bound to NF-kB did indeed contain NF-kB, another probe known to bind NF-kB was
incubated with the same nuclear extracts and produced a band at an equivalent
position to the IFN-P promoter probe (data not shown). In addition, the nuclear
extracts were incubated with NF-kB p65 antibody or a negative control antibody, (an
antibody for another transcription factor PAX), prior to incubation with the labelled
probes. When run on the gel, the specific NF-kB antibody caused a band shift
indicating the specificity of the original band presumed to contain NF-kB. This was
associated with p65 antibody binding to NF-kB, which slows probe:transcription
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factor complex movement through the gel (Figure 6J (ii)). Although promising, this
experiment was only performed once due to time constraints and so must be
interpreted as preliminary data. Subsequent repeat experiments carried out by Pia
Dosenovic, Gerald Mclnerney and Mauro D'Amato in the Karolinska Institut have
generated more evidence to support the theory that SFV4 interferes with NF-kB
association with the IFN-p promoter.
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Figure 6J: IFN-p promoter bound NF-kB during an SFV4 or SFV4nsP2RDR
infection.
(i) Nuclear extracts from MEFs infected at a moi of 50 with SFV4 (WT), SFV4nsP2RDR
(RDR) or mock infected with PBS (M) were collected at 5 and 7 hours post-infection. The
samples were incubated with [12P]CTP labelled probes specific for NF-kB. (ii) Nuclear
extracts from MEFs infected with SFV4 at 5 hours post-infection were incubated with NF-kB
p65 antibody or PAX antibody and then incubated with labelled probes prior to the gel run.
WT 5hr nuclear lysate
+
qp65 qPAX
— NFkB + :,2P-oligo + q p65
— NFkB + -,2P-oligo
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Summary of Findings
SFV4 and SFV4nsP2RDR had similar replication rates in BHK cells and
MEFs.
SFV4nsP2RDR induced significantly more IFN-(3 transcripts than SFV4 in
two cell types (p < 0.05, Kruskal Wallis test) and more functional IFN.
At 12 hours post-infection SFV A7(74) RNA levels were similar to SFV4
RNA levels and both strains of virus induced similar levels of IFN-(3
transcripts.
At 12 hours post-infection p-actin and GAPDH transcripts were
significantly reduced in virally infected cells compared to mock infected
cells (p < 0.05, Kruskal Wallis test).
Both P-actin and GAPDH transcripts were down regulated to similar levels
in SFV4 and SFV4nsP2RDR infected cells.
Global cellular transcription and translation was shut-off in both
infections.
IRF-3 and NF-kB translocated to the nucleus in SFV4 and SFV4nsP2RDR
infections.
Possibly less NF-kB was bound to the IFN-P promoter at 7 hours post¬
infection during an SFV4 infection than during an SFV4nsP2RDR
infection.
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Discussion
In adult mice, virulent strains of SFV including SFV4 induce panencephalitis whereas
avirulent strains of SFV e.g. A7(74) induce a restricted CNS infection. One possible
explanation for the different pathologies is that virulent strains induce less IFN.
However, in vivo data has suggested that both V13 (virulent) and A7 (avirulent)
strains induce similar amounts of IFN in mouse blood, muscle and spleen samples
(Smillie et al., 1973). In the present study, comparisons of SFV4 and A7(74) in two
cultured cell lines, L-929 and MEFs, indicated that both SFV4 and A7(74) replicated
to similar levels and induced similar levels of IFN-p gene expression. This indicates
that in vitro, SFV A7(74) is not impaired in its ability to induce IFN gene expression
compared to SFV4.
In both L-929 cells and MEFs, SFV4nsP2RDR induced significantly higher levels of
IFN-P transcripts per copy of viral RNA than SFV4 (p < 0.05, Kruskal Wallis test).
The levels of IFN-p induced by SFV4nsP3A50 were similar to SFV4; however,
SFV4nsP3A50 could only infect 50 - 60 % of the cell monolayer, as determined by
immuno-fluorescence using antibodies specific for nsP3 or E2 (data not shown). All
of the other strains investigated infected 95 - 100 % of the cell monolayer.
SFV4nsP3A50 has a deletion in the 3' end of nsP3; this is a highly phosphorylated
region. The importance of this hyperphosphorylation of nsP3 has yet to be elucidated.
To date, deletions in the C-terminal region of nsP3 are associated with significantly
reduced viral RNA synthesis (Vihinen et al., 2001). In figure 61, several MEFs
infected with SFV4nsP3A50 showed NF-kB nuclear translocation but no SFV E2
antigen. One explanation would be that virus entered the cell but could not replicate,
at least to the level of structural protein production. The hyperphosphorylated region
of nsP3 could be involved in the formation of the replicase complex or in transcription
of the genomic or sub-genomic RNA. However in 50 % of cells, nsP3 (replicase
polyprotein) and E2 (structural polyprotein) were detected and so the
hyperphosphorylated region of nsP3 is not critical for replication in all cells but its
deletion is severely detrimental to replication in the up to 50 % of cells. Another
possible explanation is that the ability of the SFV4nsP3A50 to replicate within a cell
is dependent upon the cell cycle stage and that at a certain stage of the cycle cell the
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hyperphosphorylated region is essential for virus replication. Alternatively, cytokines
expressed by the infected cells, such as TNF-a, could induce NF-kB nuclear
translocation.
In comparison to SFV4, SFV4nsP2RDR reproducibly induced higher levels of IFN-P
transcripts and functional IFN per copy of virus RNA or per unit of infectious virus.
Transcription and translation shut-off experiments indicate that this increase in gene
expression was specific to IFN-p. SFV4nsP2 contains a nuclear translocation signal
consisting of three sequential arginine residues. In SFV4nsP2RDR the second
arginine residue is replaced with an aspartic acid residue (Rikkonen et ah, 1996).
Disruption of this signal prevents nsP2 nuclear translocation. Theoretically, the nsP2
RDR nuclear localisation signal mutation could be functioning in the cytosol or in the
nucleus and in either case wt nsP2 could be suppressing IFN responses or the mutant
nsP2 could be augmenting them. To induce expression of IFN-p, several transcription
factors need to be activated; NF-kB, IRF-3 and AP-1 are activated in the cytoplasm
and translocate into the nucleus where they associate with chromatin remodelling
elements e.g. CREB binding protein (CBP) prior to binding the IFN-P promoter.
Cells in culture most likely detect virus infection by cytoplasmic dsRNA binding
proteins, such as RIG-I and mda-5. Both of these proteins signal through CARD
domains to induce a kinase cascade, ultimately activating TBK-1, IKK-s and TAK-1
(Andrejeva et ah, 2004; Yoneyama et al., 2004). TBK-1 and IKK-s phosphorylate
IRF-3, enabling it to form homodimers and enter the nucleus (Fitzgerald et al., 2003;
Sharma et al., 2003); TAK-1 activates IKK, which phosphorylates IkB targeting it for
ubquitination and degradation (Kawai et al., 2005). This releases NF-kB enabling it
to enter the nucleus. Immuno-staining specific for each of these transcription factors
showed that both accumulated in the nucleus in SFV4 and SFV4nsP2RDR infections,
although the proportion ofNF-kB or IRF-3 in the nucleus of either infection was not
established. The preliminary EMSA data suggests that nsP2 may reduce NF-kB
binding to its positive regulatory domain within the IFN-P promoter. Modulation of
IFN expression has been observed in one other alphavirus, Sindbis virus (Frolova et
al., 2002). All alphaviruses encode a conserved proline residue at position 726 in
nsP2. When this is mutated, higher levels of IFN are induced in comparison to
another Sindbis virus mutant with comparable replication kinetics (Frolova et al.,
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2002). Flowever, the Sindbis virus nsP2 mutants cannot induce host cell transcription
or translation shut-off similarly to the wt virus, therefore the conserved proline
residue of nsP2 may not specifically downregulate IFN induction (Gorchakov et ah,
2004).
There are few examples of alphaviruses that interact with IFN-P induction; however,
many other viruses target IRF-3 and NF-kB. For example, the VP35 protein of Ebola
virus (Basler et al., 2003), NS3/4A ofHepatitis C virus (Foy et ah, 2003) and the
NS1/NS2 complex of respiratory syncytial virus (Bossert et ah, 2003) prevent IRF-3
phosphorylation and hence dimerisation, reducing IRF-3 nuclear accumulation.
Herpes simplex virus 1 also prevents nuclear accumulation of IRF-3 through its ICP0
protein (Melroe et ah, 2004). More relevant to the postulated SFV4 nuclear
mechanism, the ML protein of Thogoto virus does not affect nuclear accumulation,
but interferes with IRF-3 dimerisation and IRF-3 recruitment of CBP (Hagmaier et ah,
2003; Jennings et ah, 2005). Several other viruses bind to and inactivate or inhibit
activation of IRF-3; these include rotavirus (Graff et ah, 2002), human papilloma
virus (Ronco et ah, 1998), simian virus 5 (Poole et ah, 2002) and Sendai virus
(Komatsu et ah, 2004). NF-kB, unlike IRF-3, is not specific to IFN induction. It
additionally promotes the expression of inflammatory genes, therefore viruses that
interfere with NF-kB suppress inflammation as well as the IFN response (Karin and
Greten, 2005). NF-kB is downregulated by human herpes virus 8, vIRF-3 protein
inhibits the activation of IkB kinase (3 (Lubyova and Pitha, 2000; Seo et ah, 2004).
Vaccinia virus NIL protein suppresses the expression ofNF-kB by interacting with
IKK and TBK-1 to prevent NF-kB release from IkB in the cytoplasm (DiPerna et ah,
2004). Adenovirus E3 10.4k and 14.5 k proteins suppress assembly of the TNF
receptor signalling complex at the plasma membrane, which also signals through NF-
kB, and decreases the surface levels of TNFR1 (Fessler et ah, 2004). Of particular
interest is the picornavirus mechanism to suppress NF-kB activation. Picornaviruses
intercept NF-kB post-activation; poliovirus, ECHO virus and rhinovirus 3C proteins
cleave the p65-RelA subunit ofNF-kB (Neznanov et ah, 2005). SFV4 nsP2 is also a
protease (Merits et ah, 2001) so it is plausible to suggest that nuclear SFV4nsP2
inhibits NF-kB IFN-(3 promoter binding by cleaving NF-kB.
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SFV has been detected in astrocytes and oligodendrocytes at 183 days post-infection
(Khalili-Shirazi et al., 1988), indicating viral persistence in the brain. The brain is an
immuno-privileged site and therefore ideal for establishing a persistent infection.
Partial suppression of IFN during the early stages of infection would enable SFV to
establish a viraemia in the periphery, which would consequentially lead to neuronal
infections. Other alphaviruses produce persistent infections; Ross River virus (RRV)
induces epidemic polyarthritis, which is a relapsing disease. RRV is known to
enhance macrophage activity, a potential cause of the associated pathology, and
dysregulate CD80, IFN-y and TNF-a signalling, which may facilitate persistence of
RRV infection (Way et al., 2002). The Sindbis virus genome can be detected up until
17 months post-infection in Balb/c mice (Levine and Griffin, 1992), although the
route to persistence and the immune mechanism responsible for infectious virus
clearance has yet to be completely defined.
Summary
Different CNS pathology is observed between virulent and avirulent strains of SFV.
The objectives of this chapter were to determine whether this pathology could be
related to differential expression of IFN. Similar levels of IFN-P transcripts were
induced by both SFV A7(74) and SFV4. However, an SFV4 mutant that had a
defective nuclear localisation signal in the nsP2 protein reproducibly induced higher
levels of IFN-p transcripts and functional IFN than SFV4. Cellular transcriptional
and translational shut-off experiments indicated that the increased gene induction
during an SFV4nsP2RDR infection was specific to IFN-p. This suggests that nsP2 is
an antagonist of IFN-P induction. Preliminary data implied that the underlying
mechanism might involve prevention ofNF-kB binding to the IFN-P promoter.
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Chapter 7: Final Discussion
The Role of Type I Interferon in SFV encephalitis
IFN is a powerful component of the anti-viral innate immune response (Issacs and
Lindenmann, 1957). Mice lacking the IFNAR are unable to respond to IFN and are
highly susceptible to a variety of infections such as vaccinia virus, lymphocytic
choriomeningitis virus, vesicular stomatitis virus, Sindbis virus and SFV (Muller et
ah, 1994; Van den Broek et ah, 1995; Hwang et al., 1995; Ryman et ah, 2000;
Fazakerley et ah, 2002). In the case of SFV, IFNAR7" mice infected ip with SFV4
succumb to a morbid infection within two days whereas wt mice infected with the
same virus survive the infection (Fazakerley et ah, 2002), demonstrating the
importance of IFN in controlling SFV infection.
Recently, research has been heavily focused on delineating the signalling pathways
responsible for IFN gene expression. Several receptors, which detect virus and
ultimately induce IFN-P expression have been described and include TLR-3, PKR,
RIG-I and mda-5 (Yoneyama et ah, 2004; Clemens et ah, 1993; Andrejeva et ah,
2004). TLR-3 detects dsRNA (Alexopoulou et ah, 2001) and is located both within
the endosome and on the surface of some cells. The endosomal and surface location
of this receptor suggests that it may be capable of detecting virus within the
surrounding environment of the cell. The other receptors, PKR, RIG-I and mda-5 also
bind dsRNA but are cytoplasmic and are therefore well placed to detect virus
infection of the cell. The importance ofPKR as a sentinel of infection that induces
IFN-p gene expression is disputed and is dependent upon the infecting virus.
Newcastle disease virus (NDV) induces similar levels of IFN-a and IFN-P transcripts
in both the absence and presence of PKR, in vivo and in vitro (Yang et al., 1995). In
contrast, PKR is required for IFN-P gene expression in reovirus infection of primary
myocyte cardiac cultures (Stewart et al., 2003), EMCV infection ofU-937 cells (Der
and Lau, 1995) and rotavirus infection of intestinal epithelial cells (Vijay-Kumar et
al., 2005). This thesis examined the importance ofPKR for IFN-P gene induction
following an SFV4 infection. The study indicated that PKR is required, but not
critical for IFN-P expression during the early stages of infection (up to 12 hours post-
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infection). Continued IFN-(3 expression in the absence ofPKR demonstrated that
other cellular proteins exist that can detect SFV replication intermediates or virions.
The recently discovered RIG-I or mda-5 CARD-domain containing proteins which
detect dsRNA (Andrejeva et al., 2004) may be responsible for this gene expression.
RIG-I"" cells infected with vesicular stomatitis virus (VSV) have severely impaired
IFN-P responses compared to wt cells (Kato et al., 2005). Further evidence to support
the importance of RIG-I for IFN expression was found during HCV infection. HCV
antagonises RIG-I signalling, the HCV NS3-4A protease cleaves the RIG-I adaptor
protein IPS-1 (Foy et al., 2005). In contrast to RIG-I, mda-5 and TLR-3, PKR has not
been associated with IRF-3 activation, a transcription factor required for IFN-P
expression. This may further suggest that PKR only plays a minor role in IFN-P
expression. It would be of interest to investigate the importance ofRIG-I for IFN-P
induction in SFV infection and hence determine which cellular protein is responsible
for IFN-P induction in SFV infection. This may also provide further insight into SFV
biology with regards to the location of the dsRNA binding protein.
Intriguingly, despite the requirement ofPKR for complete IFN-p expression, the
absence ofPKR had no effect upon the level of SFV4 replication. In both wt and
PKR0/0 cells the levels of virus RNA detected were similar at all three time points (4,
8 and 12 hours post-infection). In other virus infections, for example Bunyamwera
virus (Streitenfeld et al., 2003), VSV and influenza virus (Balachandran et al., 2000)
virulence is increased and where measured, virus titres are slightly higher in the
absence ofPKR. It would be expected that since PKR enhances IFN-P gene
expression, absence of PKR could allow greater virus replication. Additionally, PKR
induces host cell translation shut-off; continued cellular translation should also enable
more virus replication. However, in SFV4 infection the levels of virus transcripts
remain constant in the two cell types, implying that SFV4 replication is not affected
by PKR at early time points. PKRo/0 mice infected with SFV or Sindbis virus, a close
relative of SFV, do not demonstrate an increase in morbidity or mortality in
comparison to wt mice (Fazakerley, unpublished; Ryman et al., 2002). Although, at
around 6 days post infection virus titres are higher in PKR 0/0 mice implying that the
anti-viral effects of PKR are most effective during the later stages of infection
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(Fazakerley, unpublished; Ryman et al., 2002). Further evidence implying that PKR
does not affect SFV is found during Sindbis virus infection, where only a minor role
is attributed to PKR for the induction of host translation shut-off (Gorchakov et ah,
2004). A possible explanation for the minor affects of PKR on SFV and Sindbis virus
infections is that SFV and Sindbis virus may possess resistance to PKR. Recently, a
highly stable hairpin loop downstream of the translation start site of Sindbis virus
26 S mRNA has been implicated in resistance to PKR phosphorylation of eIF-2a
(Ventoso et al., 2006). This structure stalls the ribosome at the correct start site
enabling translation to bypass the requirement of an initiation complex. In other virus
infections resistance to PKR is a common feature of virus antagonism of the IFN
response. For example, HSV ICPy34.5 gene product recruits a cellular phosphatase to
dephosphorylate and hence inactivate PKR (He et al., 1997); adenovirus VA RNAs
associate with the dsRBM ofPKR and prevent its activation (Kitajewski et al., 1986);
influenza virus NS1 protein antagonises dsRNA binding to PKR by sequestering
dsRNA within the nucleus (Lu et al., 1995); HCV NS5A protein binds to and
inactivates PKR (Gale et al., 1997) and the HIV transactivator protein (Tat) is an
inhibitor of PKR expression (Roy et ah, 1990; Agy et al., 1990). In conclusion, whilst
PKR is an important cellular defence mechanism against viral infections, through the
induction of IFN-P and activation of host translation shut-off, as demonstrated by the
multitude of viruses that encoded PKR antagonists, it does not affect SFV replication.
Possible strategies of SFV resistance to PKR are not known and further investigations
into this area would be an interesting extension of this study.
SFV strains can be divided into two types, virulent and avirulent. Virulent strains
induce a panencephalitis in both neonatal and adult mice, whereas an interesting
consequence of avirulent strains is age-dependent pathology. Avirulent strains only
induce panencephalitis in neonates infected up until 12 days of age. Adult mice
infected with an avirulent strain of SFV develop a restricted CNS infection
(Fazakerley et al., 1993). One possible explanation for this age-dependent pathology
is that immature CNS cells have an impaired ability to induce IFN. IFN is one of the
first responses to virus infection; if immature CNS cells were impaired in their ability
to produce IFN, this could contribute to a more extensive infection that leads to
increased pathology that is observed in neonates. Some evidence exists to support
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this theory, differential levels of IFN expression have been demonstrated in NDV or
Sendai virus infected neonatal umbilical cord blood mononuclear cells and human
adult mononuclear cells (Neustock et ah, 1993). However, gene array analysis of
Sindbis virus infected adult and neonatal mouse brains demonstrates that neonates
produce high levels of inflammatory genes transcripts, including IFN transcripts.
This study also showed that a single gene product was found to be upregulated in
adult mice compared to neonatal mice, ISG 12, and over expression of this protein
extended the survival of Sindbis virus infected neonates (Labrada et ah, 2002). As
both young and older mice induce high levels of IFN transcripts, this suggests that
ISG 12 may be controlled by another factor which is not expressed in neonates.
In the present study, SFV4 infection of neonate and adult mouse brains demonstrated
that functional IFN in addition to IFN-P and IFN-a transcripts could be detected and
that the main driving force in the production of IFN was the level of virus RNA. This
demonstrates that the neonate brain is not impaired in its ability to induce IFN.
IFN is unlikely to be the major determinant of age-dependent pathology of avirulent
SFV infections and therefore other factors must contribute to this pathology. Possible
explanations include: i) that avirulent virus is unable to spread in the adult mouse
brain due to structural differences between the adult and neonatal mouse brains, ii)
that neonate neurones are more susceptible to apoptosis than adult neurones, iii) that
the adult immune system can control the avirulent infection whereas the neonatal
immune response is impaired. Taking each point in turn, up until 12 days post
partum, neonates are still developing their synaptic connections (reviewed by
Fazakerley JK, 2001), this includes neuronal synaptogenesis and differentiation,
which involves a significant amount of smooth membrane vesicle production
(reviewed by Fazakerley, 2001). Evidence suggests that increased smooth
membrance production is important for SFV replication as SFV A7(74) infection of
mice pre-treated with aurothiolates (gold containing compounds) results in wide
spread infection and high virus titres (Scallan and Fazakerley, 1999). These
observations were not due to toxic effects of the aurothiolates resulting in neuronal
death. It seems that the aurothiolates alter neuronal physiology to increase smooth
membrane proliferation which allows virus replication (Mehta et ah, 1990).
Additionally, in the adult brain, the rostral migratory stream, which is an area of the
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brain where neurones are constantly being replaced and differentiating is permissive
to infection with avirulent strains (Sammin et ah, 1999). This suggests that CNS
metabolic differences play a role in the age-dependent pathology of avirulent SFV
strains. Immature neurones are highly susceptible to apoptosis; a mechanism used to
remove incorrect or weak synapses in the developing CNS. As the brain matures
around the age of 12 days, neurones become more resistant to apoptosis (Scallan et
ah, 1997). Potentially avirulent strains can spread throughout the neonatal mouse
brain by inducing neuronal apoptosis. Programmed cell death is normally associated
with preventing virus spread; however, there are examples of viruses that exploit this
mechanism, such as influenza virus. Influenza virus triggers apoptosis through
induction of Fas ligand. Blocking Fas expression reduces the spread of the infection
(Wurzer et ah, 2004). At present nothing is known about the relationship between the
spread of SFV infection and apoptosis, demonstrating that further investigations into
this area are required. An alternative explanation is that the adult CNS immune
response can control the avirulent infection whereas the neonate CNS immune
response is impaired. The maturity of the adaptive immune response has a significant
role in protection against virus infections. For example, respiratory syncytial virus
(RSV) causes more severe infections in animals less than 6 months old. A
comparison of infections between young and older calves demonstrated that the older
calves express higher numbers of mononuclear cells, B cells and bovine RSV-specific
IgA and IgG responses (Grell et ah, 2005). HSV infected neonates are impaired in
their ability to activate CD8 T cells and demonstrate reduced CTL effector functions
in comparison to adults (Evans and Jones, 2005). A similar pathology was observed
in Hantavirus infected neonates; 3-day-old mice infected with Hantavirus have
reduced numbers of IFN-y producing CD8 T cells compared to adults (Araki et ah,
2004). In CMV infection of young children, it was the levels of IFN-y producing
CD4 T cells that were reduced in comparison to adults (Tu et ah, 2004). However,
during SFV infection adult SCID mice, lacking functional B and T cell responses,
show a similar restricted infection to wt adults (Amor et ah, 1996) indicating that viral
spread is not controlled by the adaptive immune response.
In the adult mouse brain it is possible that virulent strains are able to overcome the
CNS immune responses whereas the avirulent strains are not. To date, none of the
SFV proteins have been assigned a role for interference of the host immune responses.
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However, several pieces of data imply that the nsP2 of SFV and Sindbis virus can
interfere with IFN expression (Frolova et al., 2002; Fazakerley et al, 2002). NsP2
possesses ATPase, GTPase, RNA triphosphatase and RNA helicase activities
(Rikkonen et al., 1994a; Gomez de Cedron et al., 1999). It is involved in terminating
negative strand production, controlling subgenomic RNA synthesis and cleaving the
non-structural polyprotein (Suopanki et al., 1998; Merits et al., 2001). Approximately
50 % of nsP2 is targeted to the nucleus (Rikkonen et al., 1992; 1994b). An nsP2
mutant, SFV4nsP2RDR demonstrated that the nuclear localisation signal (NLS) of
nsP2 was not essential for viral replication but was a determinant of neurovirulence
(Fazakerley et al., 2002; Rikkonen, 1996). Mice inoculated ic with SFV4nsP2RDR
survived whereas those infected with SFV4 died and demonstrated higher brain virus
titres than those infected with the mutant virus. To determine the role of the IFN
response in this pathology, both viruses were inoculated into IFNAR"7" mice; all mice
succumbed to infection regardless of the inoculating strain and produced similar virus
titres (Fazakerley et al., 2002). Potentially, the ability of SFV4nsP2RDR to replicate
in vivo is reduced and this slower replication allows time for control by the IFN
response. Alternatively, SFV4 downregulates the IFN response, or is not susceptible
to it, whereas SFV4nsP2RDR cannot suppress the response or is susceptible to it.
Research with Sindbis virus (SV) indicates that mutating the nsP2 P726 residue,
conserved throughout the alphaviruses, suppresses cytopathic effect and increases IFN
production (Frolova et al., 2002). In the present study, SFV4 was compared to
SFV4nsP2RDR to determine the ability of either strain to induce IFN-P transcripts
and functional IFN in vitro, where they are known to replicate at similar rates
(Fazakerley et al., 2002). In comparison to SFV4, SFV4nsP2RDR reproducibly
induced higher levels of IFN-P transcripts and functional IFN per copy of virus RNA
or per unit of infectious virus. Transcription and translation shut-off experiments
indicated that this increase in gene expression was specific to IFN-p. IFN-P gene
expression is regulated by several transcription factors, including NF-kB and IRF-3.
Both are maintained in an inactive state within the cytoplasm and can only translocate
to the nucleus when activated upon cell detection of virus infection. Many viruses
prevent IRF-3 and NF-kB nuclear accumulation. For example, the VP35 protein of
Ebola virus (Basler et al., 2003), NS3/4A ofHepatitis C virus (Foy et al., 2003) and
the NS1/NS2 complex of respiratory syncytial virus (Bossert et al., 2003) all prevent
178
Final Discussion
IRF-3 phosphorylation and hence dimerisation, reducing IRF-3 nuclear accumulation.
Herpes simplex virus 1 also prevents nuclear accumulation of IRF-3 through its ICPO
protein (Melroe et ah, 2004). NF-kB is downregulated by human herpes virus 8
vIRF-3 protein, which inhibits the activation of IkB kinase p subunit (Lubyova and
Pitha, 2000; Seo et ah, 2004). Vaccinia virus NIL protein suppresses the expression
ofNF-kB by interacting with IKK and TBK-1 to prevent NF-kB release from IkB in
the cytoplasm (DiPerna et ah, 2004). The A238L gene product of African swine fever
virus acts as an IkB homologue and prevents NF-kB activation after virus infection
(Powell at ah, 1996; Revilla et ah, 1998). During SFV4 and SFV4nsP2RDR infection
both NF-kB and IRF-3 were observed to accumulate in the nucleus. The proportion
ofNF-kB or IRF-3 in the nucleus following infection was not established for either
virus; however, this data implies that SFV4 suppression of IFN-P gene expression
acts after the transcription factors have entered the nucleus. Other viruses also
interfere with IFN-P gene expression after transcription factor nuclear translocation.
For example, the ML protein of Thogoto virus interferes with IRF-3 dimerisation and
IRF-3 recruitment of CBP (Hagmaier et al., 2003; Jennings et ah, 2004) and
picornavirus (poliovirus, ECHO virus and rhinovirus) 3C proteins cleave the p65-
RelA subunit ofNF-kB post-activation (Neznanov et al., 2005). In the present study,
preliminary EMSA data suggested that nsP2 reduced NF-kB binding to its positive
regulatory domain within the IFN-P promoter. SFV4 nsP2 is a protease (Merits et al.,
2001) so it is plausible to suggest that like the picornaviruses, nuclear SFV4 nsP2
inhibits NF-kB IFN-P promoter binding by cleaving NF-kB. However, further
investigations are required to clarify the mechanism of SFV4 nsP2 NF-kB
interference.
Recent investigations have provided further data to support the role of SFV4 nsP2 in
NF-kB antagonism. TNF-a is a cytokine whose expression is regulated by NF-kB
(reviewed in Ware, 2005). SFV4nsP2RDR was shown to induce higher levels of
TNF-a in comparison to SFV4, suggesting that nuclear nsP2 is required to
downregulate TNF-a expression (Pia Dosenovic, Karolinska Institutet, unpublished
data). This result provides another link between nsP2 and NF-kB. There is some
evidence that another alphavirus, Ross River virus (RRV), also reduces the mRNA
levels ofTNF-a, alongside other pro-inflammatory cytokines in RRV antibody
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dependent enhanced (ADE) infection of macrophages stimulated with LPS. The
suppression of transcript levels correlated with a reduction in the nuclear levels of
several transcription factors including NF-kB (Mahalingam and Lidbury, 2002).
However, in this study due to the complexities of the infection model, the authors
could not distinguish between the affects ofRRV and ADE infection upon NF-kB.
A side issue of this study demonstrated that high levels of IL-10 are expressed by
macrophages during a RRV infection (Mahalingam and Lidbury, 2002). IL-10 is an
immuno-suppressive cytokine that can inhibit the production of IFN-y, TNF-a and
IL-12 and importantly suppresses NF-kB activation (Moore et al., 2001). In an SFV
infection the role of IL-10 is not yet known. One way by which NF-kB is repressed
during an SFV infection could be by IL-10, although, IL-10 is not produced
immediately and is more associated with the adaptive immune response.
This thesis has discovered intriguing features of the relationship between IFN and
SFV. The studies described, showed that both neonatal and adult mouse brains
express IFN during an SFV infection, that PKR is required but is not critical for IFN-
P induction and that a virulent strain of SFV suppresses IFN-P expression putatively
through regulation ofNF-kB gene induction. These results have opened up further
questions such as, during an SFV infection which cellular proteins are responsible for
IFN-P induction if not PKR and how SFV4 regulates NF-kB gene induction, which
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